AIIMS Directory
of Projects
Project Browser:
- All current Research Projects and Principal Investigators are listed here.
- Search by keywords, topics, funding agencies, researcher name to find research areas and collaborators.
| Name | Project Title | Funding | ||||
|---|---|---|---|---|---|---|
| N-2436 | Dr. Gautam Sharma | Center for Integrative Medicine and Research (CIMR) | 1/9/2023 | 31-08-28 | All India Institute of Medical Sciences (AIIMS) | Government |
| AY-2371 | DR. RIMA DADA | Impact of yoga based lifestyle intervention on polycystic ovarian syndrome (PCOS) - reg | 10/8/2023 | 9/8/2026 | AYUSH, Ministry of Health and Family Welfare | AYUSH |
| T-323 | Dr. Sachit Anand | SARANSH Systematic Reviews and Networking Support in Health)” | 27-05-24 | 26-05-25 | AYUSH, Ministry of Health and Family Welfare | AYUSH |
| N-2486 | Dr. Sudip Sen | Evaluating the potential role of Homoeopathic medicines in a cellular model of cerebral palsy in vitro | 29-08-24 | 28-08-26 | AYUSH, Ministry of Health and Family Welfare | AYUSH |
| BG-001 | DR. DEEPAK AGRAWAL | Development of Bio Resorbable Cranial Implants for Neurosurgical Cranioplasty Procedure across Institutes of National Importance | 18-05-23 | 1/3/2025 | Biotechnology Industry Research Assistance Council (BIRAC) | BIRAC |
| N-2391 | Dr. Ashima Nehra Wadhwan | Extension and Digitalization of Indian Aphasia Battery (IAB) | 15-12-23 | 14-12-25 | Biotechnology Industry Research Assistance Council (BIRAC) | BIRAC |
| N-2413 | Dr. Anju Singh | Validation study of indigenous HPV tests for cervical cancer screening (i-HPV) | 22-01-24 | 21-06-25 | Biotechnology Industry Research Assistance Council (BIRAC) | BIRAC |
| BG-002 | Dr. Pragyan Acharya | A point-of-care acute kidney injury predictor for patients with acute-on-chronic liver failure | 23-01-24 | 22-07-25 | Biotechnology Industry Research Assistance Council (BIRAC) | BIRAC |
| BG-003 | DR. ALOK THAKAR | Minimally Invasive Nano-Enabled Targeted Technology for Sentinel Lymph Node (SLN) Detection in Head-Neck Cancer | 28-03-24 | 27-09-25 | Biotechnology Industry Research Assistance Council (BIRAC) | BIRAC |
| BG-005 | DR. VINEET AHUJA | Development of an encapsulated cocktail of gut microbiota-derived metabolites as a potential therapeutic modality for ulcerativecolitis | 28-05-24 | 27-11-25 | Biotechnology Industry Research Assistance Council (BIRAC) | BIRAC |
| BG-004 | DR. VINEET AHUJA | A point of care assay for detection of drug levels and anti-drug antibodies for therapeutic drug monitoring of biologics used for treatment of inflammatory bowel disease | 10/6/2024 | 9/12/2025 | Biotechnology Industry Research Assistance Council (BIRAC) | BIRAC |
| N-2503 | Dr. Pratik Kumar | Development of environment -friendly polymer gel bolus with anti-microbial properties for the radiation treatment of cancer patients. | 11/10/2024 | 10/10/2026 | Biotechnology Industry Research Assistance Council (BIRAC) | BIRAC |
| N2181 | DR. ALOK THAKAR | Centre for medical innovation and entrepreneurship (CMIE) | 25-05-21 | 24-05-26 | BIRAC & AIIMS, New Delhi | BIRAC |
| N-2332 | DR. R.K. CHADDA | BSF-AIIMS Tele-Counseling Helpline Project | 1/4/2023 | 31-03-25 | Border Security Force (BSF) | Government |
| N2055 | Dr. Ram Kishor Sah | Traditional Uses of Kachnar ( Bauhinia variegate) for Human and Nutrition: An Epidemiological Study in Tribal Districts of Jharkhand , India | 11/2/2020 | 2/2/2025 | Central Coalfields Limited (CCL) | Government |
| N2056 | Dr. Ram Kishor Sah | TO Evaluate the Relationshiop of Burning Fuel wood and Biomass Cooking on Human eyes, Cardiac Chronic Illnesses and Mental Health of native Tribal communities of Jharkhand, India | 11/2/2020 | 2/2/2025 | Central Coalfields Limited (CCL) | Government |
| N-2339 | Dr. Puneet Misra | An exploratory series of n of 1 responder restricted study of Ayurveda regimen on quality of life among elderly population in Ballabhgarh district of Haryana-A community based study | 15-05-23 | 14-05-26 | Central Council for Research in Ayurvedic Science (CCRAS) | AYUSH |
| N-2421 | DR. D.S.ARYA | fellowship | 1/2/2024 | 31-01-26 | Central Council for Research in Ayurvedic Science (CCRAS) | AYUSH |
| N-2458 | Dr. Jasbir Kaur | Neuroprotective effect of medicinal plants of Ayurveda in glaucome - an in vitro mechanistic study | 1/6/2024 | 31-05-26 | Central Council for Research in Ayurvedic Science (CCRAS) | AYUSH |
| N-2445 | Dr. Manoj Kumar Sahu | A randomized placebo control study to evaluate the effect of AYUSH SR as adjunct to usual care for cardiac rehabilitation on biochemical, physical and psychological parameters, in adult patients who underwent Coronary Artery Bypass | 1/7/2024 | 30-06-27 | Central Council for Research in Ayurvedic Science (CCRAS) | AYUSH |
| N2290 | Dr. Rupesh K. Srivastava | To investigate the bone protective potential of selected homeopathic formulations (SHFs) in osteoporotic conditions | 23-09-22 | 22-09-25 | Central Council for Research in Homoeopathy (CCRH) | AYUSH |
| N-2346 | Dr. Sudhir Chandra Sarangi | Effect of homeopathic based drug formulation on epileptogenesis and its interaction with antiepileptic drugs: A study in experimental model of epilepsy and associated post-ictal depression in rats. | 15-06-23 | 14-06-26 | Central Council for Research in Homoeopathy (CCRH) | AYUSH |
| N-2347 | DR. Sushma Bhatnagar | Homoeopathic treatment as an add-on therapy for Pain Management in Cancer Patients: A Prospective, Randomized, Exploratory study | 1/7/2023 | 30-06-25 | Central Council for Research in Homoeopathy (CCRH) | AYUSH |
| N-2435 | Dr. Sudhir Chandra Sarangi | Toxicity studies of Homeopathic drugs | 10/10/2024 | 9/10/2026 | Central Council for Research in Homoeopathy (CCRH) | AYUSH |
| N2318 | Dr. Pooja Gupta | Chemotherapeutic effect of a selected Unani Medicine in xenograft mouse model of lung cancer | 1/2/2023 | 31-01-26 | Central Council for Research in Unani Medicine (CCRUM) | AYUSH |
| N-2367 | Dr. Arvind Kumar Kairo | Local application of specific Unani drug for medical management of Oral submucous fibrosis (OSF): A randomized conrolled clinical trial | 1/8/2023 | 31-07-26 | Central Council for Research in Unani Medicine (CCRUM) | AYUSH |
| N-2511 | Dr. Sudhir Chandra Sarangi | Evaluation of safety and efficacy of Unani Pharmacopieial formulation(s) (Khamira-i-Gazaban AmbariJadwar Odd Salib Wala and Majon-e-Najah as a thereputic aduvant to antiepileptic frugs in drug resistant epilepsy | 10/10/2024 | 9/10/2026 | Central Council for Research in Unani Medicine (CCRUM) | AYUSH |
| N2329 | Dr. Piyush Ranjan | A randomized controlled trial of six months of yoga based Comprehensive Treatment Module vs. Standard Therapy in improving severity of symptoms, Disability and Quality of life in patients with Medically Unexplained Physical Symptoms | 28-03-23 | 27-09-25 | Central Council for Research in Yoga And Naturopathy (CCRYN) | AYUSH |
| N-2418-CSR | Dr. Nand Kumar | Speech Marker to Detect Depression in Community | 10/2/2024 | 9/8/2026 | Coal India Limited | Government |
| T096 | DR. RAVINDER GOSWAMI | 1/1/2014 | 1/1/2028 | Council of Scientific and Industrial Research (CSIR) | CSIR | |
| N-2431 | Dr. J.S.Titiyal | A study of demographic, familial, biomechanical & genetic pattern of keratoconus patients in a hospital based Indian population | 1/4/2024 | 31-03-27 | Council of Scientific and Industrial Research (CSIR) | CSIR |
| N-2510 | DR. SURABHI GUPTA | Effect of Antidepressant Drugs on Placental Functions. | 1/11/2024 | 31-10-27 | Council of Scientific and Industrial Research (CSIR) | CSIR |
| N-2427 | Dr. T. Velpandian | Potential Anti-angiogenic Role of Azirines in Ocular Neovascular Conditions | 1/3/2024 | 28-02-26 | CSIR-Central Drug Research Institute (CDRI) | Government |
| DR2238 | Dr. Suriya Prakash M | Wearable soft robotics for upper limb muscle power augmentation with BMI interface | 17-12-21 | 16-12-25 | Defence Research and Development Organisation (DRDO) | DRDO |
| DR2286 | Dr. Bhavuk Garg | Biomechanical study on the efficacy of rehabilitation for subjects with trauma-induced gait impairment | 7/9/2022 | 15-11-25 | Defence Research and Development Organisation (DRDO) | DRDO |
| N935 | Dr. Sandeep Singh | Stanford India biodesign SiB programme | 3/7/2007 | 31-12-28 | Department of Biotechnology (DBT) | DBT |
| N1481 | DR. Achal Kumar Srivastava | A population based prospective cohort study to unravel the causes of stroke and cognitive decline: A cross-cultural perspective | 14-02-14 | 13-08-25 | Department of Biotechnology (DBT) | DBT |
| BT-1481A | DR. Achal Kumar Srivastava | Site-2 CRHSP, Ballabhgarh, Unravelling the causes of stroke and cognitive decline in general population: A cross-cultural perspective. | 14-06-16 | 13-08-25 | Department of Biotechnology (DBT) | DBT |
| BT-2011 | DR. Manjari Tripathi | Dementia Science Programme: Incidence/Prevalence/Risk/Intervention analysis of dementia and basic research thereof | 19-07-19 | 17-06-25 | Department of Biotechnology (DBT) | DBT |
| BT-2124 | DR. D.K.MITRA | STriTuVaD In Silico Trial for Tuberculosis Vaccine Development | 30-12-20 | 31-05-25 | Department of Biotechnology (DBT) | DBT |
| BT-2179 | Dr. M. Jeeva Sankar | Sepsis-related mortality in neonates in India: A multidisciplinary, multi-institutional research program for context-specific solutions. | 9/3/2021 | 8/3/2026 | Department of Biotechnology (DBT) | DBT |
| BT-2171 | Dr. kajal Jain | Identification of potential pathogen(s) among neonates with culture-negative sepsis | 9/3/2021 | 8/3/2026 | Department of Biotechnology (DBT) | DBT |
| BT-2177 | DR. VAISHALI SURI | To analyze the molecular profile of pediatirc gliomas and establish robust and economical methods for molecular subgrouping and risk stratification. | 25-03-21 | 28-02-25 | Department of Biotechnology (DBT) | DBT |
| BT-2180 | Dr. Archna Singh | Understanding Inter Compartmental Crosstalk between Insulin- sensitive and insulin- resistant obese and non-obese phenotypes using Adipose Tissue | 4/8/2021 | 31-03-25 | Department of Biotechnology (DBT) | DBT |
| BT-2182 | Dr. Sachin Kumar | Elucidation of the role of long noncoding RNA-Ginir as a biomarker in lung tumorigenesis | 19-08-21 | 18-08-25 | Department of Biotechnology (DBT) | DBT |
| BT-2185 | Dr. Subhash Chandra Yadav | Cryo-Electron Microscope Imaging facility for biological specimens (Cells and Tissue) | 27-08-21 | 26-08-26 | Department of Biotechnology (DBT) | DBT |
| BT-2176 | Dr. Vineet Choudhary | Deciphering the functions of the conserved fat storage-inducing transmembrane(FITM2) protein in lipodystrophy and insulin resistance through systems approaches | 1/9/2021 | 31-08-25 | Department of Biotechnology (DBT) | DBT |
| BT-2187 | Dr. Mayank Singh | Development of BCMA based Chimeric antigenic receptor T (CAR T) cell in Multiple myeloma (MM). | 16-09-21 | 15-03-25 | Department of Biotechnology (DBT) | DBT |
| N2239 | Dr. Avinash Kumar | Mechanism of hyperammonemia induced skeletal muscles mitochondrial dysfunction: Therapeutic opportunity | 21-10-21 | 20-10-26 | Department of Biotechnology (DBT) | DBT |
| BT-2189 | Dr. Rupesh K. Srivastava | “To elucidate the immunomodulatory role of probiotics in modulating bone health in post-menopausal osteoporosis via its effect on ILC3-ILCreg cell axis” | 29-12-21 | 28-03-25 | Department of Biotechnology (DBT) | DBT |
| BT-2191 | Dr. Ashutosh Halder | An investigation on underlying mechanism of PCOS in association with endocrine disrupting chemicals (Bisphenol A and advanced Glycation End products | 15-02-22 | 14-02-25 | Department of Biotechnology (DBT) | DBT |
| BT-2193 | Dr. Subhradip Karmarkar | To investigate the Role of Peroxisome Proliferator- Activated Receptor Gamma in Human Placental Development and Preeclampsia | 15-02-22 | 14-03-25 | Department of Biotechnology (DBT) | DBT |
| BT-2196 | DR. NEERJA GUPTA | Mission Program on Pediatric Rare Genetic Disorders. | 30-03-22 | 29-03-27 | Department of Biotechnology (DBT) | DBT |
| BT-2195 | DR. SUJATA MOHANTY | To Investigate the Role of human Mesenchymal Stem Cell Derived Exosomes as a Cell Free Therapeutic Approach for amelioration of symptoms of Autism Spectrum Disorders | 29-06-22 | 28-06-25 | Department of Biotechnology (DBT) | DBT |
| N-2417 | Dr. Vikram Saini | Understanding the molecular programs that regulate germs cells development | 7/9/2022 | 6/9/2027 | Department of Biotechnology (DBT) | DBT |
| BT-2199 | Dr. Sandeep Bhoriwal | Determining the mechanism and consequences of inter-regulation between two tumor suppressors: p53 and BLM helicase | 18-10-22 | 17-10-25 | Department of Biotechnology (DBT) | DBT |
| BT-2203 | DR. SHEFFALI GULATI | Role of Artificial Intelligence (AI) In Autism Spectrum Disorder | 30-01-23 | 29-01-25 | Department of Biotechnology (DBT) | DBT |
| BT-2198 | DR. SAMEER BAKHSHI | Molecular and Pharmacogenetic marker evaluation in relation to the toxicity and clinical response of acute lymphoblastic leukemia treatment in Indian children (MPGx- INDALL) | 8/2/2023 | 7/2/2027 | Department of Biotechnology (DBT) | DBT |
| BT-2208 | DR. ARUNDHATI SHARMA | National Networking program for artificial intelligence based methods for healthcare data | 16-03-23 | 15-03-28 | Department of Biotechnology (DBT) | DBT |
| BT-2207 | DR. VINEET AHUJA | Studying the mechanism of Rab 7 based regulation of Goblet cell function in ulcerative colitis | 29-03-23 | 28-03-26 | Department of Biotechnology (DBT) | DBT |
| BT-2209 | Dr. Chittaranjan Behera | Geome wide DNA methylation profiling to study role of epigenetic modification in suicide completers in Indian population | 1/9/2023 | 31-08-26 | Department of Biotechnology (DBT) | DBT |
| BT-2211 | Dr. Ashok Sharma | a pilot study evaluating role of Homoeopathic medicine in Cancer patients as adjuvant treatment to chemotherapy/ radiotherapy, and correlating with Molecular Profiling | 2/9/2023 | 1/9/2026 | Department of Biotechnology (DBT) | DBT |
| BT-2206-A | Dr. Prasenjit Das | Department of Biotechnology Consortium on Celia Disease- Development and Characterization of Enteroids from human small intestinal biopsies | 4/9/2023 | 3/9/2026 | Department of Biotechnology (DBT) | DBT |
| BT-2206 | DR. GOVIND K MAKHARIA | Department of Biotechnology Consortium On Celiac Disease- Extension and Nurturing of national biorepository of well-defined patients with celiac disease. | 4/9/2023 | 3/9/2028 | Department of Biotechnology (DBT) | DBT |
| BT-2217 | Dr. Sarita Mohapatra | Platform for discovery of novel therapeutic monoclonal antibodies against MDR and XDR Klebsiella pneumoniae | 13-09-23 | 12/9/2026 | Department of Biotechnology (DBT) | DBT |
| BT-2197 | DR. KALPANA LUTHRA | Development of therapeutic broadly neutralizing monoclonal antibodies against circulating HIV-1 clade C in children and adults. | 18-09-23 | 17-09-26 | Department of Biotechnology (DBT) | DBT |
| BT-2212 | Dr. Krishna K Inampudi | Connecting pathogenesis to Calcium signallings in protozoan parasite E.histolytica | 19-09-23 | 18-09-26 | Department of Biotechnology (DBT) | DBT |
| BT-2213 | Dr. Pradeep Sharma | National Network Project of Department of Biotechnology, Indian Institute of Technology, Roorkee | 20-09-23 | 19-09-28 | Department of Biotechnology (DBT) | DBT |
| BT-2200 | Dr. Shilpa Sharma | Forming Standard Operating Procedures for Safe Pediatric Thoracoscopy and Laparoscopy Surgery in Rabbits) | 26-09-23 | 25-09-26 | Department of Biotechnology (DBT) | DBT |
| N-2411 | Dr. T. Velpandian | Ocular hypotensive effect of ricinoleic acid in glaucoma: an alternative therapy” | 11/12/2023 | 10/12/2026 | Department of Biotechnology (DBT) | DBT |
| BT-2214 | Dr. Jyotirmoy Banerjee | Calcium permeable ion channels as therapeutic targets to manage neuropathic pain | 28-12-23 | 27-12-26 | Department of Biotechnology (DBT) | DBT |
| BT-1/BIOCARE | DR. S.SENTHIL KUMARAN | Biocare women scientist fellowship | 10/1/2024 | 9/1/2027 | Department of Biotechnology (DBT) | DBT |
| BT-2/BIOCARE | DR. SUJATA MOHANTY | fellowship | 18-03-24 | 17-03-27 | Department of Biotechnology (DBT) | DBT |
| T-315 | DR. SHEFFALI GULATI | Janaki Ammal-National Women Bioscientist Award-2023 (Senior Category). The title of the project is “Aligning artificial intelligence for de novo screening and diagnostic tools in childhood Neurodevelopmental disorders and linking it with specific therapeutic intervention plans: The reflection ahead” | 26-03-24 | 25-03-25 | Department of Biotechnology (DBT) | DBT |
| BT-2216 | Dr. Saurabh Mittal | N-acetyl cysteine therapy in patients with pulmonary tuberculosis: A Pilot Open-Label Randomized controlled trial | 15-04-24 | 14-04-26 | Department of Biotechnology (DBT) | DBT |
| BT-2219 | Dr. Sudip Kumar Datta | Development of a SERS based portable device for detection of urinary and salivary cotinine to monitor the compliance towards tobacco abstinence | 20-05-24 | 19-05-27 | Department of Biotechnology (DBT) | DBT |
| BT-2220 | DR. RAVINDER GOSWAMI | Utility of low glycaemic index of rice in the management of type 2 diabetes: randomized cross-over trial on glycemic control, related parameters and quality of life | 13-06-24 | 12/6/2028 | Department of Biotechnology (DBT) | DBT |
| BT-2221 | DR. Uddipan Das | Structural Insights into Mycobacterium tuberculosis Multidrug Transporter | 21-06-24 | 20-06-27 | Department of Biotechnology (DBT) | DBT |
| BT-2222/20 | DR. GOVIND K MAKHARIA | Fluorescent Sensors for the detection of citrulline in the plasma of patients with celiac disease and other enteropathies Aiding biopsy free diagnosis follow-up monitoring of the disease: Molecular Design and Synthesis of Chemoselective Glyoxal Probes. | 30-07-24 | 29-01-25 | Department of Biotechnology (DBT) | DBT |
| BT-2222 | DR. GOVIND K MAKHARIA | Fluorescent Sensors for the detection of citrulline in the plasma of patients with celiac disease and other enteropathies Aiding biopsy free diagnosis follow-up monitoring of the disease: Molecular Design and Synthesis of Chemoselective Glyoxal Probes. | 30-07-24 | 29-01-25 | Department of Biotechnology (DBT) | DBT |
| BT-2223 | Dr. Jyotirmoy Banerjee | Deciphering the contribution of proestrous-estrous transition to seizure susceptibility in drug resistant epilepsy pathologies | 17-09-24 | 16-09-27 | Department of Biotechnology (DBT) | DBT |
| BT-2224 | DR. VANDANA JAIN | Assessing the genesis of the 'thin fat' Asian Indian phenotype: A longitudinal study on body composition,and metabolomics profile in children born preterm or small for gestational age. | 18-09-24 | 17-09-27 | Department of Biotechnology (DBT) | DBT |
| BT-2227 | Dr. Yashdeep Gupta | Role of extracelluar vesicles in lipid metabolism and development of diabetes in women with prior gestational diabetes. | 25-09-24 | 24-09-27 | Department of Biotechnology (DBT) | DBT |
| BT-2225 | Dr. Mona Sharma | Role of Mitochondria-Endoplasmic Reticulam Cross-Talk in Follicular Dynamics in Premature Ovarian Insufficiency | 30-09-24 | 29-09-27 | Department of Biotechnology (DBT) | DBT |
| BT-2226 | DR. Manjari Tripathi | Role of non-coding RNAs(ncRNAs) in clinicopathological classification and molecular perturbances associated with Focal Cortical Dysplasia(FCD) | 29-10-24 | 28-10-27 | Department of Biotechnology (DBT) | DBT |
| I1066 | Dr. Aashish Choudhary | Regional Viral Research and Diagnostic Laboratory (RVRDL). | 1/4/2019 | 31-03-26 | Department of Health Research (DHR) | DHR |
| I1180 | Dr. Chitra Sarkar | Establishment of DHR-ICMR Advance Medical Oncology Diagnostic Services (DIAMOnDS) | 5/2/2020 | 31-03-26 | Department of Health Research (DHR) | DHR |
| I1200 | DR. ASHISH SURI | Material characterization of brain tissue and development of tissue-device interaction based neurosurgical simulation tool. | 1/10/2020 | 31-03-25 | Department of Health Research (DHR) | DHR |
| DHR-1352 | DR. Manjari Tripathi | A case-control study to investigate gut microbioda dysbioisis in drug-refractory epilepsy patients using whole-metagenomic shotgun sequencing | 15-12-21 | 15-06-25 | Department of Health Research (DHR) | DHR |
| DHR-1368 | Dr. Biswaroop Chakrabarty | Developing models based on biomarker and clinicoelectroencephalographic parameters to predict severity and outcome in pediatric status epilepticus: a longitudinal observational study | 15-01-22 | 14-10-25 | Department of Health Research (DHR) | DHR |
| DHR-1329 | Dr. Deepshi Thakral | Identification and characterisation of plasma-derived cell free nucleic acid based markers for early detection and monitoring of replace in AML | 31-01-22 | 30-01-25 | Department of Health Research (DHR) | DHR |
| I1392 | Dr. Rajni Yadav | Clinical pathological and genetic characterization of Neonatal cholestasis | 15-02-22 | 14-02-25 | Department of Health Research (DHR) | DHR |
| DHR-1390 | DR. PANKAJ HARI | Efficacy of low dose, short course prednosolone regimen for relapse of steroid sensitive nephrotic syndrome in children: A multicentre, randomized, placebo-controlled trial | 11/4/2022 | 10/4/2025 | Department of Health Research (DHR) | DHR |
| DHR-1407 | Dr. Piyush Ranjan | Ultrafast Detection and Quantitative assessment of Dengue Fever Viral Load using Infrared Technologies | 27-05-22 | 26-05-25 | Department of Health Research (DHR) | DHR |
| DHR-1350 | Dr. Vishesh Jain | Role of Urinary Prohibitin and other urinary biomarkers levels, at diagnosis, in children with favorable histology Wilms tumor in predicting tumor response and risk of recurrence | 1/7/2022 | 30-06-25 | Department of Health Research (DHR) | DHR |
| DHR-1440 | DR. S.SENTHIL KUMARAN | Identification of prognostic and diagnostic biomarkers in parkinson's disease (With juvenile/young onset) using deep learning methods | 15-11-22 | 14-09-25 | Department of Health Research (DHR) | DHR |
| DHR-1531 | DR. SEEMA SEN | Aberrant Lipid Metabolism Pathways as Novel Molecular Targets in Aggressive Ocular Malignancies | 15-02-23 | 14-02-26 | Department of Health Research (DHR) | DHR |
| DHR-1509 | DR. KH REETA | Correlation of antidepressant therapy with orexinergic pathway intergrating targeted metabolomics in patients with major depressive disorder: a longitudinal study | 15-02-23 | 14-02-26 | Department of Health Research (DHR) | DHR |
| DHR-1523 | Dr. Jasbir Kaur | Elucidating the role of environmentally exposed organochlorime pesticides in the pathogenesis of diabetic retinopathy | 28-02-23 | 27-02-26 | Department of Health Research (DHR) | DHR |
| DHR-1534 | Dr. Pratap Sharan | Immune system Network in Palliative Care patients with Depression. | 28-02-23 | 27-02-26 | Department of Health Research (DHR) | DHR |
| DHR-1494 | Dr. Aditi Sinha | Efficacy of IV rituximab versus oral mycophenolate mofetil in sustaining remission in steroid-resistant nephrotic syndrome maintained on calcineurin inhibitors for more than two years : An open-lable randomized controlled trial | 28-02-23 | 27-02-26 | Department of Health Research (DHR) | DHR |
| DHR-1496 | Dr. Harlokesh Narayan Yadav | Evaluation of the cardioprotective effect of remote ischaemic preconditioning in acute coronary syndrome patients and its correlation with vitamin D | 28-02-23 | 27-02-26 | Department of Health Research (DHR) | DHR |
| DHR-1510 | DR. RAVINDER GOSWAMI | Neuropsychiatric and cognitive dysfunctions in hypoparathyroidism, its natural course after 10 years of follow up in patients with idiopathic hypoparathyroidism on conventional therapy and effect of these dysfunctions on their calcemic control | 8/3/2023 | 7/3/2026 | Department of Health Research (DHR) | DHR |
| DHR-15241 | DR. S.SENTHIL KUMARAN | Exploring cognition and numeracy skills in financial decision making in neurodegenerative disorders using MR techniques, and the effect of Transcranial Direct Stimulation (tDCS) on improvement of cognitive functions | 20-03-23 | 19-03-26 | Department of Health Research (DHR) | DHR |
| DHR-1541 | DR. S.SENTHIL KUMARAN | Exploring cognition and numeracy skills in financial decision making in neurodegenerative disorders using MR techniques, and the effect of Transcranial Direct Stimulation (tDCS) on improvement of cognitive functions | 20-03-23 | 19-03-26 | Department of Health Research (DHR) | DHR |
| DHR-1542 | Dr. Yatan Pal Singh Balhara | Development of a tool for identification diagnosis and early intervention for mental disorders among persons with addictive disorders | 20-03-23 | 19-03-26 | Department of Health Research (DHR) | DHR |
| DHR-1571 | Dr. Prabhoo Dayal | Identifying predictors of Suicidal RIsk in individuals with alcohol Use Disorder Using a combined Biomarker and Clinical Risk Assessment Approach | 20-03-23 | 19-03-26 | Department of Health Research (DHR) | DHR |
| DHR-1585 | Dr. Sharmistha Dey | Identification of mitochondria-related proteins as plausible biomarkers and therapeutic targets in Alzheimer's disease | 19-07-23 | 18-07-26 | Department of Health Research (DHR) | DHR |
| DHR-1590 | Dr. T. Velpandian | Quantitative Metabolomic Analysis of Endogenous Trace Amines (ligands of TAAR receptors) in the Age-related Neurodegenerative Diseases: In the search for Biomarker and Therapeutic target | 19-07-23 | 18-07-26 | Department of Health Research (DHR) | DHR |
| DHR-1584 | Dr. Ranveer Singh Jadon | Prevalence of dynapenia/sarcopenia and its association with metabolic parameters, body composition and bone mineral density in postmenopausal women: A cross- sectional study | 2/8/2023 | 1/8/2026 | Department of Health Research (DHR) | DHR |
| DHR-1596 | DR. RIMA DADA | Elucidating the role of molecular signatures with Yoga therapy in Diabetes | 3/8/2023 | 2/8/2026 | Department of Health Research (DHR) | DHR |
| DHR-1591 | DR. VIVEKA P. JYOTSNA | Effect of comprehensive sleep program (Sleep hygiene and relaxation technique) on sleep quality and glycemic/metabolic control in patients with diabetes mellitus: A randomised control trial | 7/8/2023 | 6/8/2026 | Department of Health Research (DHR) | DHR |
| DHR-1625 | DR. SANDEEP SETH | Proteomic and Inflammatory signatures of cardiac injury in Long-Covid culminating into heart failure | 24-08-23 | 23-08-26 | Department of Health Research (DHR) | DHR |
| DHR-1598 | Dr. Archana Kumari | A prospective cohort study on trajectories of postmartum weight, risk factors associated with weight retention and its relationship with metabolic derangements till 18 months post-delivery among women in India (AIIMS PPWR Cohort study) | 24-08-23 | 23-08-26 | Department of Health Research (DHR) | DHR |
| DHR-1593 | Dr. Upendra Baitha | To study the role of serum proteomics profiles in subjects with metabolic syndrome | 24-08-23 | 23-08-26 | Department of Health Research (DHR) | DHR |
| DHR-1597 | Dr. Pragyan Acharya | An Integrative Clinico-Development for the Monitoring of Non-Alcoholic Fatty Liver Disease (NAFLD) Progression to Adverse Outcomes | 24-08-23 | 23-08-26 | Department of Health Research (DHR) | DHR |
| DHR-1630 | Dr. Prasun Chatterjee | Efficacy of adjunct probiotics in combination with standard of care as compared to standard of care alone in elderly patients with moderate unipolar depression: A randomized double-blind parallel-group placebo-controlled | 13-09-23 | 12/9/2025 | Department of Health Research (DHR) | DHR |
| DHR-1603 | Dr. Jayanth Kumar | Delineating the molecular mechanisms involved in relapse of pediatric B-cell Acute Lymphoblastic Leukemia | 22-09-23 | 21-09-26 | Department of Health Research (DHR) | DHR |
| DHR-1602 | DR. RADHIKA TANDON | Phase-I clinical trial study to explore the feasibility and evaluate the clinical outcomes and safety of keratoplasty using bioengineered cross-linked human corneal graft in comparison with fresh human coreas | 26-09-23 | 25-09-26 | Department of Health Research (DHR) | DHR |
| DHR-1635 | Dr. Manoj K. Tembhre | Defining the whole exome sequencing based genetic determinants in Indian patients with congenital heart disease | 8/11/2023 | 7/11/2026 | Department of Health Research (DHR) | DHR |
| DHR-1646 | Dr. Koushik Sinha Deb | Remote monitoring & Prediction of depression treatment response through smartphone app-a prospective, cohort study | 21-11-23 | 20-11-26 | Department of Health Research (DHR) | DHR |
| DHR-1645 | Dr. M D Ray | Pattern of recurrence and clinico-Molecular correlation in relapsed epithelial ovarian cancer patients undergoing secondary CRS+ HIPEC. | 28-11-23 | 27-11-26 | Department of Health Research (DHR) | DHR |
| DHR-1699 | Dr. Sujata Satapathy | Pre-conception integrated Health CARE for Women development of a perceived preconception Health Risk Assessment tool and community-based Health Risk-reduction sensitization programme | 15-12-23 | 14-12-26 | Department of Health Research (DHR) | DHR |
| DHR-1647 | Dr. Sujata Satapathy | Pre-conception integrated Health Care for Women: Development of a Perceived preconception health risk Assessment tool and community-based health risk-reduction sensitization programme | 15-12-23 | 14-12-26 | Department of Health Research (DHR) | DHR |
| DHR-1618 | Dr. Hitender Gautam | Detection and Molecular Characterization of Diarrheagenic Escherichia coli as a cause of morbidity and mortality in children under 05 years of age presenting with acute diarrhea | 1/1/2024 | 31-12-26 | Department of Health Research (DHR) | DHR |
| DHR-1735 | Dr. M Vanathi | Epidemiologic and genetic study of anterior segment developmental anomalies with primary infantile corneal opacification in Asian Indian Population | 7/3/2024 | 6/3/2027 | Department of Health Research (DHR) | DHR |
| DHR-1640 | Dr. Prabudh Goel | Multi-centric study for metabolomic profiling of Hypospadias: First study on Indian cohort to characterise the metabolic derangements and identify Biomarkers or new therapeutic targets in different (Severity-based) sub-type of the disease | 10/3/2024 | 9/3/2027 | Department of Health Research (DHR) | DHR |
| DHR-1732 | Dr. Viney Gupta | Genetic profiling and classification of childhood and early onset Glaucoma | 12/3/2024 | 11/3/2027 | Department of Health Research (DHR) | DHR |
| DHR-1752 | Dr. Awadh Kishore Pandit | Swallow-graphy for stroke patients | 1/4/2024 | 31-03-27 | Department of Health Research (DHR) | DHR |
| DHR-1766 | Dr. Saurabh Kedia | Real time longitudinal assessment of diet and its inflammatory component in patients with inflammatory bowel disease from India: a prospective cohort study | 1/4/2024 | 31-03-26 | Department of Health Research (DHR) | DHR |
| DHR-1723 | DR. SUJATA MOHANTY | Novel Bioink Based 3D printed organoid As a high throughput platform for animal-free drug screening in cardiac spectrum of disease | 1/4/2024 | 31-03-27 | Department of Health Research (DHR) | DHR |
| DHR-1749 | DR. TULIKA SETH | An integrated phosphoproteomic and blood based miRNA profiling to predict high risk MDS and its progression to AML and to explore the role of inflammation in disease progression | 1/4/2024 | 31-03-27 | Department of Health Research (DHR) | DHR |
| DHR-1751 | Dr. Ranjan Gupta | Menstrual patterns and sexual function in patients with systemic lupus erythematosus: focus on longitudinal interaction with disease activity. | 10/4/2024 | 9/4/2027 | Department of Health Research (DHR) | DHR |
| DHR-1724 | Dr. Piyush Ranjan | Development of risk prediction model for occurrence of non-alcoholic fatty liver disease based on clinical, biochemical and lifestyle related variable in overweight and obese Indian adults | 10/4/2024 | 9/4/2027 | Department of Health Research (DHR) | DHR |
| DHR-1729 | Dr. Satyavir Yadav | To investigate atherosclerotic risk factors related miRNA network regulating the inflammasome pathway in coronary artery disease | 10/4/2024 | 9/4/2027 | Department of Health Research (DHR) | DHR |
| DHR-1734 | DR. NAVAL K.VIKRAM | To compare the effect of Indo-Mediterranean Diet with continuous energy restriction diet on hepatic steatosis and fibrosis, RNA Biomarkers, body composition and metabolic parameters in adults with non-alcoholic fatty liver disease | 10/4/2024 | 9/4/2027 | Department of Health Research (DHR) | DHR |
| DHR-1763 | Dr. Subhradip Karmarkar | Targeting SLE heterogeneity in geriatric and childhood lupus using single-cell transcriptomics and validation using a CRISPR-based gene editing system for patient-specific precision medicine. | 14-06-24 | 13-06-27 | Department of Health Research (DHR) | DHR |
| DHR-1771 | Dr. Bimal Kumar Das | Bacteriophage cocktails for the treatment of Acute respiratory infections caused by MDR ESKAPE pathogens. | 12/9/2024 | 11/9/2027 | Department of Health Research (DHR) | DHR |
| DHR-1774 | Dr. Saroj Kumar | Exomes in health: Isolation, Characterization and Biomedical application | 25-09-24 | 24-09-29 | Department of Health Research (DHR) | DHR |
| D481 | Dr. K Aparna Sharma | Implementation of WHO ANC Model using web application in primary, secondary and tertiary health care levels by trained health care providers, semi-skilled health care providers and community health workers | 31-05-19 | 31-03-25 | Department of Science & Technology (DST) | DST |
| D599 | DR. U.SINGH | INSPIRE Faculty Award | 21-10-20 | 20-10-25 | Department of Science & Technology (DST) | DST |
| D608 | DR. URVASHI B. SINGH | Epidemiological impact and intersection of the COVID-19 and Tuberculosis Pandemics in Brazil, Russia, India and South Africa | 3/4/2021 | 31-03-25 | Department of Science & Technology (DST) | DST |
| D608-A | DR. URVASHI B. SINGH | Epidemiological impact and intersection of the COVID-19 and Tuberculosis Pandemics in Brazil, Russia, India and South Africa | 3/4/2021 | 31-03-25 | Department of Science & Technology (DST) | DST |
| D614 | DR. SUJATA MOHANTY | DST-INSPIRE Fellowship | 15-10-21 | 14-10-26 | Department of Science & Technology (DST) | DST |
| D618 | DR. RAJ KUMAR YADAV | “Efficacy of a yoga-meditation based lifestyle intervention in patients with obesity and major depressive disorder: A randomized controlled trial” | 18-02-22 | 17-02-25 | Department of Science & Technology (DST) | DST |
| D621 | Dr. Rishi Dhawan | CRISPR Mediated Genetic Correction of Sickle Cell Disease Towards Clinical Trials in a Small patients cohort | 29-03-22 | 28-03-27 | Department of Science & Technology (DST) | DST |
| D620 | Dr. Siddharth Sarkar | “Real world effectiveness of add-on-yoga for patients with opioid dependence stabilized on treatment” | 2/4/2022 | 1/4/2025 | Department of Science & Technology (DST) | DST |
| D-642 | Dr. Nasreen Akhtar | Efficacy of 'Common Yoga Protocol; by AYUSH for Chronic insomnia, a to arm, open label, parallel randomized controlled clinical trial | 2/4/2022 | 1/4/2025 | Department of Science & Technology (DST) | DST |
| D622 | Dr. Bichitra Nanda Patra | Effect of additional yoga intervention in Children and Adolescents with major Depressive Disorder: A rendomisied controlled trail | 2/4/2022 | 1/4/2025 | Department of Science & Technology (DST) | DST |
| D-624 | DR. UMA KANGA | Immunogenetic variants (HLA-KIR repertoire) and their functional relevance in Hematopoietic Stem Cell Transplantation outcome | 1/10/2022 | 30-09-25 | Department of Science & Technology (DST) | DST |
| D-626 | Dr. Baibaswata Nayak | Cancer stemnes signatures of Hepatitis B virus (HBV) induced hepatocellular carcinoma (HCC) | 1/11/2022 | 31-10-25 | Department of Science & Technology (DST) | DST |
| D-630 | Dr. Subhash Chandra Yadav | Development of nanotechnology based detection system for BCR-ABL fusion protein | 20-03-23 | 19-03-26 | Department of Science & Technology (DST) | DST |
| D-629 | Dr. Piyush Ranjan | Development and evaluation of comprehensive cognitive retraining module for patients with obesity to achieve clinically significant weight loss - An Open Label Randomized Controlled Trial | 21-03-23 | 20-03-26 | Department of Science & Technology (DST) | DST |
| D-632 | Dr. Bichitra Nanda Patra | Effect of transcranial direct current stimulation tDCS on cognitive function, symptoms and functioning in Children and Adolescents with Attention Deficit Hyperactivity Disorder ADHD A Randomised Controlled Study | 27-03-23 | 26-03-26 | Department of Science & Technology (DST) | DST |
| D-634 | Dr. Prasun Chatterjee | Development and validation of an android based application App to assess cognitive status of older people through speech, emotion, visuo-spatial pattern recognition | 29-03-23 | 28-03-25 | Department of Science & Technology (DST) | DST |
| D-633 | DR. NEERJA GUPTA | Pharmacokinetic and Dynamic correlation for optimum therapy of NTBC for the Treatment of Indian Patients with Hereditary Tyrosinemia type 1 | 29-03-23 | 28-03-26 | Department of Science & Technology (DST) | DST |
| D-641 | DR. S.SENTHIL KUMARAN | Detection of Early Signs of Postural of function Decline in Parkinson patients using EEG and fMRI | 11/4/2023 | 10/4/2028 | Department of Science & Technology (DST) | DST |
| D625 | Dr. Maneesh Singhal | Development and evaluation of device for real-time monitoring of vascular perfusion in transferred tissue | 25-04-23 | 24-04-25 | Department of Science & Technology (DST) | DST |
| D-640 | DR. B.R.MIRDHA | Characterization of human antibody responses to Plasmodium vivax in India | 25-04-23 | 24-04-28 | Department of Science & Technology (DST) | DST |
| D-638 | DR. SHEFFALI GULATI | Enrichment through demonstration and sensitization of paramedics, teachers and students towards children with neurological/neurodevelopmental disorders using multimodal approach and evaluating KAP levels at pre and post intervention. | 15-05-23 | 14-05-25 | Department of Science & Technology (DST) | DST |
| D-635 | Dr. Ashok Sharma | Genome wide analysis of microRNA mediated regulation of cancer Tests Antigen POTE in Triple Negative Breast Cancer | 26-05-23 | 25-05-26 | Department of Science & Technology (DST) | DST |
| D627 | DR. ANANT MOHAN | Investigating and translating genomic evidence for public health response to SARS-CoV-2 (INSIDE-SARS-CoV-2) | 10/7/2023 | 9/7/2026 | Department of Science & Technology (DST) | DST |
| D-639 | DR. RITU DUGGAL | Treatment of temporomandibular joint disorders based on Vienna concept of functional occlusion. | 10/7/2023 | 9/7/2025 | Department of Science & Technology (DST) | DST |
| D-636 | Dr. Uma Sharma | Identification of urinary and lipidomic biomarkers for major depressive disorder (MDD) and generalized anxiety disorder (GAD) by combined application of NMR and LC MS-based metabolomics approach | 11/7/2023 | 10/7/2026 | Department of Science & Technology (DST) | DST |
| D-631 | Dr. Puneet Khanna | Association between DNA telomere length in peripheral blood leukocytes and Post-Operative cognitive dysfunction POCD and Post-Operative delirium POD in elderly patients undergoing major Orthopadic Surgery under general anesthesia A prospective observational study | 24-07-23 | 23-07-26 | Department of Science & Technology (DST) | DST |
| D-637 | Dr. Prabhakar Singh | Effects of maternal chronic Intermittent hypoxia on the cholinergic system and cognitive function of offspring in rats | 30-08-23 | 29-08-26 | Department of Science & Technology (DST) | DST |
| D-643 | DR. RAMA JAYASUNDAR | Studying the interplay between Prakriti phenotyping, microbiome and NMR metabolomics-based microbiome-dependent metabolises in healthy population to identify novel phenotyping markers | 31-08-23 | 30-08-26 | Department of Science & Technology (DST) | DST |
| D-645 | Dr. Ajay Logani | Optimization, clinical validation and product realization of the dental trauma splint prototype. | 7/3/2024 | 6/3/2027 | Department of Science & Technology (DST) | DST |
| D-644 | Dr. Niraj Kumar | Development and validation of robotic probe holder device for ultrasound-guided central venous canulation | 22-03-24 | 21-03-27 | Department of Science & Technology (DST) | DST |
| D-651 | Dr. Shivangi Saha | Development of an Artificial-intelligence tool to aid in standardized remote management of Hand Fractures. | 19-07-24 | 18-07-26 | Department of Science & Technology (DST) | DST |
| D-649 | DR. Manjari Tripathi | Understanding the neurobiological clinicopathological role of genomic and non-coding transcriptomic perturbances in pharmacoresistant epilepsy | 18-11-24 | 17-11-27 | Department of Science & Technology (DST) | DST |
| D-650 | DR. SANJEEV SINHA | Development of machine learning models for predicting obstructive sleep apnea | 9/1/2025 | 8/1/2027 | Department of Science & Technology (DST) | DST |
| T-345 | DR. SANJAY K. RAI | To research related to health -related issues during the upcoming Maha Kumbh Mela 2025 | 13-01-25 | 26-02-25 | Department of Urban Development, Government of Uttar Pradesh | Government |
| T-338 | Dr. Kunaal Dhingra | ‘Technical Resource Centre (TRC) under the Centre for Evidence for Guidelines | 1/10/2024 | 30-09-25 | DHR MOH&FW | DHR |
| T-337 | Dr. Sachit Anand | Technical Resource Centre (TRC) under the Centre for Evidence for Guidelines, | 1/10/2024 | 30-09-25 | DHR MOH&FW | DHR |
| N-2457 | Dr. Swati Kedia Gupta | Effectiveness, Efficacy, and Feasibility of a Therapist-Aided App for Exposure and Response Prevention: A Parallel-group, Pilot Randomized Control Trial | 15-03-24 | 14-03-27 | iHub Anubhuti-IIITD Foundation | Government |
| N-2465 | Dr. Koushik Sinha Deb | Development of a Digital Mental Health Research Platform for AI Phenotyping, Deep Learning and Prediction of Mental Health Conditions in India | 18-03-24 | 17-03-26 | iHub Anubhuti-IIITD Foundation | Government |
| N1817 | DR. SHEFFALI GULATI | Centre of advanced research & excellence in childhood neuro-development disorders in the child neurology division of the Deptt. of Pediatrics at the AIIMS, New Delhi. | 1/12/2017 | 31-03-25 | IIFCL | Government |
| N-2460 | DR. RAMA JAYASUNDAR | Semi-automatic segmentation and classification of MR images through ischemic stroke as case studies | 12/6/2024 | 11/6/2026 | IIT, Bombay | Government |
| T-324 | DR. DEEPAK AGRAWAL | Chanakya Chair Professorship award entitled “Continuous closed CSF Glucose Monitoring using CGM sensor in patients with External ventricular drainage for early detection of CSF infection | 1/5/2024 | 30-04-25 | IITI Drishti CPS Foundation, IIT Indore | Government |
| T-333 | DR. SANJEEV SINHA | Advanced study of obstructive sleep apnea (OSA) in patients with heart failure: Incorporating Artificial intelligence in OSA-Heart failure diagnosis and management | 11/9/2024 | 10/9/2025 | IITI Drishti CPS Foundation, IIT Indore | Government |
| BT-2123-WT | DR. ANANT MOHAN | Longitudinal effects of Air Pollution Exposures on Lung growth and development of biomarker of lung function deficit in Urban Children | 1/10/2020 | 30-09-25 | India Alliance DBT wellcome | DBT |
| BT-2172-WT | Dr. Vineet Choudhary | Molecular Mechanisms of Lipid Droplet Biogenesis | 1/9/2021 | 31-08-26 | India Alliance DBT wellcome | DBT |
| BT-2192-WT | Dr. Prabhat Singh Malik | Developing precision immunotherapy for value- based treatment of lung cancer in India | 1/10/2021 | 30-09-26 | India Alliance DBT wellcome | DBT |
| BT-2194-WT | Dr. Mamta Bhushan Singh | “Scaling-up The Competency of Primary Care Workers to Manage Epilepsy by Task-Sharing (STOP-Epilepsy)” | 1/10/2021 | 30-09-26 | India Alliance DBT wellcome | DBT |
| BT-2205-WT | Dr. Rohan Malik | A molecular understanding of early-onset inflammatory bowel disease (IBD) using animal models and whole exome sequencing of paediatric IBD patients | 1/1/2023 | 31-12-27 | India Alliance DBT wellcome | DBT |
| BT-2204-WT | Dr. Archana Singh | ChAracterizing, RevIving, Supporting, Monitoring and Managing Sustainable Food Systems to address malnutrition in indigenous tribal communities of India. CARISMMA susstainable food systems study. | 1/4/2023 | 31-03-28 | India Alliance DBT wellcome | DBT |
| BT-2210-WT | Dr. Roopa Rajan | Molecular signatures of Parkinson's Disease in vivo: a deep brain stimulation approach | 1/9/2023 | 31-08-28 | India Alliance DBT wellcome | DBT |
| BT-2215-WT | Dr. Archana Kumari | Study and Action on Hysterectomy: Evidence on women's health through the Lief course in India | 15-02-24 | 14-02-29 | India Alliance DBT wellcome | DBT |
| BT-2218-WT | DR. RAJESH SAGAR | A randomized controlled trial to evaluate a technology-enabled platform to manage depression with or without behavioural activaton in patients with cancer in India | 1/6/2024 | 31-05-29 | India Alliance DBT wellcome | DBT |
| N1558 | DR. GOVIND K MAKHARIA | Exploration for development of wheat with low immunogenic gluten | 11/3/2015 | 31-03-26 | Indian Council of Agriculture Research. | Government |
| I866 | Dr. Sunil Kumar | Patterns of care and survival studies in cancer cervix, cancer breast and head & neck cancer | 15-09-14 | 31-03-25 | Indian Council of Medical Research (ICMR) | ICMR |
| I1056 | Dr. Ritu Gupta | CARE in Acute Myeloid Leukemia | 1/3/2019 | 28-02-25 | Indian Council of Medical Research (ICMR) | ICMR |
| I1058 | DR. NIKHIL TANDON | Centre for Advanced Research and Excellence (CARE) in Young Diabetes | 1/3/2019 | 9/5/2025 | Indian Council of Medical Research (ICMR) | ICMR |
| I1054 | DR. PRAMOD K.GARG | CARE in Pancreatic Diseases | 1/3/2019 | 28-02-25 | Indian Council of Medical Research (ICMR) | ICMR |
| I1061 | DR. ANANT MOHAN | CARE in Exhaled Breathing Condensate | 1/3/2019 | 28-02-25 | Indian Council of Medical Research (ICMR) | ICMR |
| I1059 | Dr. Nand Kumar | CARE (Centre for Advance Reseach & Excellence) in Neuromodulation on Mental Health. | 25-03-19 | 24-03-25 | Indian Council of Medical Research (ICMR) | ICMR |
| I1177 | DR. MADHULIKA KABRA | National Registry for Rare & Other genetic Disorders | 1/11/2019 | 31-10-26 | Indian Council of Medical Research (ICMR) | ICMR |
| I1194 | DR. Rohit Bhatia | HTA of National Stroke Care Registry Programme development of Hospital Based Stroke Registries (HBSR) i different region of India | 1/3/2020 | 31-03-25 | Indian Council of Medical Research (ICMR) | ICMR |
| I1203 | DR. PURVA MATHUR | Centre of Advanced Reserach (CAR) in Hospital Acquired Infections- Prevention and Control | 15-10-20 | 14-10-25 | Indian Council of Medical Research (ICMR) | ICMR |
| I1235 | DR. NAVAL K.VIKRAM | To compare the effect of Intermittent Fasting and Continuous Energy Restriction on body composition, multiple metabolic and physiological parameters in obese adults | 1/2/2021 | 31-01-25 | Indian Council of Medical Research (ICMR) | ICMR |
| I1266 | DR. G. KARTHIKEYAN | Randomised-placebo controlled trial of Digoxin in patients with rheumatic heart disease | 1/2/2021 | 31-01-25 | Indian Council of Medical Research (ICMR) | ICMR |
| I1282 | Dr. Vishnu V.Y. | Centre for Advanced Research and Excellence in Disability and Assistive Technology | 31-03-21 | 29-03-26 | Indian Council of Medical Research (ICMR) | ICMR |
| I1178 | Dr. Ramakrishnan | Evaluation of a health system-based intervention on change in thrombolysis rate in ST segment elevated myocardial infarction (STEMI) acute coronary syndrome (ACS) across selected districts of the country - A health implementation research project. (ICMR-STEMI-ACT) | 1/4/2021 | 31-03-25 | Indian Council of Medical Research (ICMR) | ICMR |
| I1255 | Dr. Saurabh Kumar Gupta | Neuro developmental outcomes in infants undergoing surgery for congenital heart defects- A prospective multi-centre cohort study | 15-06-21 | 14-06-25 | Indian Council of Medical Research (ICMR) | ICMR |
| I1274 | Dr. Rajni Sharma | The effect of low glycemic index diet in the form of traditional Indian millets in obese children:a randomized controlled trial | 1/7/2021 | 31-01-25 | Indian Council of Medical Research (ICMR) | ICMR |
| I1187A | DR. Rohit Bhatia | Indian multiple Sclerosis and Alliied Demyelinating Disorders Registery and Research Network | 16-08-21 | 15-08-25 | Indian Council of Medical Research (ICMR) | ICMR |
| I1314 | Dr. S Arulselvi | Evaluation of Cathepsin B in peripheral blood of Isolated Traumatic Brain Injury patients and its correlation | 1/9/2021 | 28-02-25 | Indian Council of Medical Research (ICMR) | ICMR |
| I1193 | DR. NITISH NAIK | Contemporary Outcomes in Cardiac Channelopathies Guided By Genotype and Phenotype Based Management | 1/9/2021 | 31-08-26 | Indian Council of Medical Research (ICMR) | ICMR |
| I1278 | Dr. Sanjay Kumar | “The Role of trace elements in Renal Stone Disease: An Observational Cross-Sectional study” | 1/9/2021 | 28-02-25 | Indian Council of Medical Research (ICMR) | ICMR |
| I1323 | DR. SURABHI GUPTA | “To study the Mechanisms Underlying the Pathogenesis of Pre-eclampsia” | 15-09-21 | 14-03-25 | Indian Council of Medical Research (ICMR) | ICMR |
| I1328 | Dr. T. Velpandian | The extent of Aqatic Exposure of Certain Endocrine Disruptors (High Volume Chemicals) | 1/10/2021 | 31-03-25 | Indian Council of Medical Research (ICMR) | ICMR |
| I1338 | Dr. Sudip Kumar Datta | “Evaluation of the role of vitamin D receptor (VDR) polymorphism on the efficacy of calcitriol therapy in stage 3 to 5 chronic kidney disease (CKD): a prospective double-blind study” | 1/11/2021 | 31-05-25 | Indian Council of Medical Research (ICMR) | ICMR |
| I1355 | Dr. Kunzang Chosdol | Stydy of the FATI-PDCD4 signaling axis in Periampullary cancer | 15-12-21 | 14-12-25 | Indian Council of Medical Research (ICMR) | ICMR |
| I1365 | Dr. M. Kalaivani | “Development of longitudinal growth reference and assessment of growth velocity, cardio metabolic measures and its correlation among children in India- A prospective study” | 16-12-21 | 30-04-25 | Indian Council of Medical Research (ICMR) | ICMR |
| I1351 | Dr. Nishkarsh Gupta | Effect of Regional Anaesthesia on immune response, recurrence and matastasis in breast cancer surgery: a prospective randomized control study | 1/1/2022 | 31-03-25 | Indian Council of Medical Research (ICMR) | ICMR |
| I1382 | Dr. Haresh K.P. | A phase II study to evaluate the efficacy of Stereotactic Body Radiotherapy (SBRT) for high risk organ confined adenocarcinoma of prostate | 1/2/2022 | 31-01-25 | Indian Council of Medical Research (ICMR) | ICMR |
| I1381 | Dr. Haresh K.P. | An institutional phase I/II study to evaluate safety and efficacy of high dose weekly hypopractionated palliativge breast radiotherapy in fungating advamced unresectable or metastatic breast cancer | 1/2/2022 | 31-01-25 | Indian Council of Medical Research (ICMR) | ICMR |
| I1376 | DR. DEEPAK AGRAWAL | Development and validation of prognostic models for patients with traumatic brain injury : A comparison of the modern machine learning methods | 3/2/2022 | 2/2/2025 | Indian Council of Medical Research (ICMR) | ICMR |
| I1380 | Dr. Vishnu V.Y. | Development and characterization of a non-viral vector for gene transfer and assessment of efficacy in cellular models | 15-02-22 | 14-02-25 | Indian Council of Medical Research (ICMR) | ICMR |
| I1371 | Dr. Baibaswata Nayak | Determination of receptor mediated pathogenesis of SARS-CoV2 variants and immunomodulation by viral proteins | 15-02-22 | 14-02-25 | Indian Council of Medical Research (ICMR) | ICMR |
| I1375 | Dr. Bhavuk Garg | A comparative Study between Pentoxifylline and Teriparatide for the treatment of Postmenopausal Osteoporosis: A Randomised Controlled Trial | 15-02-22 | 14-02-25 | Indian Council of Medical Research (ICMR) | ICMR |
| I1345 | Dr. VIJAY HADDA | ICMR's Network of Pulmonary Fibrosis (INPF) | 4/3/2022 | 3/3/2025 | Indian Council of Medical Research (ICMR) | ICMR |
| I1383 | Dr. Haresh K.P. | A pilot study to develop and validate an artificial intelligence platform for the management of breast cancer | 15-03-22 | 14-03-25 | Indian Council of Medical Research (ICMR) | ICMR |
| I1385 | Dr. Sanjeev Kumar Bhoi | To study the pattern of mesenchymal stromal, hematopoietic stem and progenitor cells in peripheral blood of trauma hemorrhagic shock patients | 15-03-22 | 14-03-25 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1419 | DR. Rohit Bhatia | “STENOSIS: Longterm Single versus Dual Antiplatelet Therapy In patints with Intracranial Atherosclerotic Disease: A Randomized Trial” | 16-03-22 | 15-03-25 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1420 | DR. Rohit Bhatia | “Randomized trial of Biosimilar TNK versus TPA during Endovascular Therapy For Acute Ischemic Stroke Due To Large Vessel Occlusions: RE-OPEN” | 25-03-22 | 24-03-25 | Indian Council of Medical Research (ICMR) | ICMR |
| I1384 | DR. ANANT MOHAN | A longitudinal, multisystem, and genetic assessment of incidence and risk for chronic sequelae following Covid-19 infection | 25-03-22 | 24-03-25 | Indian Council of Medical Research (ICMR) | ICMR |
| I1389 | DR. D.S.ARYA | “Randomized double blinded placebo controlled clinical trial for the evaluation of effect of vitamin K supplementation on bone mineral density in prostate cancer patients” | 28-03-22 | 27-03-25 | Indian Council of Medical Research (ICMR) | ICMR |
| I1395 | Dr. Immaculata Xess | Advanced Mycology Diagnostic and research centre in Northern region of India | 28-03-22 | 27-03-25 | Indian Council of Medical Research (ICMR) | ICMR |
| I1396 | DR. SANDEEP SETH | Ranolazine for heart failure with preServed Ejection fraction (HFpEF): A randomized double-blind placebo controlled [RISE-HFpEF study] | 28-03-22 | 1/5/2025 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1421 | DR. Rohit Bhatia | Indian trial of tranexamic acid in spontaneous intraccerebaral hemorrhage (INTRINSIC Trial) | 30-03-22 | 29-03-25 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1537 | DR. Rohit Bhatia | Establishment of the Indian Stroke Clinical Trial Network Phase-II (INSTRuCT Network Phase-II)' | 30-03-22 | 29-03-25 | Indian Council of Medical Research (ICMR) | ICMR |
| I1394 | Dr. Ravi Ranjan | A study on thalassemia Awareness Screening and councselling among Young Adults of Delhi & NCR (India) | 1/4/2022 | 31-03-25 | Indian Council of Medical Research (ICMR) | ICMR |
| I1387 | DR. HARI PRASAD G | Serum proteomics for the identification of biomarkers to flag predilection of COVID-19 patients to various organ morbidities | 1/4/2022 | 31-03-25 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1435 | Dr. Yashdeep Gupta | To develop and evaluate the effectiveness of multidisciplinary education and care model for individuals with diabetes affected with COVID-19: A two-arm parallel Randomized Control Trial | 1/4/2022 | 31-03-25 | Indian Council of Medical Research (ICMR) | ICMR |
| I1398 | Dr. Raja Tiwari | Pilot study on utility of Robotic surgery for Brachial plexus reconstruction | 25-04-22 | 24-04-25 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1408 | DR. PUNIT KAUR | A multi-omics study and development of a prognostic computational model for COVID-19 to orrelate clinical outcomes and disease sequeal with differential immunological response, mutational and vaccination status in India | 1/5/2022 | 30-04-25 | Indian Council of Medical Research (ICMR) | ICMR |
| I1361 | Dr. S. Ramakrishnan | Efficacy of intravenous immunoglobulin in acute rheumatic carditis witth moderate to severe valvular lesions: A prospective Randomized Open Labelled Trial | 1/5/2022 | 30-04-25 | Indian Council of Medical Research (ICMR) | ICMR |
| I1403 | Dr. Koushik Sinha Deb | An exploratory study to assess the magnitude of in-patient restraint and seclusion practices in India through the development of a framework for uniform restraint reporting across the country | 1/5/2022 | 30-04-25 | Indian Council of Medical Research (ICMR) | ICMR |
| I1321 | Dr. Mamta Bhushan Singh | “Can capacity building at primary care level improve access to epilepsy care in Chhattisgarh? An Implementation Research” | 2/5/2022 | 1/5/2025 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1412 | Dr. Richa Aggarwal | Implementation of Antimicrobial stewardship programme [AMSP] in various tertiary care centres across India | 1/6/2022 | 31-05-25 | Indian Council of Medical Research (ICMR) | ICMR |
| I1414 | Dr. Ranjan Gupta | Magnitude, characterstics and endurance of immune response to COVID 19 Vaccination in patients with Systemic Lupus erythematosus A multicentric cohort study | 13-06-22 | 12/6/2025 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1411 | DR. SEEMA SOOD | Exploring SELEX technology for potential POCT development for Genital Chlamydia trachomatics | 20-06-22 | 19-06-25 | Indian Council of Medical Research (ICMR) | ICMR |
| I1410 | DR. VAISHALI SURI | Methylation array-based profiling of gliomas in adolescents and young adults (AYA) to improve sub-clasification and prognosis prediction | 1/7/2022 | 30-06-25 | Indian Council of Medical Research (ICMR) | ICMR |
| I1409 | Dr. Manoj Kumar | Structure-based design of lead compounds targeting persistent Mycobacterium tuberculosis to shorten the treatment duration | 1/7/2022 | 30-06-25 | Indian Council of Medical Research (ICMR) | ICMR |
| I1224 | Dr. Prabudh Goel | Development of Technology based Doctor-Patient Interface to Facilitate Patient Care and Health Reserach in Paediatric Urology | 1/7/2022 | 30-06-25 | Indian Council of Medical Research (ICMR) | ICMR |
| I1404 | Dr. Rachna Bhargava | A study to examine psycho-social & behavioural domains among school going adolescents during covid-19 pandemic: mixed study design | 15-07-22 | 14-07-25 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1418 | Dr. Deepshi Thakral | Development of electrochemical biosensor for detection of circulating tumor DNA mutations in Acute myeloid leukemia | 15-07-22 | 14-07-25 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1417 | DR. SHYAM PRAKASH | Molecular interaction of iron trafficking gene variants with mitochondrial dysfunction in metabolically associated fatty liver disease | 15-07-22 | 14-07-25 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1416 | Dr. Puneet Misra | Situational Analysis of Health Care Facility and Community preparedness for Implementis Govt. of India Guidelines for Gestational Diabetes Mellitus, (An ICMR Task Force Study). | 15-07-22 | 14-07-25 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1425 | DR. PRAMOD K.GARG | Epidemiology of pancreatitis and major gastrointestinal disease: A multi centre study across India | 15-07-22 | 30-06-25 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1423 | Dr. Jasbir Kaur | Cell-free DNA as a potential molecular marker for retinoblastoma: diagnostic and therapeutic approach | 16-07-22 | 15-07-25 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1422 | DR. RAKESH YADAV | ICMR's National Hospital based Registry on Venous-thrombo-Embolic Disorders. | 20-07-22 | 19-07-25 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1431 | Dr Anushree Gupta | Molecular Characterization of 5' UTR Of EDN1 gene containing single +139 'A' Insertion Mutation | 1/8/2022 | 31-07-25 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1406 | Dr. Bimal Kumar Das | Evaluation of role of B-1 cells in modulating the response of T cells in HIV infected patients: cohort study | 1/8/2022 | 31-07-25 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1427 | Dr. Harlokesh Narayan Yadav | Anemia exploring the role of vitamin D essential element and lifestyle in Indian population | 1/8/2022 | 31-07-25 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1426 | Dr. Surabhi Gupta | To study the effect of selective serotonin in reuptake inhibitors (SSRIs) on testicular functions | 1/8/2022 | 31-07-25 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1428 | Dr. Nand Kumar | “A comprehensive genomics approach to predict respoder's vs non-responders against common anti-depressant therapy” | 1/8/2022 | 31-07-25 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1436 | Dr. Sunil Kumar | Neoadjuvant chemotherapy followed by surgery versus Surgery followed by adjuvant chemotherapy for resectable Gastric adenocarcinoma 2x2 factorial phase3-Multicentric Randomized Controlled Trial | 12/8/2022 | 11/8/2025 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1433 | DR. RAJESH SAGAR | Burden and magnitude of COVID-19 vaccine anziety, hesitancy and its correlates in India | 15-08-22 | 14-08-25 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1430 | Dr. Savita Yadav | Identifying dysregulation of miRNAs and their targets in idiopathic recurrent pregnancy loss | 15-08-22 | 14-08-25 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1432 | Dr. Jasbir Kaur | Identification of microRNA signatures for retinal neovascularization in retinopathy of prematurity using bioinformatics and experimental approach | 16-08-22 | 15-08-25 | Indian Council of Medical Research (ICMR) | ICMR |
| I1377 | Dr. Sandeep Singh | ICMR-National Centre for Assistive Health Technology | 1/9/2022 | 31-08-27 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1294 | Dr. Prabhoo Dayal | Evaluation of Neurocognitive, Personality, Emotional and Psychosocial Biomarkers as candidate Endophenotypes for Opioid use Disorder & their relationship with polymorphism in opioid & Dopmanine receptor Genes: Implications for prevention & Treatment | 1/9/2022 | 31-08-25 | Indian Council of Medical Research (ICMR) | ICMR |
| I1330 | DR. RAKESH LODHA | Clinical Efficacy additional of Agastya Haritaki [Classical Ayurvedic formulation] and Yoga to standard treatment care in the management of bronchial Asthma in Children and Adolescents. A randomized controlled trial | 1/10/2022 | 9/2/2025 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1439 | Dr. Gagandeep Singh | Molecular epidemiology and In-Vitro Antifungnal susceptibility of Cryptic aspergillus species from clinical and enviornment samples | 1/11/2022 | 31-10-25 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1438 | Dr. Deepali Garg | Samrtphone app for management of gestational diabetes mellitus in urban and rural settings in India: A randomized controlled trial | 15-11-22 | 14-11-25 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1451 | Dr. Sushma Sagar | Surgical innovation laboratory (SIL) for advancing patient care, Education and Research | 16-11-22 | 15-11-25 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1437 | Dr. Rajesh Kumar Singh | Thalidomide as treatment of optochiasmatic arachnoiditis in Tuberculous meningitis: A prospective randomized open blinded endpoint (PROBE) Study | 18-11-22 | 17-11-25 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1443 | Dr. Garima Kachhawa | Assessment of markers of preeclampsia after delivery and correlation with future risk factors of Cardio vascular disease in women | 1/12/2022 | 30-11-25 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1445 | DR. SHYAM PRAKASH | Characterization and expression of transfer RNA derived small RNAs as circulating biomarker for disease diagnosis and prognosis in NAFLD | 1/12/2022 | 30-11-25 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1454 | DR. RIMA DADA | To study of effect of yoga on DNA methylation alterations of imprinted genes and key genes of developmental importance in idiopathic recurrent pregnancy loss following spontaneous or assisted conception | 1/12/2022 | 30-11-25 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1448 | Dr. Ranveer Singh Jadon | Randomized controlled trial to study the impact of weight bearing and resistance exercise with utritional interventions on bone and muscle health in obese patients with osteroscaropenia | 1/12/2022 | 30-11-25 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1446 | DR. NAVAL K.VIKRAM | Randomized controlled trial to compare the effect of dietary intervention and resistance exercises on changes in skeletal muscle strength, mass and function in Type 2 Diabetes patients with Dynapenia and Sarcopenia | 1/12/2022 | 30-11-25 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1572 | DR. SUMAN JAIN | Development of complex biomimetic artificial nerve-graft for repairing spinal cord injury | 1/12/2022 | 30-11-25 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1442 | Dr. Neetu Bhari | Morphological pattern of skin lesions in different complementation group in children with xeroderma pigmentosum and its correlation with various cutaneous and extra-cutaneous cancers and photoaging | 1/12/2022 | 30-11-25 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1447 | Dr. Animesh Ray | Effect of High dose vitamin D3 on hemoglobin concentrations of mechanically ventilizted patients with sepsis A placebo-controlled randomized controlled trail | 1/12/2022 | 30-11-25 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1441 | Dr. Geetika Singh | Evaluation of novel target antigens in membranous nephropathy and their clinical correlation: an attempt to reclassify cases based on target antigens in the Indian population | 1/12/2022 | 30-11-25 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1449 | Dr. Jhuma Sankar | Assessing the microcirculating and its response to different fluid volumes in children with septic shock | 1/12/2022 | 30-11-25 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1450 | Dr. Lata Singh | Clinical relevance of Mitochondrial-mediated ferroptosis in intraocular childhood Malingnancies | 1/12/2022 | 30-11-25 | Indian Council of Medical Research (ICMR) | ICMR |
| I1331 | Dr. Sudhir Chandra Sarangi | Genetic expression of monoaminnergic neurotransmission related polymorphisms and their association with antidepressant response in Indian patients suffering from depression | 5/12/2022 | 4/12/2025 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1461 | Dr. Animesh Ray | A preliminary study to validate BM-AspICU alogrithm for disgnosing invasive pulmonary aspergillosis in critically ill mechanically vantilated patients using post-mortem minimally invasive tissue sampling | 9/12/2022 | 8/12/2025 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1458 | Dr. Atul Batra | Paired targeted genomics profiling of triple nagative breast cancer to understand the mechaanisms of chemoresistance and develop novel treatment targets | 12/12/2022 | 11/12/2025 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1452 | Dr. Mona Sharma | Effect of Semen cryopreservation on Sperm Telomere Biology and Fertilization Potential | 15-12-22 | 14-12-25 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1456 | DR. RAMA JAYASUNDAR | Scientific validation of ayurvedic concept of guna and anupana by studying its interplay with NMR phytometabolomics and permeability analysis in intestinal and liver cells | 15-12-22 | 14-12-25 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1453 | DR. Achal Kumar Srivastava | “To unravel clinic-genetic association of non-lesiional epilepsy syndromes through deep targeted clinical sequencing | 15-12-22 | 14-12-25 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1463 | Dr. Viney Gupta | Novel genes in the pathogenesis of glaucome:A validation in glaucoma patients and animal model. | 22-12-22 | 21-12-25 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1457 | Dr. Vishnu V.Y. | Strategic Multimodal intervention in at-risk Elderly Indians for prevention of Dementia (SMRUTHI INDIA): A cohort multiple randomized controlled trial (cmRCT) | 30-12-22 | 29-12-25 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1476 | DR. ANANT MOHAN | Evaluating the role of MicroRNAs as Biomarkers for early diagnosis and prognosis of Lung Cancer: A comparative study using Exhaled Breath Condensate, sputum, blood and Bronchial brushing | 1/1/2023 | 31-12-25 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1462 | Dr. Ram Kishor Sah | To evaluate the clinical utility of tear biomarkers for early detection of keratoconus using s mass spectrometry-based proteomic approach | 1/1/2023 | 31-12-25 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1469 | Dr. Noopur Gupta | A metageonomic approach to evaluate the human ocular ,microbiome in patients with dry eye disease and limbal stem cell deficiency | 1/1/2023 | 31-12-25 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1495 | DR. NIKHIL TANDON | Evaluate of maternal and fetal outcomes in women diagnosed with GDM or normoglycaemia using IADPSG criteria, among women diagnosed with normolycaemia by DIPSI criteria: Prospective multi-centre observational cohort study | 2/1/2023 | 1/1/2026 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1455 | DR. Achal Kumar Srivastava | “Post-acute Covid-19 Neurological Sequelae: deciphering Molecular signatures by intergrating Data Sources of Covid-19 and Neurodegenerative Disease and Their Validation | 2/1/2023 | 1/1/2026 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1488 | Dr. Ethayathulla, Abdul Samath | Screening of green tea antioxidants to reactivate anti-cancer activity of mutant p53 in breast cancer cell lines | 2/1/2023 | 1/1/2026 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1460 | Dr. Hitender Gautam | Site -specific biomarkers to differentiate infection from either colonization or aseptic inflammation in ICU | 5/1/2023 | 4/1/2026 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1478 | Dr. Amrita Chawla | Development of evaluation of artificial intelligence system for detection and classfication of occlusal caries | 15-01-23 | 14-01-26 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1502 | Dr. Ambuj Roy | Impact of Indian adaptation of mediterranean diet versus low fat diet on dietary inflammatory index in patients with coronary artery disease | 16-01-23 | 15-01-26 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1473 | Dr. Manoj K. Tembhre | Deciphering the impact of Fc? receptors on Neutrophil extracellular trap (NETs) formation potential of neutrophils in active psoriasis and its correlation with diseases severity | 16-01-23 | 15-01-26 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1471 | Dr. Sandeep R Mathur | To investigate metabolic perturbations in Endometerial Cancer by targeted transcriptomics approach in an Indian Cohort | 16-01-23 | 15-01-26 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1465 | Dr. Aanchal Kakkar | Evaluation of specific molecular alterations and tumor immune microenvironment for detection of clinically actionable targets in high garde salivary gland carcinomas | 16-01-23 | 15-01-26 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1470 | DR. GOVIND K MAKHARIA | Exploration of immunopathogenesis of extra-intestinal organ involvement in patients with Celiac Disease | 18-01-23 | 17-01-26 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1481 | Dr. Rashmi Shukla | Deciphering the complexities of apparently balanced chromosomal rearrangements associated with clinical phenotype by whole genome sequencing | 19-01-23 | 18-01-26 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1472 | Dr. Anita Chopra | Study of expression, functions, and clinical significance of DNS damage repair pathway genes in acute lymphoblastic leukemia | 27-01-23 | 26-01-26 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1507 | DR. RENU DHINGRA | SMARCE 1 mediated mechanisms of transcriptional modulation in trophoblast cell invasion during placentation and their status in preeclampsia | 27-01-23 | 26-01-26 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1491 | Dr. Shikha Gupta | Novel Genes in Axenfeld Rieger Syndrome Pathogenesis | 27-01-23 | 26-01-26 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1468 | DR. NAVAL K.VIKRAM | To evaluate the personality traits and assess the impact of humanistic psychotherapy for trait specific intervention on body composition and metabolic parameters in obese subject | 1/2/2023 | 31-01-26 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1459 | DR. ASHISH SURI | ICMR-Centre of excellence for Neurosurgery Medical Devices | 1/2/2023 | 31-01-26 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1485 | DR. Achal Kumar Srivastava | Integrated Molecular modelling and in vivo approach to discover potent phytochemicals for improving cognitive decline in Alzheimer's disease | 1/2/2023 | 31-01-26 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1501 | Dr. Ambuj Roy | Establishing a repository of biological samples for Coronary Artery Disease on a cohort of patients undergoing angiography at a Tertiary Hospital | 1/2/2023 | 31-01-26 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1479 | Dr. Pranay Tanwar | Utility of droplet digital PCR (ddPCR) as a novel tool for the detection of Methylated Circulating tumor DNA (meth-ctDNA) as a biomarker for early diagnosis and tumor surveillance in Head & Neck Cancer patients | 1/2/2023 | 31-01-26 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1482 | Dr. Deepali Jain | An integrated geonomic approach to define genetic landscape of non-small cell lung carcinoma in Indian Population | 1/2/2023 | 31-01-26 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1512 | Dr. Saroj Kumar | A case control study to develop Exosomes based Molecular Signature of Parkinsons Disease | 1/2/2023 | 31-01-26 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1546 | Dr. Chandra Prakash Prasad | Evaluating the theranostic potential of canonical and non-canonical WNT signalling in Gallbladder cancer | 1/2/2023 | 31-01-26 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1466 | Dr. Piyush Ranjan | Development and Evaluation of an Individualized Weight management module for young adults | 1/2/2023 | 31-01-26 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1480 | Dr. Megha Brijwal | Expanded viral etiological investigation of genital ulcer disease with phenotyping and genotyping for antiviral drug resistance in herpes simplex viruses | 1/2/2023 | 31-01-26 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1486 | Dr. Jitendra Kumar Meena | Assessment of Breast cancer risk profile and factors implicit in differential incidence rates within rural and urban populations in India by developing a machine learning-based risk prediction tool | 1/2/2023 | 31-01-26 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1592 | Dr. Shalimar | A Phase III, multicentre, randomized, double-blind, placebo-controlled, interventional study on efficacy and safety of Standardized fraction of Picrorhiza kurroa Royal Ex Benth (Picroliv® for 24 week in the Management of Non-Alcoholic Fatty Liver Disease (NAFLD) | 2/2/2023 | 1/2/2025 | Indian Council of Medical Research (ICMR) | ICMR |
| I1388 | DR. ANANT MOHAN | Development and validation of Artificial Intelligence tool for Screening/Detection of pulmonary TB and other lung disease using chest X-Ray | 9/2/2023 | 8/2/2025 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1490 | Dr. Junaid Alam | To study the effect of Immediate Post Operative Prosthesis in relation to post surgical outcome, balance and quality of life in Above Knee Amputation patients (post traumatic): A pilot Randomized Controlled Trial | 15-02-23 | 14-02-26 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1506 | Dr. Kapil Dev Soni | A study on development and piloting of trauma ICU registry and comprehensive critical care for critically ill patients admitted to Trauma Intensive Care Unit of level-1 trauma centre in India: A prospective observational study | 15-02-23 | 14-02-26 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1538 | Dr. S. Ramakrishnan | Mission Delhi Phase II: Delhi emergency life heart attack Initiative | 15-02-23 | 14-02-26 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1489 | DR. VANDANA JAIN | Programming effect of relative weight gain, fat -free mass gain in infancy on body composition and insulin sensitivity in mid-childhood: Follow-up of a birth cohort | 15-02-23 | 14-02-26 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1483 | DR. Sushma Bhatnagar | To build the capacity of palliative care services in the 10 hospitals in North India to reduce suffering in patients with chronic debilitating conditions | 16-02-23 | 15-02-26 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1492 | Dr. Ranjit Kumar Sahoo | A comparative analysis of Secretome of Mesenchymal Stem Cells (MSCs) derived from different sources, with a focus on immunosuppressive potential in Acute GVHD | 16-02-23 | 15-02-26 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1493 | Dr. Atul Batra | Carboplatin in patients with metastatic castrate resistant postate cancer (mCRPC) harboring somatic or germline homologous recombination repair (HRAA) gene mutations: A phase IIsingle-arm trial (CIPHeR) | 16-02-23 | 15-02-26 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1498 | Dr. Vishnu V.Y. | Exploring genetic variants in Moyamoya Disease (MMD) and Intracranial Major Artery/Occlusion (ICASO) in India | 16-02-23 | 15-02-26 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1536 | Dr. Rakesh Kumar Deepak | Clinical utility of liquid biopsy in cardiac allograft rejection | 16-02-23 | 15-02-26 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1552 | Dr. Elavarasi.A | Efficacy and safety of Onabotulinum toxin A (Botbox) injections in the upper esophageal sphincter for the treatment of Pharyngo-esophageal Dysphagia due to cricopharyngeal dysfunction- A Randomized double blinded placebo controlled Trial | 16-02-23 | 15-02-26 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1533 | Dr. Rupesh K. Srivastava | To investigate the therapeutic potential of probiotics in treatment and management of osteoporosis role of regulatory B cells (Bregs) | 20-02-23 | 19-02-26 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1513 | DR. SAMEER BAKHSHI | Developing Articial intelligence based model for detection of malignant potential of pulmonary nodules in sarcoma using computed tomographic imaging and its prospective validation | 20-02-23 | 19-02-25 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1570 | Dr. Sachin A Borkar | To study the effect of locally administered multifunctional cocktail on postoperative pain and blood loss in elective lumbar spine surgeries: A prospective randomized control trial | 20-02-23 | 19-02-26 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1504 | Dr. Subodh Kumar | Impact of psychosocial intervention on quality of life and stress biomarkers in patients with traumatic limb amputation/s: A randomized controlled trial | 27-02-23 | 26-02-26 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1521 | Dr. Siddharth Sarkar | A time series approach to evaluation the role of Co-occurring depression and anxiety as determinants outcome, disability and quality of life among patients with opioid dependence | 1/3/2023 | 28-02-26 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1580 | Dr. Rajesh Sinha | Femtosecond laser-Assisted large Diameter Corneal Intrastomal Lenticule implantation with collagen cross linking in advanced Keratoconus | 1/3/2023 | 28-02-26 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1561 | Dr. Vishnu V.Y. | Psychosocial and economic effect of Dementia Care giving and factors associated: A Multicentre Study | 1/3/2023 | 28-02-25 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1524 | Dr. Deepika Mishra | Multiregion sequencing to unveil the intratumoral heterogeneity and novel biomarkers in oral squamous cell carcinoma in an Indian Population: Case Control Study | 1/3/2023 | 28-02-26 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1526 | Dr. Piyali Mandal | Metabolic and addiction indices in Indian opioid dependent subjects on Buprenorphine-naloxone maintenance treatment: A longitudinal Study | 1/3/2023 | 28-02-26 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1505 | Dr. Vikender Singh | Comparisons of the outcomes of using connective tissue graft versus volume-stable collagen matrix with modified coronally advanced flap for the treatment of multiple adjacent gingival recessions: A randomized clinical trial with molecular analysis | 1/3/2023 | 28-02-26 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1497 | Dr. Upendra Baitha | Correlation of muscle strength and hand grip with body composition in different body mass index participants | 1/3/2023 | 28-02-26 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1528 | Dr. Ritu Gupta | Characterizing the functional role of DNA binding domain lacking novel alternative splice form of TETI in acute myeloid leukemia, leukemic stem cells and can it be chemically targeted | 1/3/2023 | 28-02-26 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1553 | Dr. Ambuj Roy | Effectiveness of yoga based cardiac rehabilitation (yoga-care) programme in heart failure: A randomized controlled clinical trial | 1/3/2023 | 28-02-26 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1464 | DR. NEENA MALHOTRA | Effectiveness of An individualized lifestyle intervention in Pcos Women Who wish to conceive: A Multi-Centred Randomized Controlled Trial | 1/3/2023 | 28-02-26 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1525 | DR. NEENA MALHOTRA | Role of autologous stem cells and platelet rich plasma therapy for regenerating endometrium in women with asherman's syndrome and atrophic endometrium- A pilot study | 1/3/2023 | 28-02-26 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1522 | Dr. Namrata Sharma | Differentiation, molecular characterization & translation application of culture expanded human corneal endothelial | 1/3/2023 | 28-02-26 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1515 | Dr. Sujata Satapathy | Development of a Bi-Lingual Mobile-App based Neuro-cognitive screening tool for early identification of children aged 3-11 years with Autism and ASD Co-morbid with ADHD | 1/3/2023 | 28-02-26 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1514 | DR. SAMEER BAKHSHI | Decoding mitochondrial heterogeneity and deciphering potential therapeutic targets in pediatric acute myeloid leukemia | 1/3/2023 | 28-02-26 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1484 | DR. URVASHI B. SINGH | Validation of Indigenously Developed Doagnostic Kit based on Detection of Proteomic markers from Urine for Diagnosis of Pulmonary and Extra-pulmonary Tuberculosis | 1/3/2023 | 28-02-26 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1517 | DR. SANJEEV SINHA | To evaluate thee treatment outcomes and extent of adherence of National TB Elimination Programme (NTEP) among various surgical and non-surgical specialties in extra-pulmonary tuberculosis patients: a multicentric prospective cohort study | 1/3/2023 | 28-02-25 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1508 | Dr. Sharmistha Dey | ECM proteins as blood-based biomarkers and therapeutic target for Alzheimer's disease | 1/3/2023 | 28-02-26 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1549 | Dr. Avinash Chakrawarty | Blood plasma derived exosomal profiling of cytokines and chemokines in frail elderly and assessment of impact of Nordic walking intervention on exosomes | 1/3/2023 | 28-02-26 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1511 | DR. NAVAL K.VIKRAM | A study on association of Metabolic Dysfunction Associate Fatty Liver Disease (MAFLD) and dynapenia/sarcopenia with cardio-metabolic risks | 1/3/2023 | 28-02-26 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1529 | Dr. Gagan Hans | Magnetic resonance spectroscopy in depressed subjects treated with electroconvulsive therapy | 1/3/2023 | 28-02-26 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1530 | Dr. Vivek Shankar | :Obesity-A risk factor for intervertebral disc degeneration: An exploratory study by biochemical parameters | 1/3/2023 | 28-02-26 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1634 | Dr. Vivek Shankar | Obesity-A risk factor for intervertebral disc degeneration: An exploratory study by biochemical parameters | 1/3/2023 | 28-02-26 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1500 | DR. R.LAKSHMY | To study the association of circulating endothelial progenitor cells (EPC) with intrinsic capacity (IC) in older adults | 1/3/2023 | 28-02-25 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1527 | Dr. Pooja Gupta | To evaluate the anticancer activity of ivermectin with gefitinib in epidermal growth receptor mutated lung cancer cell line and xenograft mouse model | 2/3/2023 | 1/3/2026 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1567 | Dr. Keshav Goyal | Infrared pupilometry as a diagnostic tool in assessment of Non convulsive status epilepticus in severe TBI patients at level-1 trauma centre in India | 6/3/2023 | 5/3/2025 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1540A | Dr. Sudhir K Gupta | Establishing the cause in sudden unexplained deaths in Young | 9/3/2023 | 8/3/2025 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1540 | Dr. Sudheer Arava | Establishing the cause in sudden unexplained deaths in Young | 9/3/2023 | 8/3/2025 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1543 | Dr. AMIT GUPTA | To study the effectiveness of trauma quality improvement programs (TQIP's) in improving Trauma Care outcomes at Tertiary Care Hospitals in India | 15-03-23 | 14-03-26 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1545 | Dr. Saroj Kumar | Development of exosome-based drug delivery system for naturally inspires novel multifunctional Neuroprotective molecules and their biological evaluation in Alzheimer's disease models | 15-03-23 | 14-03-26 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1554 | Dr. Sanjeev Kumar Bhoi | Adaptive model to strengthen facility-based emergency care system for providing quality emergency care among red triage patients (Time sensitive and other emergencies) at all levels of health care facilities | 15-03-23 | 14-03-26 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1535 | Dr. Shalini Gupta | Design and development of a safe portable, economical, non-invasive, point of care digital infrared imaging system for screening and early detection of oral cancer an exploratory pilot study | 15-03-23 | 14-03-26 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1621 | Dr. Ranjit Kumar Sahoo | Breaking plasticity of CCL18/CD163+ Tumor associated macrophages for improving response of refractory cases of Choronic Myeloid Leukemia towards chemotheray | 20-03-23 | 19-03-26 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1566 | Dr. Vishnu V.Y. | Identification of the genetic architecture of facioscapulohumeral muscular dystrophy in India | 24-03-23 | 23-03-26 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1558 | Dr. Shashank Chauhan | Post-burn Scars and contractures: A hospital-based study of the burden of disease socioeconomic and clinical factors affecting the outcome and steps to mitigate them | 24-03-23 | 23-03-25 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1563 | Dr. Sudheer Arava | Clinicopathological correlation and amyloid subtyping in cases of cardiac amyloidosis: an observational study | 24-03-23 | 23-03-26 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1573 | DR. ANITA DHAR | An observational study to evaluate the role of impaired NAD+ biosynthesis in calf skeletal muscle dysfunction in people with peripheral artery disease | 24-03-23 | 23-03-26 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1548 | DR. R.LAKSHMY | Effect of augmentation of intracellular BH4 levels, by GTPCH-I gene transfer, on nitric oxide synthase activity, protein levels and dimerization in ECFCs from CAD patients and its effect on ECFC functionality | 24-03-23 | 23-03-25 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1574 | Dr. Prashant Jauhari | Intermediate and log-term therapeutic efficacy of rTMS in drug refractory focal epilepsy of childhood: A randomized, Double-blind, Sham-controlled study | 24-03-23 | 23-03-26 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1569 | Dr. Anjan Kumar Dhua | Infrared signature of pediatrics surgical wound thermographic profiles and early-stage test-accuracy study to predict the surgical site infection and development of deep learning based artificial intelligence technique for automatic image segmentation | 25-03-23 | 24-03-26 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1562 | Dr. Ajay Godwin Potnuri | Evaluation of Guduchi Sattva for its anti-platelet and thrombolytic potential using in-vitro experimental models | 25-03-23 | 24-03-25 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1503 | DR. Rohit Bhatia | Medical Application based post stroke care strategy for survivors and their caregivers: A Randomized controlled trial (MOBILITY) for survivors and their caregivers: a randomized controlled & hospital (CMC), Ludhiana, Punjab | 25-03-23 | 24-03-26 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1564 | Dr. Sujata Satapathy | Early detection and rehabilitation of Neuro-Cognitive and Psycho-Behavioural deficits in children with cancers: Development of a screening scale and a Double-blind Randomized control study | 25-03-23 | 24-03-26 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1547 | Dr. Jyotirmoy Banerjee | Deciphering the role of platelets in drug resistant epilepsy | 25-03-23 | 24-03-26 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1560 | Dr. Mayank Singh | Elucidation of Molecular mechanism of Oncogenesis mediate by Ubiquitin specific peptidase 37 (USP37) and its therapeutic potential in prostate cancer | 27-03-23 | 26-03-26 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1568 | DR. SAMEER BAKHSHI | Estimation of the prevalence of Epstein Barr virus positivity in aggressive mature B-Non-Hodgkin Lymphoma in the Indian subcontinent and deciphering the genetic basis of its impact on disease biology and survival | 27-03-23 | 26-03-26 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1544 | Dr. Prasenjit Das | Development and validation of explainable deep learning network-based software for automated interpretation & grading of Duodenal mucosal biopsies from patients with celiac disease | 1/4/2023 | 31-03-25 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1551 | DR. ARUNDHATI SHARMA | Development of Artificial intelligence-based models for prediction of Self-Harm amongst the patients of depression | 1/4/2023 | 31-03-26 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1575 | Dr. Sujata Sharma | Exploring the structure-function interrelationships of type 1 and type 2 Ribosome inactivating proteins (RIPs) from iris bulbs for Anti-Tumor Activity | 1/4/2023 | 31-03-26 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1519 | Dr. Venkatesan Sampath Kumar | Cross Sectional Hospital based study to assess prevalence of knee deformities in children and its correlation with Nutritional status and regulators of bone metabolism | 1/4/2023 | 31-03-26 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1550 | DR. PUNIT KAUR | Designing Novel Inhibitory Molecules to Quorum Sensing in Gram-Negative Bacteria | 1/4/2023 | 31-03-26 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1582 | Dr. Manjunath Maruti Pol | RNA-seq based case-control study to identify alternatively spliced events in colorectal adenocarcinoma-Bioinformatics and genomics-based study | 1/4/2023 | 31-03-26 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1565 | Dr. Pradeep Sharma | Identification of novel drug molecules against a lethal angionvasive disease, mucormycosis | 1/4/2023 | 31-03-26 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1576 | DR. NEENA MALHOTRA | Prospective evaluation of etiological factors, trajectory of comorbidities and efficacy and safety of various therapeutic agent among Indian women with polycystic ovary syndrome (PCOS): A Multicentric ICMR-PCOS Cohort study Phase-II | 15-05-23 | 14-05-28 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1577 | Dr. T. Velpandian | Exlporing the interplay of the sex steroid hormone intracrinology with the sphingolipid metabolism in the pathogenesis of vernal keratoconjunctivitis | 15-05-23 | 14-05-25 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1555 | Dr. Ashish Bindra | Micronutrient deficiency in children with moderate to severe traumatic Brain Injury: Burden and association with outcome | 16-05-23 | 15-05-26 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1556 | Dr. Harlokesh Narayan Yadav | Design and Development of wirlessly powered nanoscale integrated antenna Enbaled Ladies Cardiac Pacemaker Systerh for Wirless Monitoring of Heart Health | 1/6/2023 | 31-05-26 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1557 | Dr. Shashank Chauhan | Prevalence of cyanide poisoning in victims of burn injuries-A Hospital based study | 1/6/2023 | 31-05-26 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1467 | DR. M.C. SHARMA | Unravelling RNA Landscape in posterior fossa ependymal tumors using integrative transcriptome analyses | 1/6/2023 | 31-05-26 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1475 | Dr. Prabhakar Singh | To study the role of cholinergic transmission on the amyloid beta induced neurodegeneration and therapeutic interventions for Alzheimer's disease | 5/6/2023 | 4/6/2026 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1539 | Dr. Dinu S Chandran | Functional and Biochemical assessment of cardiovascular sequelae in COVID-19 survivors and its association with imbalance in Renin Angiotensin Aldosterone pathway: an observational study | 15-06-23 | 14-06-26 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1586 | Dr. Hari Krishna Raju Sagiraju | Oral Potentially malignant lesion atlas project: Validating the efficacy of novel, point-of-Care diagnostic and developing an integrated multimensional, prognostic nomogram | 15-06-23 | 14-06-26 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1415 | Dr. Awadh Kishore Pandit | Fever, Hyperglycemia, Swallowing and hypertension management in acute stroke: A cluster randomized: Trial (Indian Quality Improvement in stroke care study (FeSSH) phase-II | 1/7/2023 | 30-06-25 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1581 | DR. R.LAKSHMY | Diet and Biomarker survey in Indian (DABS-1) | 1/7/2023 | 30-06-25 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1559 | Dr. Nasreen Akhtar | Nuclear Factor kappa B activation, Hypoxia inducible Factor-1 and inducible Nitric Oxide Synthase expression in human vascular endothelial cells by serum of adults with obstructive Sleep Apnea. | 15-07-23 | 14-07-26 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1588 | Dr. Deepika Mishra | Generate Medical imaging datasets (MIDAS)for tobacco induced oral lesions to enhance research in health in India | 1/8/2023 | 31-07-26 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1520 | Dr. Ritesh Kumar Netam | Neural Mechanism of sleep deprivation induced metabolic changes in rats | 1/8/2023 | 31-07-26 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1583 | Dr. Prasun Chatterjee | Validating Biomarker panel in five different cohorts to define and predict biological ageing, disease burden and mortality in human subjects-A Pilot prospective cohort study | 14-08-23 | 13-08-26 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1643 | DR. NITISH NAIK | Effectiveness of Indoor air purifiers on Heart Failure outcomes (The PURI-HF Trial) | 1/9/2023 | 31-08-26 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1594 | Dr. Prabhat Singh Malik | Evaluation of low dose nivolumab with neoadjuvant chemotherapy in non-small cell lung cancer | 1/9/2023 | 31-08-26 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1516 | Dr. D. N. Sharma | Involved quadrant irradiation (IQI) post breast conservation Surgery: A phase 3 randomized controlled trial | 1/9/2023 | 31-08-26 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1587 | Dr. Nishant Verma | Proteomics study of glardia intestinails isolates to associate with different clinical spectrum and extrapolate its invasive potential | 4/9/2023 | 3/9/2026 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1623 | Dr. Deepti Vibha | Music Therapy for rehabilitation in post-stroke non-fluent aphasia: the Indian adaptation | 25-09-23 | 24-09-26 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1599 | Dr. Shashank Chauhan | Evaluation of inflammatory salivary biomarkers as a surrogate indicator of systemic response to thermal burn injuries: an observational study | 25-09-23 | 24-09-26 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1610 | Dr. Roopa Rajan | Reproductive Transcranial Magnetic Stimulation to the inferior parietal Lobule in Task specific focal hand dystonia: A crossover, Sham-control, Blinded outcome Assessment study | 25-09-23 | 24-09-26 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1614 | Dr. Rohan Malik | Whole exome sequencing to detect the prevalence of monogenic variants in an Indian Pediatric Cohort with Inflammatory bowel disease | 25-09-23 | 24-09-26 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1608 | Dr. Bhavuk Garg | Integration and application of artificial intelligence in care of patients with scoliosis | 27-09-23 | 26-09-26 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1606 | Dr. Vijay Sharma | Establishment of a fragility fracture Liaison Service at AIIMS: A multicentric study | 27-09-23 | 26-09-26 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1609 | Dr. Bhavuk Garg | Determination of safety and feasibility of thoracic laminar screw through morphometric analysis and cadaveric use followed by the development of a commercially viable laminar screw insertion system | 29-09-23 | 28-09-26 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1639 | Dr. Samarth Mittal | Comparison of conventional remaining technique with reamer irrigator aspirator (RIA) for hemodynamic, cardiac changes and embolic load during fixation of shaft femur fracture using an intramedullary nail and estimation of osteogenic growth factors in RIA graft aspirate | 29-09-23 | 28-09-26 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1589 | Dr. Anu Gupta | Efficacy of Bacopa monnieri Linn on cognitive functions & alterations in blood metabolites in patients with amnestic mild cognitive impairment and early Alzheimer Disease: A double-blind, randomized placebo-controlled trial | 1/10/2023 | 30-09-26 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1783 | Dr. Sunil Kumar | Population Based Cancer Registry in India | 1/10/2023 | 30-09-26 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1600 | DR. URVASHI B. SINGH | Development of Surface Plasmon Resonance Array Biosensor for Rapid Molecular Drug Resistance Detection for MDR and XDR TB | 15-10-23 | 29-09-25 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1613 | Dr. Senjam Suraj Singh | Assessment of unmet needs and access to assistive technologies among the general population through digital Rata tool-cross-sectional survey in India | 15-10-23 | 14-10-25 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1637 | Dr. Puneet Misra | A randomized controlled trial to see effect of community-based yoga program on diabetes, blood pressure, lipid profile and wellness in Rural and Tribal Community Setting, and its feasibility to integrate with Health and Wellness centres (HWC) in the Country | 15-10-23 | 14-10-25 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1612 | Dr. Ranjan Gupta | Antinuclear Antibody Immunofluorescence pattern in systemic lupus Erythematosus: Diagnostic and prognostic evaluation using artificial intelligence | 15-10-23 | 14-10-25 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1611 | Dr. Prabhoo Dayal | Development & pilot testing of a Biomarker feedback and Cognitive-social Health information-Processing (C-SHIP) Model Based Novel Multi-component intervention for Smokeless Tobacco Cessation during Pregnancy | 16-10-23 | 15-10-26 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1605 | Dr. Seema Singhal | Diagnostic and Prognostic value of cell free DNA (cfDNA) in epithelial ovarian cancer-A cohort study | 16-10-23 | 15-10-26 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1601 | Dr. Ritu Gupta | Development of an innovative low-cost deployable AI-based diagnostic tool (BCanDL tool) for hematopoietic cancers and creation of blood cancer cell atlas (BCanCell Atlas) | 16-10-23 | 15-10-26 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1631 | DR. SAMEER BAKHSHI | Improving survival in childhood-Acute Lymphoblastic Leukemia in India (IS-CALL): ICiCLE implementation study | 16-10-23 | 15-10-26 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1617 | Dr. Vivek Tandon | Pilot study to develop a 5-ALA based immunofluorescence platform utilizing indigenously developed visualization device and to study its impact on extent of resection in high-grade Gliomas in a case-control study | 16-10-23 | 15-10-25 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1632 | Dr. Akash Kumar | Improving survival in childhood-Acute Lymphoblastic Leukemia in India (IS-CALL): ICiCLE implementation study | 16-10-23 | 15-10-26 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1616 | Dr. Kalpana Bansal | Effectiveness of a Smart Phone based educational app versus conventional method to improve the oral health of children in day care centres-a cluster randomized trial | 20-10-23 | 19-02-26 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1641 | Dr. Samarth Mittal | Effectiveness of institutional physio therapeutic intervention on functional movement, strengthening and flexibility among school going sports children aged 15-18 years: A cluster randomised controlled trial | 25-10-23 | 24-10-25 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1615 | DR. SOMESH GUPTA | Development of a metabolite based point-of-care test for diagnosis of bacterial vaginosis in Indian Women | 27-10-23 | 26-10-26 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1604 | Dr. Chittaranjan Behera | Establishment of multi-centre identification portal and DNA database for identification of unidentified dead bodies in India by using molecular, bioinformatics tools and techniques | 1/11/2023 | 31-10-26 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1622 | DR. RAKESH LODHA | SAFE-ICU: An Open Big-Data and Reproducible AI Resource for Early Prediction of Intensive Care Outcomes | 1/11/2023 | 31-10-26 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1624 | Dr. Deepali Garg | Expression of immune checkpoints in circulation and at maternal-fetal interface and its correlation with whole exome sequencing based genetic variants in pre-eclampsia patients | 15-11-23 | 14-11-26 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1638 | DR. VANDANA JAIN | Effect of millet and legume-based complementary feeding intervention from 6 mo to 2y of age on growth, hemoglobin and body composition in term near-term low birth weight infants: A randomized controlled trial | 16-11-23 | 15-11-26 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1636 | Dr. Sachit Anand | Influence of Vitamin D-Binding protein gene polymorphisms on Urinary microbiome-Metabolome profiles of children with Congenital Uropathies prone to Urinary tract infections | 1/12/2023 | 30-11-26 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1642 | DR. RACHNA SETH | Improving survival IN childhood Acute Lymphoblastic Leukemia in India (ISCALL): ICiCLe implementation study | 1/12/2023 | 30-11-26 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1626 | Dr. Rajesh Kumar Singh | Comparison of simultaneous plasma exchange (PLEX) and Intravenous methylprednisolone (IVMPS) versus IVMPS with add on PLEX in the treatment of acute severe myelitis of Neuromyelitis optica spectrum disorders (NMOSD): A prospective randomized open label blinded (PROBE) study | 1/12/2023 | 30-11-26 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1619 | DR. RACHNA SETH | Integration of targeted gene sequencing in BCR- ABL like pediatric acute lymphoblastic leukemia (ALL): Role of specific genetic alteration and their association with clinical presentation, outcomes and clonal diversity at relapse | 15-12-23 | 14-12-26 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1629 | Dr. Baibaswata Nayak | Hypoxia, angiogenesis and stemness markers predicting outcome of locoregional and immunotherapy for hepatocellular carcinoma | 18-12-23 | 17-12-26 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1651 | Dr. Geetanjali Bade | Immune signatures and role of neutrophils in pathophysiology of post tuberculosis pulmonary sequelae | 1/1/2024 | 31-12-26 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1648 | Dr. Ranveer Singh Jadon | A randomised controlled trial of vitamin D supplementation on leukocyte telomerase length and telomerase activity in obese individuals from north Indian with non-alcoholic fatty liver disease | 1/1/2024 | 31-12-26 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1649 | Dr. Amandeep Singh | Evaluation the association of Fatty Kidney with Risk of cardiometabolic disorders and kidney functions: A comparative study of metabolically healthy and unhealthy obese and non obese Asian Indian Individuals | 1/1/2024 | 31-12-26 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1656 | Dr. Jayanth Kumar | Customization Development of a CRISPR-Case based AAV (Adeno Associated Virus) vector for HDR (Homology Directed Repair) mediated genetic correction as a therapeutic intervention for Gaucher's disease | 10/1/2024 | 9/1/2027 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1633 | Dr. Kapil Sikka | A study on frailty, cognitive dysfunction and associated comorbidities with Hearing loss in Geriatric population | 14-01-24 | 13-01-27 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1717 | Dr. Kana Ram Jat | Culture of nasal epithelial cell for diagnosis of primary Cliiary Dyskinesia | 15-01-24 | 14-01-27 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1669 | Dr. Puneet Misra | Efficacy and safety of Punarnavadi Mandura alone and in combination with Drakshavaleha compared to iron folic acid in the treatment of moderate iron deficiency anaemia among non-pregnant women of reproductive age group: A community based three arm multi-centre randomized controlled trial | 15-01-24 | 14-07-25 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1630 | Dr. Satyavir Yadav | Oral Anticoagulation (Vitamin K antagonist) for Pulmonary Artery Hypertension(PAH) - A pilot randomized Control Trial | 15-01-24 | 14-01-27 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1652 | Dr. Satyavir Yadav | Oral Anticoagulation (Vitamin K antagonist) for Pulmonary Artery Hypertension(PAH) - A pilot randomized Control Trial | 15-01-24 | 14-01-27 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1654 | Dr. Siddharth Jain | Efficacy and Safety of leuprolide acetate in reducing ovarian toxicity of intravenous cyclophosphamide in young females with autoimmune rheumatic diseases: An assessor-blineded, randomized controlled trial | 15-01-24 | 14-01-27 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1650 | Dr. S Arulselvi | Study of Vitamin D receptor (VDR) gene polymorphism and vitamin D deficiency in North Indian patients with Intervertebral disc (IVD) degeneration | 15-01-24 | 14-01-27 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1657 | Dr. Atul Batra | An investigator-initiated phase II randomized controlled trial of low-dose pembrolizumab in addition to standard neoadjuvant chemotherapy in patients with triple negative breast cancer | 15-01-24 | 14-01-27 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1653 | Dr. Animesh Ray | Development and Validation of Immunoassays to Aid in Diagnosis and Assessing treatment response in Chronic Pulmonary Aspergillosis | 15-01-24 | 14-01-27 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1658 | Dr. Divya M R | Pan-India multicentric study on NeuroCYSTicercosis: unravelling its metabolOMICs and proteOMICs architecture to enable its diagosis and understand epilepsy(CYST-OMICS) | 15-01-24 | 14-01-27 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1670 | Dr. Tej Prakash Sinha | Evaluation of the waterbath ultrasound technique (WBT) in the diagnosis of distal hand and foot injuries in the emergency department | 15-01-24 | 14-07-26 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1668 | Dr. Seema Singhal | Evaluation of self-collection with an indigenous device and point of care HPV test for cervical cancer screening (Self-Care Cervix study) | 16-01-24 | 15-01-27 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1700 | Dr. Akshay Kumar | Improving crucial procedures in Emergency Department Resusciation Area-Emergency Airway Management and Cardiac Arrest CARE-an implementation Research Project | 20-01-24 | 19-01-27 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1595 | Dr. Shweta Kedia | Creation of Gold standard Medical imaging datasets of dural based lesions treated with primary Gamma knife radiosurgery or Microsurgery for developing artificial intellegence tools | 21-01-24 | 20-01-27 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1689 | DR. SUJATA MOHANTY | Assessing the Efficacy of Engineered Extracellular Vesicles Targeting NLRP3 Inflammasome in the Neuroinflammatory Disease Model | 23-01-24 | 22-01-27 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1655 | DR. RAKESH LODHA | Long Term lung function outcomes in children with intrathoracic tuberculosis: an ambispective observational study | 25-01-24 | 24-01-27 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1713 | Dr. Gour Surya Sri Krishna | Dissecting the potential molecular signature by proteomics and metabolomics in predicting the clinico-radiological course of cerebral edema following traumatic brain injury | 25-01-24 | 24-01-27 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1673 | Dr. Pramod Kumar Gautam | Elucidating the therapeutic role of docetaxel-loaded-HSP70 peptide complex in PDX Mouse Model | 29-01-24 | 27-01-27 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1675 | Dr. Jyotirmoy Banerjee | Modulators of a4-containing GABAA receptors: Potential therapy for focal cortical dysplasia (FCD) | 29-01-24 | 28-01-27 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1706 | Dr. Suvashis Dash | Development of an Artificial intelligence-based app for remote delivery of speech therapy in cleft lip and palate patients (SWARA-Speech-therapy with artificial intelligence remote assistance | 1/2/2024 | 31-01-27 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1665 | Dr. Amit Kumar Malviya | Evaluation of the effect of fibrinogen on peripartum hemorrhage in placenta accreta spectrum (PAS) disorders, a double blind randomized controlled trial | 1/2/2024 | 31-01-27 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1703 | Dr. Varun Surya | Development of a low-cost multimodal optical imaging microscopic device for early oral cancer diagnosis. | 1/2/2024 | 31-01-27 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1667 | Dr. Yatan Pal Singh Balhara | ICMRs Mltistate implementation Research Study on Integration of Screening and Management of Mental and Substance Use Disorders with Other Non Communicable Disease (ICMR-MINDS) | 1/2/2024 | 31-01-27 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1664 | DR. SEEMA SOOD | Point -of- care test development for bacterial vaginosis (BV): Bench to bedside (Clinical Validation of proof-of-concept) | 1/2/2024 | 31-01-27 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1620 | Dr. Sidharth Sharma | Development of a Prototype Lab-On-A-Chip for Rapid Microbial Detection during Nonsurgical Endodontic Therapy | 1/2/2024 | 31-01-27 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1661 | Dr. Asmita Patil | To study the protective effect of antioxidant Vitamin C and E on diesel exhaust polluted microenvironment induced testicular injury in laboratory rat | 1/2/2024 | 31-01-27 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1672 | Dr. Sanjeev Kumar Bhoi | Randomized open-labellled, phase IIa/IIb clinical trials to study the safety and efficacy of intervenous conjugated estrogen therapy in reducing the incidence of sepsis/septic shock in Trauma Hemorrhagic shock patients | 2/2/2024 | 1/2/2027 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1733 | Dr. Shalini Gupta | Evaluation of non-invasive adjuncts in OPMDs for early detection of oral cancer and development of risk-based OPMD management protocol in a primary healthcare setting | 2/2/2024 | 1/2/2027 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1687 | Dr. Uma Sharma | An integrated metabolomics and lipidomics approach for identifying biomarkers for early diagnosis and histological subtyping of the Non-Small-Cell-Ling Cancer | 2/2/2024 | 1/2/2027 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1685 | Dr. S Arulselvi | Study of association between Saliva and blood biomarkers in cognitively impaired pediatric mild head injury patients | 2/2/2024 | 1/2/2027 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1736 | DR. ANANT MOHAN | Evaluating exhaled breath condensate (EBS) as a promising non-invasive method for identification of clinically relevant genetic mutations in lung cancer | 14-02-24 | 13-02-27 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1678 | DR. ANJANA TALWAR | Effect of accute changes in ambient air pollutants on pulmonary variables, systemic and airway inflammatory markers in healthy subjects, asthmatics and COPD patients | 15-02-24 | 14-02-27 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1677 | Dr. Saurabh Mittal | A randomized controlled trial to assess the efficacy of inhaled formoterol/Glycopyrronium combination (LABA+ LAMA) vs inhaled Glycopyrronium (LAMA) alone in patients with symptomatic post tubercular lung disease | 15-02-24 | 14-02-27 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1681 | Dr. Suriya Prakash M | Therapeutic efficacy of multimodal imaging-Guided Brain Network Modulation through Personalized, Multisession, High-density Transcranial Direct Current stimulation in rug-Resistant Focal Epilepsy: A double-blind Sham-controlled study | 15-02-24 | 14-02-27 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1711 | Dr. Prakash Ranjan Mishra | Nebulized versus intravenous tranexamic acid for hemoptysis: A randomized controlled trial | 15-02-24 | 14-02-27 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1674 | Dr. Prashant T. Tayade | Effect of nostril breathing patterns in the patients of Major Depressive Disorders | 15-02-24 | 14-02-27 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1679 | Dr. Devalina Goswami | Comparison of transoral versustransnasal humidified rapid-insufflation ventilatory exchange for intubating conditions in children with difficult airway: A prospective, randomized, controlled trial | 15-02-24 | 14-02-27 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1671 | DR. PURVA MATHUR | Recurrent and Prolonged Urinary Tract Infections and its association with Gut Microbiome: A community-based study in a semi-rural setting of North India | 15-02-24 | 14-02-27 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1731 | Dr. Nayer Jamshed | Bedside, precutaneous drainage of Liver abscess in the Emergency Department by trained Emergency physicians versus radiologist- A randomised controlled trial | 15-02-24 | 14-02-26 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1778 | Dr. Archna Singh | Multisectrol Nutrition intervention for Anemia reduction initiative NARI implementation research for improving Women's Health in Tripura, India. | 15-02-24 | 14-02-27 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1698 | Dr. Subhradip Karmarkar | To investigate the effect of environmental particulate matter (urban pollutants) and heavy metal exposure on placenta trophoblast cells and fetal development | 15-02-24 | 14-02-27 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1683 | Dr. Atul Batra | Addition of low-dose pembrolizumab to capecitabine for residual triple negative breast cancer post neoadjuvant chemotherapy: An investigator-initiated multicentric open-labelled phase-III randomized controlled clinical trial | 15-02-24 | 14-02-28 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1760 | Dr. Hitender Gautam | Platform for enhanced pathogen detection for meningitis and sepsis Rapid, portable, and field-deployable diagnosis | 15-02-24 | 14-02-27 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1782 | Dr. Rajni Yadav | Development of blood-based molecular test for early detection of gallbladder cancer | 15-02-24 | 14-02-27 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1705 | Dr. Deepika Mishra | A longitudinal prospective study to develop progression prediction models of Oral Leukoplakia based on oral microbiome shifts, salivary microna biomarkers and tobacco cessation compliance | 15-02-24 | 14-02-27 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1691 | Dr. Vikram Saini | Selenium supplementation as an adjunt therapy against tuberculosis | 15-02-24 | 14-02-27 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1676 | Dr. Animesh Ray | A randomized placebo-controlled trial to assess efficacy of Vitamin-D supplementation in non-cystic fibrosis bronchiectasis patients | 15-02-24 | 14-02-27 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1682 | Dr. Supriya Mallick | A phase-II randomized controlled trial to evaluate Prophylactic cranial radiation for patients with high-risk triple-negative breast cancer and correlation with pCTC and CSF CTC | 16-02-24 | 15-02-27 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1684 | Dr. Shamim A. Shamim | Clinical Efficacy of 177Lu-FAPi radioligand therapy in metastatic Breast Cancer (mBC) Patients, refractory to other conventional treatments | 16-02-24 | 15-02-27 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1686 | Dr. Devendra Kumar Yadav | Discovery of RNA (Long non-coding) markers for CAKUT malformations predisposing to renal failure | 16-02-24 | 15-02-27 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1712 | Dr. Jayanth Kumar | Construction of therapeutic cells with synthetic circuits targeting relapse in B-cell Acute Lymphoblastic Leukemia B-ALL | 16-02-24 | 15-02-28 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1693 | Dr. Subhash Chandra Yadav | Cisplatin-encapsulated HPV virion-based targeted delivery vehicle validation on cervicectomy samples using high-resolution Cryo-Electron Tomography | 16-02-24 | 15-02-27 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1704 | Dr. Surendra Kumar Verma | Development of easy-to-use fibrin-based rapidly acting bleeding control biopolymer sheet | 16-02-24 | 15-02-27 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1786 | Dr. Yashwant Singh Rathore | A study to compare the outcomes with and without preoperative splenic artery embolization in patients with splenomegaly undergoing elective laproscopic splenectomy | 17-02-24 | 16-02-27 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1690 | Dr. Rizwana Quraishi | Hepatitis C testing using dried blood spots among people who inject drugs, with implications for diagnosis and treatment monitoring: A multi-site, cross sectional study | 20-02-24 | 19-02-27 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1709 | Dr. Ritesh Kumar Netam | To study the efficacy of Irisin and Leptin supplementation in treatment of sleep deprivation-induced Alzheimer's disease rat model | 20-02-24 | 19-02-27 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1694 | Dr. Pradeep Sharma | Development of alternative supplements to Breastmilk: A comparative study of cow, Mare and Camel colostrum on Gut Microbiota and Immunomodulation | 20-02-24 | 19-02-27 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1697 | Dr. Harshal Ramesh Salve | Air pollution imapct on Pregnancy and early childhood development in India-(APiPED Cohort) | 20-02-24 | 19-02-28 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1719 | Dr. Krishna K Inampudi | Integrative Proteomics and Metabolomics Analysis of Plasma and Exosomes for early diagnosis of Non-Small Cell Lung Cancer | 23-02-24 | 22-02-27 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1726 | Dr. Sudheer Arava | To identify the the genetic landscape of hypertrophic car (HCM) in Indian scenario | 23-02-24 | 22-02-27 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1716 | Dr. Pawan Kumar | Development and evaluation of recombinant mycobacterium indicus pranil (MIP)-based therapeutic vaccine HPV to mitigate cervical cancer risk in women with established virus infection | 23-02-24 | 22-02-27 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1692 | DR. PURVA MATHUR | Multi-Analytes lateral flow immune assay for the detection of sepsis and multi-organ dysfunction syndrome in post-trauma patients | 25-02-24 | 24-02-27 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1680 | Dr. Avinash Kumar | Chronic pancreatitis induces mitochondrial dysfunction and proteostasis in skeletal muscle | 1/3/2024 | 28-02-27 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1688 | DR. SAMEER BAKHSHI | 16S rDNA amplicon and metageonomic nanopore sequencing for rapid detection of bacterial pathogens in febrile neutropenia for pediatric acute leukemia and hematopoietic stem cell transplant | 1/3/2024 | 28-02-27 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1762 | DR. SUJATA MOHANTY | Functionalized 3D printed Tracheal Analogue for multivariate translational applications | 1/3/2024 | 28-02-27 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1696 | DR. NIKHIL TANDON | Strengthening ambulatory care for Non--Communicable disease in North India (STAR-NCD) | 1/3/2024 | 28-02-27 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1776 | DR. RAJESH SAGAR | Development and validation of scale for Assessment of High-risk attitudes and risky sexual behavior SAHAS Tool for high risk Indian youth | 1/3/2024 | 28-02-27 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1737 | Dr. Kanwaljeet Garg | Expansile duraplasty in patients with complete cervical spinal cord injury- A Prospective randomized open blinded End-Point (PROBE) Study | 1/3/2024 | 28-02-27 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1708 | Dr. Suman Das | Developing a combinatorial bio-marker based on encephalic and metabolome profile to differentiate functional dissociative seizures from epilepsya | 1/3/2024 | 28-02-27 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1756 | Dr. Ambuj Roy | Influenza vaccine to reduce cardiovascular events in patients with recent myocardial infarction: a multicentric randomized, double-blind, placebo-controlled trial. | 1/3/2024 | 29-02-28 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1695 | Dr. Sumit Malhotra | Strengthening ambulatory care for Non-communicable disease in North India (STAR-NCD) | 1/3/2024 | 28-02-27 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1727 | Dr. Subhradip Karmarkar | An integrated assessment to improve the efficacy of gene expression based PAM50 classifier with additional miRNA and Epigenetic signature to improve prognostication in Breast Cancer using PDX based platform | 1/3/2024 | 28-02-27 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1710 | Dr. Manish Soneja | Efficacy of montelukast in reducing of warning signs and severe disease in patients with dengue fever: a phase 2, double-blind, placebo-controlled randomized trial | 1/3/2024 | 28-02-27 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1722 | Dr. Sujata Satapathy | School-based transdiagnostic Trauma-focused CBT for Adolescents with depression, anxiety and PTSD: A parallel group RCT in Low, moderate, and High crime hotspots in Delhi-NCR | 1/3/2024 | 28-02-27 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1702 | Dr. Aanchal Kakkar | Multiplexed analysis of protein signature of the invasive front of Oral squamous carcinoma | 1/3/2024 | 28-02-27 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1701 | Dr. Prabudh Goel | Multi-centric Pan-India study to Develop pediatric solid tumor gene panel for the Indian population through whole exome sequencing | 1/3/2024 | 28-02-27 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1715 | Dr. Aditi Sinha | Program complement mediated kidney diseases: Developing commercial ELISA and pipelines for genetic screening, identifying biomarkers, and refining therapies | 1/3/2024 | 29-02-28 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1770 | Dr. Ekta Dhamija | Development of a Non-Invasive Machine learning-based method to predicting axillary Lymph Node Metastasis in Breast Cancer Patients using Ultrasound | 1/3/2024 | 28-02-27 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1666 | Dr. Supriya Mallick | Designing and implementation of health care model in patients with stage 2 breast cancer | 2/3/2024 | 1/3/2027 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1721 | Dr. Upendra Baitha | Long-Term exposure to air pollution and their correlation with disease severity and outcomes in patients with influenza-like illness and COVID-19 in North Indian Population: A prospective multi-centric study | 15-03-24 | 14-03-27 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1718 | DR. PURVA MATHUR | Molecular detection of Rheumatogenic Cluster of Streptococcus Dysgalactiae subsp. Equisimilis (Group C, G) in India: Early prediction of Rheumatic heart disease | 15-03-24 | 14-03-27 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1663 | Dr. Y.S.Kusuma | Equitable, Quality Universal health coverage Implementation research project for optimizing comprehensive primary health care through Health and Wellness Centres in Alluri Sitharama Raju tribal district of Andhra Pradesh-EQUIP-HWCs | 16-03-24 | 15-03-27 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1707 | Dr. Animesh Ray | Nebulized amphotericin B added to oral ozoles in chronic pulmonary aspergillosis patients: A placebo-controlled, Double-blinded multicentric Randomized controlled trial | 20-03-24 | 19-03-28 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1607 | Dr. Prabudh Goel | Laying the foundation of Hypospadias Registry (Epidemiology & Clinical Profile) in India | 20-03-24 | 19-03-27 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1730 | Dr. Subhradip Karmarkar | Study of molecular profile of Nasopharyngeal carcinoma in the north eastern region and its relation of Epstein Barr virus (EBV) infection | 20-03-24 | 19-03-27 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1725 | Dr. Piyush Ranjan | To study the epidemiology of drowing, address the need, developing IEC material and imparting the related training to at-risk school students of schools in the Yamuna River at Delhi- Prospective, non-randomized, interventional study | 25-03-24 | 24-03-27 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1740 | Dr. Shivangi Saha | Evaluation of novel dipstick-based molecular techniques for early detection of Gram-negative ESKAPE (KAPE) organism and antimicrobial resistance genes in burn wounds | 28-03-24 | 27-03-27 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1739 | DR. DEEPAK AGRAWAL | Development of risk management and health monitoring system on ventilated severe TBI patients using the concept of digital twins and probabilistic modeling | 1/4/2024 | 31-03-27 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1714 | Dr. T. Velpandian | TLRA4 linked Gut-Ocular Axis in the idiopathic uveitis: Potential pathway for Rationalizing treatment strategies | 1/4/2024 | 31-03-28 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1742 | DR. VINEET AHUJA | Identification of Sphingolipid-and Eicosanoid-based signatures as potential Diagnostic, prognostic, and Therapeutic targets for Inflammatory Bowel Disease Subtypes | 2/4/2024 | 1/4/2027 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1659 | Dr. Anju Gupta | Effect of Anaesthetic Agents on Intestinal Microbiome and Cognition in Paediatrics patients undergoing elective surgeries | 2/4/2024 | 1/4/2027 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1755 | Dr. Krishna K Inampudi | Preclinical assessment of a novel tyrosine Kinase Inhibitor, KK104 as a promising therapeutic agent for Non-Small Cell Lung Cancer (NSCLC) using Mice xenograft model | 9/4/2024 | 8/4/2027 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1728 | Dr. Satyavir Yadav | To study the role of Natriuretic peptides, NPs NPPA, NPPB in hypertensive heart disease and to investigate the effect of MTHFR-NPPB locus containing both NPPA and NPPB polymorphism and its epigenetic modifications on cardiovascular risk | 10/4/2024 | 9/4/2027 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1744 | Dr. S. Ramakrishnan | Routine Invasive Vs Ischemia Driven Strategy in Patients with ST-Segment-Elevation Myocardial Infarction presenting between 12-72 hours of Symptom onset (LATECOMER TRIAL | 15-04-24 | 14-04-28 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1746 | Dr. Rahul Yadav | To evaluate the efficacy and stability of transport disk distraction osteogenesis in ramus condyle unit reconstruction in adult population with temporomandibular joint ankylosis | 15-04-24 | 14-04-28 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1753 | Dr. Megha Brijwal | To enhance the quality of infectious disease diagnosis in India through implementation of an External Quality Assurance Program | 15-04-24 | 14-04-27 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1720 | Dr. Piyush Ranjan | Breaking barriers in fungal sepsis diagnosis and artificial resistance detection: evaluation FTIR as a cutting-edge modality | 15-04-24 | 14-04-27 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1754 | DR. NEERJA GUPTA | Application of expanded Newborn Screening integration of Metabolomics and Genomics for second Tier DNA Analysis | 1/5/2024 | 30-04-27 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1767 | DR. HARI PRASAD G | Advance center for clinical evaluation of Diagnostics of National Importance | 1/5/2024 | 30-04-27 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1748 | DR. AJOY ROYCHOUDHRY | Developing first indigeneous patient specific alloplastic total temporomandibular joint replacement system and its evaluation on mandibular kinematics, quality of life and survivability of implant in patients requiring temporomandibular joint replacement- Prospective Observational study | 1/5/2024 | 30-04-27 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1741 | DR. VINEET AHUJA | Should colorectal Cancer screening be done is Asymptomatic Indians: A Pan-India multicenter study | 1/5/2024 | 30-04-28 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1765 | Dr. Prakash Ranjan Mishra | Prospective-open-lable-singleArm-Interventional-Multicentric-Pilot-Study to evaluate the safety and effectiveness of Ozyn-DTM, a novel Intraosseous device for delivery of medications and Fluids. | 1/5/2024 | 30-04-27 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1745 | Dr. Bimal Kumar Das | Detection of Salmonell serovars and their associated resistance markers directly from blood specimen using paper-based DNA biosensor | 13-05-24 | 12/5/2026 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1743 | Dr. Thoudam Debraj Singh | ERR-? as a biomarker and therapeutic target for lung cancer and to investigate the synergetic anti-tumor effect of DN200434 (ERR? inverse agonist) and MK2206 (Akt inhibitor) in lung cancer in vivo | 15-05-24 | 14-05-27 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1761 | Dr. Tanu Sagar | Establishment of centre of Advanced Research for Bacteriophage Research and Therapy to combat Multidrug resistant infections caused by ESKAPE pathogens | 15-05-24 | 14-05-29 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1757 | DR. D.K.MITRA | Susceptibility to active tuberculosis infection in individuals with Type-2 Diabetes: A possible relevance of immune exhaustion | 23-05-24 | 22-05-27 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1759 | DR. VATSLA DADHWAL | Development, implementation and evaluation of protocolized Cardio-Obstetrics Care in improving maternal Cardiac, obstetrics and fetal outcomes of pregnant Women with Heart Diseses in INDIA | 1/6/2024 | 31-05-28 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1758 | DR. D.S.ARYA | Randomized double-blind placebo-controlled clinical trial an exploratory study to investigate the efficacy of moclobemide as an add-on treatment in castration-resistant prostate cancer patients | 1/6/2024 | 31-05-26 | Indian Council of Medical Research (ICMR) | ICMR |
| T-322 | Dr. Krishna K Inampudi | ICMR –DHR International Fellowship | 24-06-24 | 23-06-25 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1750 | Dr. Kapil Sikka | Pre-compliance and clinical validation of implantable and diagnostic devices (Otorhinolaryngology, Ophthalmic, and Orthopaedics | 1/7/2024 | 30-06-29 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1738 | Dr. Raman Deep | A study to develop and evaluate a manual-assisted, tailored brief intervention (B1) for cardiovascular risk reduction (vs care as usual) in patients with depression: A two-arm parallel randomized control trial (RCT) | 1/8/2024 | 31-07-27 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1644 | Dr. Deepak Gunjan | INDIAn asymptomatic gallStone: natural course and their predictors (INDIASTONE STUDY) | 5/8/2024 | 4/8/2027 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1747 | DR. NIKHIL TANDON | Drug intervention for prevention of type 2 diabetes among women with prior gestational diabetes mellitus and pre-diabetes in South Asia (DIVINE): A randomized control Trial | 1/9/2024 | 31-08-28 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1768 | Dr. Deepam Pushpam | ICiCLe-ALL-24 The Indian collaborative childhood leukemia randomised trial for children and adolescents with Acute lymphoblastic leukemia 2024 | 1/9/2024 | 31-08-28 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1769 | Dr. Pallavi Shukla | Implementation Research to enhance screening, Early diagnosis and Initiation of treatment for oral, Breast and cervical cancer in selected districts of India | 2/9/2024 | 1/9/2027 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1772 | DR. VINEET AHUJA | ICMR-CAR Gut Microbiome manipulation therapist in intestinal disease clinical trials networked centre. | 13-09-24 | 12/9/2029 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1764 | DR. VAISHALI SURI | Transforming CNS tumor Care: Harnessing Histopathological Data, Multiomics and Artificial Intelligence for precision Diagnosis and effective management | 16-09-24 | 15-09-29 | Indian Council of Medical Research (ICMR) | ICMR |
| T-327 | Dr. Ahitagni Biswas | ICMR-DHR Fellowship | 1/10/2024 | 30-09-25 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1773 | Dr. Mohan Lal Bairwa | Strategies for enhanced population engagement and health care seeking for prevention and control of hypertension and diabetes in India: The STEPS-INDIA Multi-Centre Study. | 15-10-24 | 14-10-28 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1777 | Dr. S. Ramakrishnan | Centre for Advanced Research in Pulmonary Hypertension | 30-10-24 | 29-10-29 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1775 | DR. RACHNA SETH | ICiCLe-ALL-24- The Indian collaborative childhood leukemia randomized trial for children and adolescents with acute lymphoblastic leukemia2024 | 1/11/2024 | 31-10-28 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1779 | DR. KALPANA LUTHRA | Comparative analysis of immunoglobulin genetic diversity in Indian-Origin bonnet and rhesus macaques, marmosets, and African Green Monkeys potential Non-Human primate Models for HIV Vaccine Research. | 25-11-24 | 24-05-27 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1781 | Dr. Atul Batra | An investigator-initiated randomized controlled trial of human recombinant platelet-derived growth factor in addition to urea cream for prevention of multikinase inhibitor-associated hand-foot skin reaction | 16-12-24 | 15-12-27 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1784 | DR. LALIT DAR | Infectious Disease-Research and Diagnostic Laboratory I-RDL | 23-12-24 | 22-12-29 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1780 | DR. PURVA MATHUR | Expanding antimicrobial resistance research and surveillance activities in the secondary level hospitals. | 1/1/2025 | 31-12-27 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1785 | Dr. Prabhat Singh Malik | Liquid Biopsy guided addition of chemotherapy with TKI in advanced EGFR mutated NSCLC An Open-label, multicentric, phase 3 randomized controlled trial LiquiACT | 2/1/2025 | 1/1/2028 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1789 | Dr. Rupesh K. Srivastava | Investigating the Diagnostic potential of Gut-Associated Metabolites in Post-Menopausal Osteoporotic Women and exploring their therapeutic potential in Pro-Clinical Model of Osteoporosis: An Osteoimmunological Approach | 13-01-25 | 12/1/2028 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1791 | DR. PRAMOD K.GARG | Early intervention with low molecular weight heparin (Enoxaparine) for prevention of moderate to severe acute pancreatitis: A Double-Blind placebo controlled Investigator Initiated Multicenter Randomised Trial | 20-01-25 | 19-01-28 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1787 | Dr. Abhishek Shankar | Implementing Communication strategies to improve the quality of Life of Cancer Survivors and Caregivers | 20-01-25 | 19-01-28 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1792 | Dr. Jagdish Prasad Meena | The efficacy and safety of the addition of bevacizumab to conventional induction chemotherapy in high-risk neuroblastoma: a multicentric randomized controlled phase-3 trial(BVC HR-NB trial) | 20-01-25 | 19-01-28 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1790 | Dr. Mayank Singh | Characterisation of Novel anti-BCMA Antibody Drug Conjugate as an Immunotherapeutic Agent for Multiple Myeloma | 24-01-25 | 23-01-28 | Indian Council of Medical Research (ICMR) | ICMR |
| I-1788 | Dr. Prabhakar Tiwari | Unraveling the Biological age signature through the epigenome BASE identifying and developing innovative precision therapeutics in temporal lobe epilepsy | 1/2/2025 | 31-01-28 | Indian Council of Medical Research (ICMR) | ICMR |
| N2315 | DR. SUMAN JAIN | To investigate the behavioral and neurobiological alteration in the decision making in affective disorders by rodent IOWA gambling task with undrlying sex differences | 16-06-22 | 15-06-25 | Indian Institute of Technology, Delhi | Government |
| N2281 | Dr. Ajoy Roychoudhury | “Development of patient-specific additively-manufactured mandibular implants with biotechnology-inspired functional lattice structures.” | 1/9/2022 | 31-08-25 | Indo German Science and Technology centre, Govt of India | Government |
| N2328 | DR. SUMAN JAIN | Evaluation of therapeutics efficacy and mechanism of repetitive transcranial magnetic stimulation on the cognitive enhancement in hypobaric hypoxia environemnt | 6/3/2023 | 5/3/2026 | Life Sciences Research Board, DRDO | Government |
| AY-2352 | DR. VINEET AHUJA | The effect of structured yoga practices on the quality of life and clinical outcomes in patients with ulcerative colitis. | 15-06-23 | 14-06-25 | Ministry of AYUSH | Government |
| T-316 | Dr. Krithika Rangarajan | Empowering Healthcare National Programs with Artificial Intelligence | 31-03-24 | 31-03-25 | Ministry of Education | Government |
| T-331 | Dr. Deepika Mishra | Point-of-care Artificial Intelligence (AI) –based screening tool for oral cancer | 1/8/2024 | 30-03-25 | Ministry of Education | Government |
| N-2507 | Dr. Sarita Mohapatra | Lable-free multiple-beam excitation and plasmon enhanced raman spectroscopy for rapid and label-free molecular detection of bacteria strains: A point-of-care fast and accurate molecular testing technique | 13-06-24 | 12/6/2027 | Ministry of Education - Scheme for Transformational and Advanced Research in Sciences (MoE-STARS) | Government |
| N-2394 | Dr. Sarita Mohapatra | Micro-nano structured urinary catheters to minimize catheter-associated urinary tract infections (CAUTI) | 26-09-23 | 25-09-26 | Ministry of Education , Indian Institute of Science | Government |
| N-2416 | Dr. Sumit Rathore | Single-cell quantitation of mRNA and protein expression of antigenic variation genes and tissue tropism characterization in Plasmodium falciparum | 26-09-23 | 25-09-26 | Ministry of Education , Indian Institute of Science | Government |
| N2266 | DR. SHEFFALI GULATI | A brain machine interface enabled biomedical assistive communication system for children with special needs. | 10/5/2022 | 9/5/2025 | Ministry of Electronics and Information Technology (MeitY) | Government |
| N-2389 | DR. RITU DUGGAL | Development of Indigenized Digital Dentistry Solutions | 14-08-23 | 13-08-26 | Ministry of Electronics and Information Technology (MeitY) | Government |
| N755 | Dr. Neeraj Nischal | Anti retroviral treatment | 24-05-05 | 31-03-25 | Ministry of Health and Family welfare | Government |
| N1932 | Dr. Ambuj Roy | National Medical College Network (NMCN) | 1/2/2017 | 31-03-26 | Ministry of Health and Family welfare | Government |
| N1583 | DR. SANJAY K. RAI | HIV Sentinel Surveilance activities. | 1/3/2015 | 31-03-25 | Ministry of Health And Family Welfare(N.A.C.O) | Government |
| N1725 | Dr. Anand Krishnan | Establishing a Technical Support Unit (TSU)for Verbal Autopsy based cause of death ascertainment in the sample registration system,Registrar Genral of India. | 1/4/2017 | 31-03-25 | Ministry of Home Affairs (MHA) | Government |
| N2036 | Dr. Alok Agarwal | Establishing and Implementing Capacity Building Mechanisms for Addiction Treatment Facilities Iin India''. | 16-12-19 | 31-03-25 | Ministry of Social Justice and Empowerment | Government |
| N1695 | DR. SAMEER BAKHSHI | Indiian Childhood collaborative leukaemia group multicenter national standerisation study for newly diagnosed acute lymhoblastic leukemia(ALL) | 20-08-16 | 31-03-25 | National Cancer Grid Research | Government |
| N-2357 | Dr. Vikram Saini | National one health program for prevention & control of zoonoses | 6/6/2023 | 5/6/2028 | National Centre for Disease Control (NCDC) | Government |
| N-2478 | DR. NIKHIL TANDON | Clinical Decision Support System (CDSS) for Ayushman Bharat Digital Mission (ABDM) Compliant Digital Health Platform | 1/7/2024 | 30-06-26 | National Health Authority (NHA) | Government |
| I-1628 | DR. SOMESH GUPTA | Aptamer-based diagnostic test for vulvovaginal candidiasis | 15-11-23 | 14-05-26 | NCBIR(ICMR) | Government |
| N1981 | Dr. Aashish Choudhary | National viral hepatitis control program sentinel surveillance laboratory. | 25-06-19 | 31-03-26 | NCDC, MOH&FW | Government |
| N-2469 | Dr. Harshal Ramesh Salve | Centre for Excellence for Air Pollution and Health under National Programme for Climate Change and Human Health | 28-05-24 | 27-05-26 | NCDC, MOH&FW | Government |
| N-2474 | Dr. Ritu Gupta | Peripheral Blood Smear Investigator (PeBSI): an AI-assisted Solution for the Differential Diagnosis of Peripheral Blood Smear. | 25-07-24 | 24-07-27 | RailTel Corporation of India Limited | Private |
| D529 | DR. SUBRATA SINHA | JC Bose Fellowship | 29-12-17 | 4/1/2026 | Science & Engineering Research Board (SERB) | SERB |
| D590 | DR. PRAMOD K.GARG | J.C. Bose Fellowship | 21-08-20 | 20-08-25 | Science & Engineering Research Board (SERB) | SERB |
| SERB-19 | Dr. Sachin Kumar | “Elucidating the role of circular RNA circLIFR in the pathogenesis of small cell lung cancer” | 21-01-22 | 20-05-25 | Science & Engineering Research Board (SERB) | SERB |
| SERB-18 | Dr. Jayanth Kumar | Deciphering the synergism between IGF2BPs and m6A machinery in B-cell Acute Lymphoblastic Leukemia | 21-01-22 | 20-05-25 | Science & Engineering Research Board (SERB) | SERB |
| SERB-26 | Dr. Pawan Kumar | “Development of a novel cancer immunotherapeutic agent by incorporating cancer/ testis NY-ESO-1 into Mycobacterium indicus pranii and evaluation of its antitumor efficacy and immune mechanism using mouse model of tumor” | 15-02-22 | 14-02-25 | Science & Engineering Research Board (SERB) | SERB |
| SERB-24 | Dr. Siddhartha Kundu | “Numerical approximation of reaction-specific disassociation constants from the convex cone of a generic metabolic network” | 21-02-22 | 20-02-25 | Science & Engineering Research Board (SERB) | SERB |
| SERB-31 | Dr. Archana Singh | “Study of humoral immune response and its genetic correlates in infection free “resisters” among household contacts of adult pulmonary tuberculosis” | 7/3/2022 | 6/3/2025 | Science & Engineering Research Board (SERB) | SERB |
| SERB-28 | Dr. Vijay Kumar D. | “Prospective Randomized Controlled Trial to assess the effectiveness of Yoga Vs standard physiotherapy and to validate yoga as a standard rehabilitation program in Anterior Cruciate Ligament (ACL) reconstruction patients” | 10/3/2022 | 9/3/2025 | Science & Engineering Research Board (SERB) | SERB |
| SERB-32 | Dr. Pawan Kumar | Targeting multiple cancer antigens for cancer immunotherapy with a recombinant Mycobacterium indicus pranii (MIP)- based approach and its evaluation using mouse tumor model | 11/3/2022 | 10/3/2025 | Science & Engineering Research Board (SERB) | SERB |
| SERB-33 | Dr. Dinu S Chandran | “ARTSENS® Age: a multimodal method & system for reliable assessment of vascular ageing associated early health markers in routine clinical practice for early screening & timely intervention” | 15-03-22 | 14-03-25 | Science & Engineering Research Board (SERB) | SERB |
| SERB-29 | Dr. Prabhat Kumar Chaudhari | “3D printed aligners as a state of the art smile designing appliance for its integration in Indian Public Hospital” | 25-03-22 | 24-03-25 | Science & Engineering Research Board (SERB) | SERB |
| SERB-36 | Dr. Pragyan Acharya | Understanding the role of neutrophil heterogeneity and its therapeutic potential in the inflammatory liver disease Acute-on-Chronic Liver Failure (ACLF) | 16-08-22 | 15-08-25 | Science & Engineering Research Board (SERB) | SERB |
| SERB-35 | Dr. Ritu Gupta | Targeting the tumor Microenvironment for novel therapeutic approaches in Multiple Myeloma (MM) | 31-08-22 | 30-08-25 | Science & Engineering Research Board (SERB) | SERB |
| SERB-34 | DR. SUMAN JAIN | A study of differential protein expression in injured spinal cord tissue of rats to predict biomarkers of recovery following Intermittent Theta-Burst stimulation iron oxide nanoparticles implantation | 1/9/2022 | 31-08-25 | Science & Engineering Research Board (SERB) | SERB |
| SERB-37 | Dr. Pooja Gupta | Correlation of germline HLA variation y next generation sequencing with immune related adverse events in caner patients | 26-09-22 | 25-09-25 | Science & Engineering Research Board (SERB) | SERB |
| SERB-43 | Dr. Dheeraj Mohania | Exploring the Tryptophan metabolism via Kynurenine pathway and their correlation with clinical outcome in Keratoconus and Finch’s endothelial corneal dystrophy patients undergoing corneal transplantation | 18-01-23 | 17-01-26 | Science & Engineering Research Board (SERB) | SERB |
| SERB-39 | Dr. Nilanchali Singh | Counseling of Clients for HPV Self Sampling by ASHAs (Accredited Social Health Activists) and by Physician: A Randomized, Open-Labelled, Non-inferiority Trial (ASHA- CHAPTER Trial) | 19-01-23 | 23-07-25 | Science & Engineering Research Board (SERB) | SERB |
| SERB-40 | Dr. Saroj Kumar | G-Quadruplex forming DNA Aptamers against human EGFR as an alternative therapeutic approach for epidermal carcinomas | 20-01-23 | 19-01-26 | Science & Engineering Research Board (SERB) | SERB |
| SERB-42 | Dr. Jhuma Sankar | Comparison of Acetate- based, Lactate-based and Multiple Electrolyte Solution versus saline (MeSLAc trial) in pediatric septic shock – A multicenter randomized controlled trial | 10/2/2023 | 9/2/2026 | Science & Engineering Research Board (SERB) | SERB |
| SERB-41 | Dr. Bhupendra Kumar Verma | Mechanistic analysis of tRNA fragments in DENV pathogenesis | 14-02-23 | 13-02-26 | Science & Engineering Research Board (SERB) | SERB |
| SERB-44 | Dr. Saumyaranjan Mallick | Genomic profile of High grade B-cell lymphoma, Not otherwise specified (HGBCL-NOS) | 14-03-23 | 13-03-26 | Science & Engineering Research Board (SERB) | SERB |
| SERB-51 | DR. SUBRATA SINHA | National Science Chair (NSC) | 1/6/2023 | 31-05-26 | Science & Engineering Research Board (SERB) | SERB |
| SERB-45 | Dr. Ritesh Kumar Netam | Effect of long term exercise on synaptic abnormalities in sleep deprived Alzheimer's disease rat model | 7/9/2023 | 6/9/2026 | Science & Engineering Research Board (SERB) | SERB |
| SERB-50 | Dr. Saroj Kumar | Design, synthesis and biological evaluation of mechanism-based novel theranostic agents for Alzheimer's disease. | 7/9/2023 | 6/9/2026 | Science & Engineering Research Board (SERB) | SERB |
| SERB-47 | Dr. Archna Singh | Exploring the link between fatty acid metabolism and bioenergetics in pediatric B-cell leukemias: implications for tumor survival and treatment response. | 11/9/2023 | 10/9/2026 | Science & Engineering Research Board (SERB) | SERB |
| SERB-46 | Dr. Asit Ranjan Mridha | Helth Care System: Early detection of Bone Cancer using Microwave Imaging and Treatment by Hyperthermia Lens Applicator. | 15-09-23 | 14-09-26 | Science & Engineering Research Board (SERB) | SERB |
| SERB-49 | Dr. Shipra Agarwal | The tumor immune microenvironment of follicular cell-derived thyroid carcinomas across different grades utilizing gene expression and spatial proteomic profiling. | 4/10/2023 | 3/10/2026 | Science & Engineering Research Board (SERB) | SERB |
| SERB-48 | Dr. Subhradip Karmarkar | To Investigate the role of inflammation in the pathogenesis of Myelodysplastic syndrome (MDS) and to identify the different MDS subtype-specific novel transcripts associated with its progression into Acute Myeloid Leukemia (AML). | 4/10/2023 | 3/10/2026 | Science & Engineering Research Board (SERB) | SERB |
| SERB-52 | Dr. Devendra Singh | Spatio-temporal expression profile of hemeoxygenase-I in experimental model of ischemic stroke in rats. | 11/10/2023 | 10/10/2025 | Science & Engineering Research Board (SERB) | SERB |
| SERB-53 | Dr. Sumit Rathore | Understanding key regulators of Mitochondrial dynamics and homeostasis in human malaria parasite Plasmodium falciparum | 16-10-23 | 15-10-26 | Science & Engineering Research Board (SERB) | SERB |
| SERB-54 | Dr. Sachit Anand | Ergonomic challenges faced by surgeons performing laparoscopic surgeries: A comprehensive assessment of work posture, muscle activation, pain, fatigue, discom fort and workload. | 7/12/2023 | 6/12/2025 | Science & Engineering Research Board (SERB) | SERB |
| SERB-55 | Dr. Pooja Gupta | A randomized open-label controlled clinical trial to decipher the role of chronopharmacokinetics and chrono-genomics of tyrosine kinase inhibitors in treatment of non-small cell lung cancer patients | 18-12-23 | 17-12-26 | Science & Engineering Research Board (SERB) | SERB |
| SERB-57 | Dr. Ayush Agarwal | Rituximab in Guillain- Barre Syndrome: a single centre, double-blind, randomized phase 3 trial | 18-01-24 | 17-01-26 | Science & Engineering Research Board (SERB) | SERB |
| SERB-56 | Dr. Avtar Singh Meena | The role of lactiplantibacillus pentosus in mitigating alcoholic liver disease through modulation of the Gut-Liver Axis | 23-01-24 | 22-01-26 | Science & Engineering Research Board (SERB) | SERB |
| SERB-58 | DR. SURABHI GUPTA | Understanding the cellular basis of lipid emulsion therapy for recurrent pregnancy loss (RPL) | 25-01-24 | 24-01-27 | Science & Engineering Research Board (SERB) | SERB |
| SERB-61 | Dr. Pragyan Acharya | Targeting the metabolic Reprogramming of Innate Immune Responses as a Therapeutic strategy in Acute-on-Chronic Liver Failure | 25-01-24 | 24-01-27 | Science & Engineering Research Board (SERB) | SERB |
| SERB-66 | Dr. Karan Madan | Integration of metabolome, transcriptome and microbiome data to differentiate between chronic hypersensitivity pneumonitis and ideiopathic pulmonary fibrosis. | 31-01-24 | 30-01-27 | Science & Engineering Research Board (SERB) | SERB |
| SERB-59 | Dr. Avtar Singh Meena | Examimomh the role of the TRPV6 channel in the development of Alchohol-induced colorectal cancer | 19-02-24 | 18-02-27 | Science & Engineering Research Board (SERB) | SERB |
| SERB-62 | Dr. Ruchi Rathore | Exploring the genomic footprints and their connotations in vulver squamous cel carcinoma | 26-02-24 | 25-02-27 | Science & Engineering Research Board (SERB) | SERB |
| SERB-60 | DR. SANJEEV SINHA | “Study of upper airway anatomy using magnetic resonance imaging in Indian obese patients with and without obstructive sleep apnea.” Funded by SERB-DST. | 26-02-24 | 25-02-27 | Science & Engineering Research Board (SERB) | SERB |
| SERB-63 | Dr. Jagdish Prasad Meena | The DNA Methylation signature and its correlation with clinical outcomes in pediatric sarcomas | 12/3/2024 | 11/3/2027 | Science & Engineering Research Board (SERB) | SERB |
| SERB-64 | Dr. Suman Das | Identifying early signs of attention-deficit/hyperacivity disorder (ADHD) in children by decoding their acoustic vocal profile | 13-03-24 | 12/3/2026 | Science & Engineering Research Board (SERB) | SERB |
| SERB-65 | Dr. Vishnu V.Y. | Prospective Diagnostic Study of Blood Glucose Estimation and Trial Fibrillation via Wearable Device in Acute Stroke Patients | 14-03-24 | 13-03-27 | Science & Engineering Research Board (SERB) | SERB |
| SERB-67 | Dr. Rakhee Yadav | Investigating the therapeutic potential of F2RL3-NLRP3 inflammasome axis modulation in ameliorating obesity induced fibro inflammation. | 13-06-24 | 12/6/2027 | Science & Engineering Research Board (SERB) | SERB |
| SERB-69 | Dr. Sumit Rathore | Understanding Role of lipid-protein interactions during life cycle of Plasmodium vivax | 6/8/2024 | 5/8/2027 | Science & Engineering Research Board (SERB) | SERB |
| SERB-70 | Dr. Rohit Verma | UTILIZING ARTIFICIAL INTELIGENCE TECHNIQUES TO IDENTIFY PHENOTYPES OF OBSESSIVE-COMPULSIVE DISORDER THROUGH ANALYZING BRAIN BIOELECTRICAL ACTIVITY AND EYE MOVEMENT PATTERNS. | 23-08-24 | 22-08-27 | Science & Engineering Research Board (SERB) | SERB |
| SERB-73 | Dr. Thoudam Debraj Singh | To investigate the synergetic anti-tumor effect of DN200434 ( a potent inverse agonist of Estrogen Related Receptor-y) and MK2206 ( Akt inhibitor) in anaplastic thyroid cancer and papillary thyroid cancer in vivo. | 3/9/2024 | 2/9/2027 | Science & Engineering Research Board (SERB) | SERB |
| SERB-71 | Dr. Subhash Chandra Yadav | A quick and cost effective nanotechnology-based visual detection of HPV induced cervical cancer: an alternative of immunofluorescence detection. | 9/10/2024 | 8/10/2027 | Science & Engineering Research Board (SERB) | SERB |
| SERB-74 | Dr. Abhinav Kumar | Profiling of inflammatory cytokines and metabolites for observation of serial changes in patients with blunt torso trauma- A prospective cohort and observational Study. | 16-10-24 | 15-10-27 | Science & Engineering Research Board (SERB) | SERB |
| D-647 | DR. RIMA DADA | Elucidating the yoga associated epigenetic modulation in infertile males. | 6/11/2024 | 5/11/2026 | Science & Engineering Research Board (SERB) | SERB |
| SER-75 | DR. SUJATA MOHANTY | Enhancing the translational potential of human mesenchymal stem cell derived extracellular vesicles via multivariate bioengineering strategies. | 16-12-24 | 15-12-27 | Science & Engineering Research Board (SERB) | SERB |
| SERB-75 | DR. SUJATA MOHANTY | Enhancing the translational potential of human mesenchymal stem cell derived extracellular vesicles via multivariate bioengineering strategies. | 16-12-24 | 15-12-27 | Science & Engineering Research Board (SERB) | SERB |
| SERB-76 | Dr. Prabudh Goel | Single-Centre study for Identification of Genetics Markers Towards Development of a Gene Panel to serve as a point of care Test to predict the Risk of Spina Bifida for the Indian Population. | 23-12-24 | 22-12-27 | Science & Engineering Research Board (SERB) | SERB |
| SERB-78 | DR. RAKESH LODHA | Investigating the casual link between Dengue virus and pediatric Acute Encephalitis syndrome using in vivo and in vitro models. | 16-01-25 | 15-01-28 | Science & Engineering Research Board (SERB) | SERB |
| N1903 | Dr. Sudheer Arava | ”Proposal for Creating & Testing Virtual Teaching Mudules(Moocs) in Various Area of Healthcare” | 28-09-18 | 31-03-26 | SWAYAM (Ministry of HRD) | Government |
| N-2492 | Dr. K Aparna Sharma | A Multicentric evaluation of Indian population - specific tools for antenatal estimation gestational age | 15-10-24 | 14-10-26 | THSTI | Government |
| N2254 | Dr. Rishi Dhawan | Genome-Wide Association study in an Indian Cohort of patients with Acquired Aplastic Anemia | 16-04-22 | 15-04-25 | American Society of Hematology (ASH) | International |
| N-2439 | Dr. Siddharth Jain | Screening for underlying inborn errors of immunity in high-risk adults and assessment of its diagnostic, treatment and prognostic implications. | 1/4/2024 | 31-03-25 | Asia Pacific League of Associations for Rehumatology | International |
| N-2368 | Dr. M. Jeeva Sankar | Sequencing of Klebsiella pneumoniae Escherichia coli, Acinetobacter baumannii, and Staphylococcus aureus isolated from neonates with sepsis. | 1/8/2023 | 31-05-25 | Bill & Melinda Gates Foundation, USA | International |
| N-2422 | DR. RAMESH AGARWAL | Sankalp: Strengthening Program Implementation and Monitoring to Achieve Single-digit Neonatal Mortality. | 1/3/2024 | 28-02-27 | Bill & Melinda Gates Foundation, USA | International |
| N-2532 | DR. RAMESH AGARWAL | Establishment of Organizational Framework for Quality Management in Health Care Delivery in the Mother and Child Block, AIIMS, New Delhi | 1/1/2025 | 31-12-27 | Bill & Melinda Gates Foundation, USA | International |
| N-2527 | Dr. Jeeva Sankar | Effect of immediate kangaroo mother care (iKMC) on culture - positive sepsis in low-birth-weight neonates in district hospitals in Chhattisgarh, India: a stepped-wedge cluster randomized trial | 1/1/2025 | 31-12-28 | Bill & Melinda Gates Foundation, USA | International |
| N-2518 | DR. UMA KUMAR | “A Phase II, randomised, placebo-controlled, dobule blind, parallel – group, efficacy and safety study of at least 48 weeks of oral BI 685509 treatment in adults with early progressive diffuse cutaneous systemic sclerosis” | 1/8/2024 | 30-10-26 | Boehringer Ingelheim Pharma GmbH & Co KG | International |
| N2323 | Dr. Vishnu V.Y. | Efficacy and Safety of Pozelimab and Cemdisiran Combination Therapy in Patients With Symptomatic Generalized Myasthenia Gravis | 1/4/2023 | 31-03-25 | British BioMedicine Clinical Trials (BBMCT) | International |
| N-2375 | Dr. Manoranjan Mahapatra | “A phase IIIb, multi-center, randomizes studr of toterability and efficacy of oral asciminib versus nilotinib in patients with newly diagnosed Philadephia Chromosome Positive Chronic Myelogenous Leukemia in Chronic Phase” | 5/8/2023 | 4/8/2025 | British BioMedicine Clinical Trials (BBMCT) | International |
| N-2408 | Dr. Manoranjan Mahapatra | “A phase 3, randomized, double-blind, study to assess efficacy and safety of ianalumab (VAY736) versus placebo in worm autoimmune hemolytic anemia (wAIHA) patients who failed at least one line of treatment (VAYHIA), CVAY736012301” | 15-12-23 | 14-12-26 | British BioMedicine Clinical Trials (BBMCT) | International |
| N-2400 | DR. SIMRAN KAUR | Assessment of Cognitive Function in patients of breast cancer on chemotherapy: A prospective longitudinal Study at tertiary care center in India | 8/11/2023 | 7/11/2026 | Cambridge University | International |
| N2163 | DR. SAMEER BAKHSHI | Molecular and Pharmacogenetic marker evaluation in relation to the toxicity and clinical response of acute Iymphoblastic leukemia treatment in Indian children (MPGx-INDALL) | 20-04-21 | 30-04-25 | CANSEARCH Foundation | International |
| N2218 | DR. ROHIT SAXENA | 3-Dbinocular motor control in Strabismus before and after surgery | 1/11/2021 | 31-01-26 | CEFIPRA, French | International |
| N2270 | DR. PURVA MATHUR | Capacity Building and Strengthening of Hospital Infection Control to detect and prevent antimicrobial resistance in India | 30-09-21 | 29-09-26 | Centers for Disease Control and Prevention (CDC), USA | International |
| N-2380 | Dr. Anand Krishnan | Burden and Sequelae of Influenza, SARS Cov2 and other respiratory Severe Acute Respiratory Infections among Indian Adult population aged 18-60 years. | 30-09-23 | 29-09-28 | Centers for Disease Control and Prevention (CDC), USA | International |
| N-2370 | Dr. Aparna Sharma | Role of Celecoxib in reducing cognitive Impairment in Patients receiving definitivechemoradiation for Head and Neck Carcinoma: A Phase II randomised Placebo Controlled for Head and Neck Carcinoma: A Phase II Randomised Placebo Controlled Trial | 1/4/2023 | 30-03-25 | Conquer Cancer, the ASCO Foundation | International |
| N-2336 | DR. PUNIT KAUR | AMR educate: A multinational and interdisciplinary research integrated education partnership for a sustainable future against infection and antimicrobial resistance threats. | 10/3/2023 | 9/8/2025 | Direktoratet for Internasjonalisering og kvalitetsutvikling i høyere utdanning (DIKU), Norway | International |
| N2159 | DR. VINEET AHUJA | A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-and Active-Controlled, Treat-Through Study to Evaluate the Efficacy and Safety of Mirkizumab in Patients with Moderately to Severely Active Crohn's Disease | 12/11/2020 | 31-05-25 | Eli Lilly and Company (India)Pvt. Ltd. | International |
| N2113 | Dr. Ambuj Roy | 18F-MC-GPGN The Efect of Tirzepatide versus Dulaglutide on Major Adverse Cardiovascular Events in Patients with Type-2 Diabetes (SURPASS-CVOT) | 16-11-20 | 15-10-25 | Eli Lilly and Company (India)Pvt. Ltd. | International |
| N2245 | DR. SHEFFALI GULATI | Protocol H8H-MC-LAHW (a)-A Phase 3, 12-Month, Open-Label Study of Lasmiditan in Pediatric Patients with Migraine-PIONEER-PEDS2 | 8/7/2021 | 3/12/2025 | Eli Lilly and Company (India)Pvt. Ltd. | International |
| N-2353 | DR. SHEFFALI GULATI | A Randomized, Double-Blind, Placebo-Controlled Study of Galcenezumab in Patients 6 to 17 Years of Age with Episodic Migraine- the REBUILD-1 Study. | 19-08-21 | 18-02-25 | Eli Lilly and Company (India)Pvt. Ltd. | International |
| N2292 | DR. VINEET AHUJA | 16T-MC-AMAX(a): A Phase3, Multicenter, Open-Label, Long-Term Extension Study to Evaluate the Long-Term Efficacy and Safety of Mirikizumab in Patients with Crohn's Disease. | 1/9/2022 | 22-04-27 | Eli Lilly and Company (India)Pvt. Ltd. | International |
| N-2363 | Dr. Ritu Gupta | To establish Cryopreservation system for Multiple Myeloma (MM) cells. | 14-07-23 | 13-07-25 | Fund for Myeloma Education and Research (FMER), USA | International |
| N1870 | Dr. Shalimar | A Randomized, Double-Blind Evaluation of the Pharmacokinetics, safety, and Antiviral efficacy of Tenofovir Alafenamide (TAF) in Adolescents with Chronic Hepatitis B Virus Infection. | 22-05-18 | 31-05-25 | GILEAD Sciences, Inc., California | International |
| N2082 | DR. UMA KUMAR | GS-US-417-0304: A Multicenter, Double-blind, Long Term Extension Study to Assess the Safety and Efficacy of Filgotinib in Subjects with Rheumatoid Arthritis. | 1/1/2019 | 31-12-25 | GILEAD Sciences, Inc., California | International |
| N-2344 | DR. NIKHIL TANDON | Effectiveness of Google-Automated Retinal Disease Assessment ARDA tool assisted diabetic retinopathy screening program among people with type 2 diabetes in India- A three arm Randomized Controlled Trial. | 15-05-23 | 14-05-25 | Google LLC | International |
| N-2366 | Dr. Ritu Gupta | To determine the incidence prevalence of second primary malignancies (SPMs) both preceding or following CLL diagnosis and their impact on the disease course and overall survival (OS) | 17-07-23 | 16-07-25 | HARMONY Alliance | International |
| N2198 | Dr. Harshal Ramesh Salve | CAPHER- Collaborative on Air Pollution and Health Effects Research, India | 5/8/2021 | 31-12-25 | Health Effects Institute (HEI), Boston USA | International |
| N-2338 | Dr. Kapil Yadav | Drivers of reduction in anemia in India: Insights from subnational exemplars | 1/3/2023 | 30-06-25 | IAVI | International |
| N-2490 | Dr. Aparna Sharma | Comprehensive genomic characterization of young onset lung adenocarcinoma in India | 1/10/2024 | 1/10/2026 | International Association of Study in Lung Cancer (IASLC) | International |
| N-2248 | Dr. Khangembam Bangkim Chandra | IAEA Transthyretin Amyloid Cardiomyopathy Study (iTAC study) | 19-10-21 | 31-12-25 | International Atomic Energy Agency | International |
| N-2247 | DR. RAKESH KUMAR | Diagnostic Accuracy of 68GaPSMA-11 PET/CT and Conventional Imaging for Initial Staging of Intermediate and High-risk Prostate Cancer Patients (the PROCA Study) | 29-10-21 | 31-10-27 | International Atomic Energy Agency | International |
| N-2407 | Dr. Chethan R. | “A randomized, double – blind, placebo – controlled, 2 arm Phase III study to assess efficacy and safety of xevinapant and radiotherapy compared to placebo and radiotheroapy for demonstrating of disease – free survival in participants with resected squamous cell carcinoma of the head and neck, who are at high risk for relapse and are ineligible for high –dose cisplatin | 1/12/2023 | 30-11-28 | IQVIA | International |
| N2190 | Dr. Anand Krishnan | Primary Health Care Support Initiative (IPSI): AIIMS New Delhi Component. | 1/7/2021 | 31-08-26 | Johns Hopkins University (JHU) | International |
| N-2404 | DR. VINEET AHUJA | An Open Label, Multicentre, Phase IV Study of Ustekinumab to Evaluate Its Safety in India Subjects with Crohn’s Disease (CD) | 4/12/2023 | 12/6/2026 | Johnson & Johnson Private Llimited | International |
| N2314 | Dr. Prabhat Singh Malik | :A study of familial aggregation in non-small cell lung cancer in India- Role of genetic susceptibility | 1/1/2023 | 31-03-25 | Lady Tata Memorial Trust | International |
| N2327 | Dr. Deepali Jain | Microbiome-metabolome axis in non-small cell lung cancer | 20-03-23 | 19-03-26 | Lady Tata Memorial Trust | International |
| N-2437 | Dr. Deepali Jain | Liquid biopsy unravelling the treatment resistant mechanisms with risk stratification in EGFR mutated non-small cell lung carcinoma | 15-03-24 | 14-03-27 | Lady Tata Memorial Trust | International |
| N2242 | Dr. Aditi Sinha | Phase 3, Randomized, Open-label, Controlled, Multiple-Dose, Efficacy, Safety, Pharmacokinetic, and Pharmacodynamic study of etelcalcetide in Pediatric Subjects 28 days to 18 Years of age with Secondary hyperparathyroidism and chronic Kidney Disease Receiving Maintenance hemodialysis | 7/2/2022 | 6/7/2026 | M/s Amgen Technology Pvt. Ltd. | International |
| N1534 | Dr. Shalimar | GS-US-320-0108: A Phase 3, Randomized, Double-blind study to evaluate the safety and efficacy of tenofovir alafenamide (TAF) 25 mg QD versus Tenofovir Disoproxil Fumarate (TDF) 300 mg QD for the Treatment of HBEAg Negative, Chronic Hepatitis B | 11/2/2014 | 31-12-28 | M/s Gilead Sciences Inc. USA | International |
| N1493 | Dr. Shalimar | GS-US-320-0110: A Phase 3, Randomized, Double-blind study to evaluate the safety and efficacy of tenofovir alafenamide (TAF) 25 mg QD versus Tenofovir Disoproxil Fumarate (TDF) 300 mg QD for the Treatment of HBEAg Positive, Chronic Hepatitis B | 18-06-14 | 31-12-26 | M/s Gilead Sciences Inc. USA | International |
| N1789 | Dr. Shalimar | GS-US-384-1943 - A phase 3, randomized, double-blind, placebo-controlled study evaluating the safety andn efficacy of selonsertib in subjects with nonalcoholic steatohepatitis (NASH) and Bridging (F3) Fibrosis | 2/11/2017 | 1/11/2026 | M/s Gilead Sciences Inc. USA | International |
| N1788 | Dr. Shalimar | GS-US-384-1944-:- A Phase3, Randomized, Double-blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Selonsertib in Subjects with Compensated Cirrhosis due to Nonalcoholic Steatohepatitis (NASH). | 2/11/2017 | 1/11/2026 | M/s Gilead Sciences Inc. USA | International |
| N-2512 | DR. SANJEEV SINHA | Secondary Cervical Cancer Prevention of Vulnerable Women with HPV and HIV Co-Infection in India | 1/8/2024 | 31-07-28 | National Institute of Health (NIH)/ National Cancer Institute (NCI), USA | International |
| N1472 | Dr. Neeraj Parakh | International study of comparative health effectiveness with medical and invasive approaches (SCHEMIA) | 29-11-13 | 31-03-26 | NATIONAL INSTITUTE OF HEALTH, USA | International |
| N1821 | Dr. Rajesh Kumari | Rapid Point of Care Detection of HPV- Associated Malignancies | 5/12/2017 | 31-08-26 | NATIONAL INSTITUTE OF HEALTH, USA | International |
| N2063 | Dr. Sharmistha Dey | Harmonized Diagnostic Assessment of Dementia (DAD) for Longitudinal Aging Study of India (LASI): Genomic Study | 15-09-19 | 31-08-26 | NATIONAL INSTITUTE OF HEALTH, USA | International |
| N-1665A | Dr. Sharmistha Dey | Harmonized Diagnostic Assessment of Demantia (DAD) for Longitudinal Aging Study of India (LASI)- Wave 2 | 20-09-21 | 30-04-26 | NATIONAL INSTITUTE OF HEALTH, USA | International |
| N-2358 | DR. NIKHIL TANDON | Precision Cardiovascular Diseases Phenotyping and Pathophysiological Pathways (P-CARRS). | 1/3/2023 | 29-02-28 | NATIONAL INSTITUTE OF HEALTH, USA | International |
| N-2488 | DR. RAKESH LODHA | Immune responses associated with severe disease in patients with primary dengue infection | 10/9/2024 | 31-07-29 | NATIONAL INSTITUTE OF HEALTH, USA | International |
| N-2425 | DR. RAJESH SAGAR | Asian Bipolar Genetics Network (A-BIG-NET) | 1/3/2024 | 29-02-28 | National Institute of Mental Health (NIMH), USA | International |
| N-2459 | Dr. Chittaranjan Behera | Building Resources for the Diversification of Genetic Data on Suicide Death | 15-05-24 | 28-02-29 | National Institute of Mental Health (NIMH), USA | International |
| N2272 | DR. SOMESH GUPTA | A randomized open-label, parallel-group study to evaluate, The safety and efficacy of abrocitinib 100 mg and 200 mg Tablets in participants aged 12 years and older with moderate to severe atopic dermatitis in India study | 3/8/2022 | 31-08-25 | pfizer Inc. | International |
| N-2450 | Dr. Haresh K.P. | “A PHASE 3, RANDOMIZED, OPEN- LABEL, MULTICENTER TRIAL OF ARV-471 (PF-07850327) VS FULVESTRANT IN PARTICIPANTS WITH ESTORGEN RECEPTOR-POSITIVE, HER2-NEGATIVE ADVANCED BREAST CANCER WHOSE DISEASE PROGRESSED AFTER PRIOR ENDOCRINE BASED TREATMENT FOR ADVANCED DISEASE (VERITAC-2) PROTOCOL NO.: C4891001 | 1/5/2024 | 30-04-26 | pfizer Inc. | International |
| N2283 | Dr. Sameer Rastogi | Phase ½ Study to evaluate Palbociclib (IBRANCE®) in combination with Irinotecan and Temozolomide and/or in combination with Topotecan and Cyclophosphamide in pediatric patients with recurrent or refractory solid tumors | 6/7/2022 | 6/5/2025 | Pfizer Ltd. | International |
| N1684 | DR. G. KARTHIKEYAN | INVICTUS: INVestigation of rheumatiCAF Treatment Using Vitamin K antagonists, rivaroxaban or aspirin studies | 1/9/2016 | 31-03-25 | PHRI, ONTARIO CANADA | International |
| N1767 | Dr. Ambuj Roy | A Global registry to study the demographics, socioeconomic and clinical factors, etiologies, pathophysiology, management, barriers to care, and outcomes of heart failure patients. | 17-08-17 | 31-12-25 | PHRI, ONTARIO CANADA | International |
| N-1954 | DR. SHEFFALI GULATI | PTC124-GD-041-MMD: A phase 3 randmozed, double-blind, placebo-controlled efficacy and safety study of ataluren in patients with Nonsense Mutation Duchenne Muscular Dystrophy and Open-Label Extension | 14-03-19 | 13-09-26 | PTC Therapeutics Inc. USA | International |
| N-2455 | DR. PUNIT KAUR | OH-AMR-Diag: Novel technological solutions for rapid detection and screening of AMR from a One-Health perspective | 1/4/2024 | 31-08-27 | Research Council of Norway | International |
| N2166 | DR. M.V.PADMA SRIVASTAVA | A phase 3, randomized, double, efficacy and study comparing SAR442168 to placebo in participants with non-relapsing secondary progressive multiple sclerosis (HERCULES) | 7/5/2021 | 30-09-25 | Sanofi | International |
| N2167 | DR. M.V.PADMA SRIVASTAVA | A phase 3, randomized, double-blind, efficacy and safety study comparing SAR442168 to placebo in participants with primary progressive multiple sclerosis (PERSEUS) | 7/5/2021 | 30-09-25 | Sanofi | International |
| N-2489 | Dr. Ayush Agarwal | “An interventional, Phase 3 extension study to investigate long-term safety and tolerability of tolebrutinib in participants with relapsing multiple sclerosis, primary progressive multiple sclerosis, or nonrelapsing secondary progressive multiple sclerosis (LTS17043)” | 26-07-24 | 25-07-29 | Sanofi | International |
| N2300 | DR. SHEFFALI GULATI | A Randomized, double-Blind, Dose Finding and comparison study of the safety and efficacy of a high dose of eteplirsen, preceded by an open-label dose escalation, in patients with patients with Duchenne Muscular Dystrophy with deletion mutations amenable to exon 51 skipping at AIIMS. | 14-11-22 | 13-11-26 | Sarepta Therapeutics, Inc. | International |
| N-2477 | Dr. Praveen Vashist | National Survey on Rapid Assessment of Effective Refractive Error and Presbyopia (RAREP) in India | 1/10/2024 | 30-09-27 | SEVA Foundation, USA | International |
| N-2397 | DR. SAMEER BAKHSHI | Randomized Controlled Trail of Olanzapine for the Control of Chemotherapy-induced Vomiting in Children Receiving Highly Emetogenic Chemotherapy. | 7/11/2023 | 31-03-25 | SickKids | International |
| T-335 | Dr. Vikram Saini | for a short term project for conducting workshop of major India stake holders to enhance or response capabilities for working with emerging and re- emerging pathogens | 1/10/2024 | 30-09-25 | Soter, USA | International |
| N-2454 | Dr. Ranjan Gupta | A PHASE2, MULTICENTER, MULTINATIONAL, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE SAFETY, EFFICACY, AND PHARMACOKINETICS OF MULTIPLE DOSE LEVELS OF ESK-001 IN ADULT PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS. | 1/6/2024 | 31-05-27 | Syneos Health | International |
| N-2348 | Dr. Sameer Rastogi | To see the early effect of sorafenib on cognition, cardiovascular and reproductive functions in patients with fibromatosis | 10/2/2023 | 9/2/2026 | The Desmoid Tumor Research Foundation (DTRF) | International |
| N2177 | DR. Achal Kumar Srivastava | Friedreich's Ataxia Clinical Outcome Measures (FACOMS) | 1/6/2021 | 31-05-26 | The Friedreich's Ataxia Research Alliance (FARA) | International |
| N-2379 | DR. Achal Kumar Srivastava | Elucidation of the peripheral immune axis in FRDA and identification of blood-based biomarkers of inflammation | 1/9/2023 | 31-08-26 | The Friedreich's Ataxia Research Alliance (FARA) | International |
| N2240 | DR. ANANT MOHAN | Preventing, Adverse Cardiac Events (PACE) in Chronic Obstructive Pulmonary Disease (COPD) | 2/2/2022 | 31-05-25 | The George Insitute for Global Health, Australia | International |
| N2154 | DR. VINEET AHUJA | Crohn,s Disease (CD) in South Asians: Defining disease biology for prevention and better treatment | 16-03-21 | 30-06-25 | The Leona M. and Harry B. Helmsley Charitable Trust (USA) | International |
| N-2386 | Dr. Manisha Jana | Radiogenomic correlation in pediatric diffuse lung diseases (DLD) | 1/11/2023 | 30-04-25 | The SPR Research and Education Foundation | International |
| T-312 | DR. SANJAY K. RAI | The WHO South-East Asia Journal of Public Health (WHO-SEAJPH) | 1/2/2024 | 31-01-25 | The WHO South-East Asia Journal of Public Health (WHO-SEAJPH) | International |
| N1853 | Dr. Kapil Yadav | National Centre of Excellence and Advanced Research on Anemia Control. | 10/5/2018 | 31-12-25 | United Nations Children's Fund (UNICEF) | International |
| N-2438 | Dr. Anand Krishnan | Using digital solutions to improve cause of death data in India. | 1/4/2024 | 31-03-25 | University of New South Wales (UNSW), Sydney | International |
| N1582 | DR. DEEPAK KUMAR GUPTA | Approaches and Decisions for Acute Pediatric TBI (ADAPT) | 5/5/2015 | 4/5/2025 | University of Pittsburgh | International |
| N-2463 | DR. VATSLA DADHWAL | Optical monitoring of placental oxygenation and metabolism | 15-07-24 | 14-01-26 | Wellcome Leap | International |
| N1122 | Dr. Anju Singh | Effectiveness and safety of 2 vs 3 doses of HPV vaccine in preventing cervical cancer: an indian multi-center randomized trial | 27-03-09 | 31-07-25 | World Health Organization (WHO) | International |
| T-260 | DR. NEERJA BHATLA | To conduct training of trainers to create a cadre of master trainers in 10 Medical Colleges across India who can effectively use competency-based training tools for first- trimester abortion for Interns | 10/5/2022 | 31-12-25 | World Health Organization (WHO) | International |
| N-2390 | DR. Manjari Tripathi | A multi-center, randomized, double-blinded phase 3 study to evaluate the efficacy, safety, and tolerability of IMU-838 versus placebo in Adults with relapsing multiple sclerosis | 1/7/2022 | 30-09-25 | Worldwide Clinical Trials | International |
| N-2452 | DR. VINEET AHUJA | A randomized, double-blind, multicenter phase 3 study in patients with moderately to severely active ulcerative colitis (UC) to compare the efficacy, safety and immunogenicity of PB016 and Entyvio® for the induction an maintenance of clinical response and remission: (UCESIVE)” | 5/3/2024 | 4/3/2026 | Worldwide Clinical Trials | International |
| N-2410 | Dr. R.K.Yadav | “A phase II, Open – Label Study of NM8074 in Patients with Atypical Hemolytic Uremic Syndrome (aHUS)” | 15-12-23 | 14-06-25 | Ablenio Sciences Private Limited | Private |
| N-2362 | Dr. Atul Batra | A Prospective, Randomized, Multicenter, Comparative, Double-Blind, Parallel study to Evaluate the Efficacy, Safety , Pharmacokinetics, and Immunogenicity of Biosimilar Pertuzumab (ENZENE) with Reference Pertuzumab (Perjeta®) , Genentech Inc.,)a in Previously Untreated Patients with HER2 Positive Metastatic Breast Cancer.” | 12/7/2023 | 13-07-26 | ALKEM Labortories Ltd | Private |
| N2105 | Dr. Atul Batra | A Phase III Double Blind, Randomised, Placebo-Controlled Study Assessing the Efficacy and safety of Capivaserib+ Abiraterone Versus Lacebo + Abiraterone as Treatment for patients with De NovoMetastatic Hormone-sensitive prostate Cancer (mHSPC) Characterized by PTEN deficiency (CAPItello-281) | 20-10-20 | 31-03-27 | AstraZeneca Pharma India Ltd | Private |
| N2133 | Dr. Prabhat Singh Malik | A Phase III, randomized, double-blind, placebo-controlled, multicenter, international study of osimertinib as maintenance therapy in patients with locally advanced, unresectable EGFR mutation-positive Non-Small Cell Lung Cancer (Stage III) whose disease has not progressed following definitive platinum-based chemoradiation therapy (LAURA) | 15-02-21 | 14-02-26 | AstraZeneca Pharma India Ltd | Private |
| N2184 | Dr. Prabhat Singh Malik | A Phase III, Randomised, Controlled, Multi-centre, 3-Arm Study of Neoadjuvant Osimertinib as Monotherapy or in Combination with Chemotherapy versus Standard of Care Chemotherapy Alone for the Treatment of Patients with Epidermal Growth Factor Receptor Mutation Positive, Resectable Non-small Cell Lung Cancer (NeoADAURA) | 15-06-21 | 14-06-26 | AstraZeneca Pharma India Ltd | Private |
| N2196 | Dr. Sachin Khurana | A Phase III, Randomized, Multicenter, Double-blind, Placebo-controlled Study to Determine the Efficacy of Adjuvant Durvalumab in Combination with Platinum-based Chemotherapy in Completely Resected Stage II-III NSCLC (MeRmaiD-1) | 16-07-21 | 15-07-26 | AstraZeneca Pharma India Ltd | Private |
| N2197 | Dr. Sachin Khurana | A phase III, randomized, multicenter, double-blind, placebo-controlled study of Durvalumab for the treatment of stageII-III NSCLC patients with minimal residual disease following surgery and curative intent therapy (MERMAID-2) | 16-07-21 | 15-07-26 | AstraZeneca Pharma India Ltd | Private |
| N2207 | Dr. Sachin Khurana | A Randomised, Double-blind, Placebo-controlled, Phase III Study of Olaparib Maintenance Monotherapy in Participants with BRCA Wild Type Advanced (FIGO Stage III-IV) High Grade Serous or Endometrioid Ovarian Cancer Following Response to Standard First-line Platinum-based Chemotherapy (MONO-OLA1) | 16-09-21 | 15-09-26 | AstraZeneca Pharma India Ltd | Private |
| N2241 | Dr. Atul Batra | A Randomised, Multicenter, Double-Blind, Phase III, study of AZD9833 (an Oral SERD) plus Palbociclib versus Anastrozole plus Palbociclib for the Treatment of Patients with Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer Who Have Not Received Any Systemic Treatment for Advanced Disease.(SERENA-4) | 3/1/2022 | 2/1/1930 | AstraZeneca Pharma India Ltd | Private |
| N-2342 | DR. UMA KUMAR | “A Multicenter Randomized Double-Blind Placebo-Controlled Phase 3 Study to Evaluate the Efficacy and Safety of Anifrolumab in Adult Patients with Active Proliferative Lupus Nephritis” | 1/4/2023 | 30-10-25 | AstraZeneca Pharma India Ltd | Private |
| N-2382 | Dr. Sachin Khurana | “Phase III Randomised, Open Label, Multicentre, Global Study of Datopotamab Deruxtecan (Dato - DXd) in Combination with Durvalumab and Carboplatin Versus Pembrolizumab in combination with Platinum- based Chemotherapy for the first –line Treatment of patients with Locally Advanced or Metastatic NSCLC Without Actionable Genomic Alterations (D926NC00001; AVANZAR)” | 27-07-23 | 26-07-28 | AstraZeneca Pharma India Ltd | Private |
| N-2388 | Dr. Arun Kumar S | “A Phase 3, International, Randomised, Double –Blind, Placebo-controlled Study to Evaluate the Effect of Sodium Zirconium Cyclosilicate on Chronic Kidney Disease (CKD) Progression in Participants with CKD and Hyperkalaemis or at Risk of Hyperkalaemia “(STABILIZE CKD)” | 8/11/2023 | 7/11/2026 | AstraZeneca Pharma India Ltd | Private |
| N-2430 | Dr. Sachin Khurana | A Phase III, Randomised, Double – blind, Placebo-controlled, Multi-Centre, Global study of Volrustomig in Women with High Risk Localy Advanced Cervical Cancer Who Have Not Progressed Following Platinum-based, Concrrent Chemoradiation Therapy (eVOLVE-Cervical | 30-01-24 | 29-01-29 | AstraZeneca Pharma India Ltd | Private |
| N-2471 | Dr. Atul Batra | A Phase III, Open-label, Randomized Study of Datopotamab Deruxtecan (Dato-DXd) With or Without Durvalumab Compared with Investigator's Choice of Chemotherapy (Paclitaxel, Nab-paclitaxel or Gemcitabine+Carboplatin) in Combination with Pembrolizumab in Patients with PD-LI Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast 05) | 1/8/2024 | 31-07-29 | AstraZeneca Pharma India Ltd | Private |
| N-2494 | Dr. Atul Batra | Cambria-2:A Phase-III, Open –Label, Randomized Study to Assess the Efficacy and Safety of Camizestrant (AZD9833,a Next – Generation, Oral Selective Estrogen Receptor Degrader) Versus Standard Endocrine Therapy (Aromatase Inhibitor or Tamoxifen) as Adjuvant Treatment for Patients with ER+/ HER2- Early Breast Cancer and an Intermediate-High or High Risk OF Recurrence Who Have Completed Definitive Locoregional Treatment and Have no Evidence of Disease” | 15-09-24 | 14-09-27 | AstraZeneca Pharma India Ltd | Private |
| N-2517 | Dr. Sachin Khurana | A Phase III, Randomized, Open-label, Global Study of Datopotamab Deruxtecan Dato- DXd in Combination with Rilvegostomig AZD2936 or Rilvegostoming Monotherapy Versus Pembrolizumab Monotherapy for the First-line Treatment of Participants With Locally-advanced or Metastatic Non-squamous NSCLC With High PD-LI Expression TC 50% and Without Actionable Genomic Alterations TROPION- Lung 10” | 1/12/2024 | 30-11-29 | AstraZeneca Pharma India Ltd | Private |
| N-2531 | Dr. Atul Batra | A Randomized 2- Cohort, Double Blind, Placebo-controlled, Phase-111 study of AZD5305 in combination with physicians choice new Hormonal agents in patients with HRRm and non HRRm metastasis castration-sensitive prostate cancer evoPAR-Prostate01” | 11/1/2025 | 10/1/2027 | AstraZeneca Pharma India Ltd | Private |
| N2106 | Dr. Deepam Pushpam | A Phase IIb/III, Randomized, Double-blind, Placebo-controlled, Multi-centre, Study of CA-170 in Combination with Chemotherapy and Radiation in Patient with Unresectable Stage III or IVa Non-Squamous Non Small Cell Lung Cancer (ASIAD-2) | 2/11/2020 | 1/11/2025 | Aurigene Discovery Technologies Limited | Private |
| N2237 | Dr. Deepam Pushpam | “A Phase IIb/III, Randomised, Double blind, placebo-controlled, multicentre, study of CA-170 in combination with Chemotherapy in patients with State IV non-squamous non-small cell lung cancer (ASIAD-3)” | 1/1/2022 | 31-07-27 | Aurigene Discovery Technologies Limited | Private |
| N2317 | Dr. Deepam Pushpam | A Phase I, Open Label, Dose-Escalation, First in Human (FIH) study evaluating the Safety, Pharmacokinetics, Pharmacodynamics and Efficacy of AUR 103 Calcium in patients with relapsed advanced malignancies (BHARAT-1) | 1/9/2022 | 31-08-26 | Aurigene Discovery Technologies Limited | Private |
| N-2306 | Dr. Deepam Pushpam | . “A Phase 1, Open Label, Dose Escalation, Dose Expansion, Multicenter, First in Human (FIH) Study Evaluating the Safety, Pharmacokinetics and Pharmacodynamics of Oral AUR105 IN Patients with Relapsed Advanced Malignancies (SURYA-1)” | 15-11-22 | 15-11-26 | Aurigene Discovery Technologies Limited | Private |
| N-2528 | Dr. Deepam Pushpam | A Phase!, Open Label, Dose Escalation, Dose Expansion, Multicenter, First in Human (FIH) Study Evaluating the Safety, Pharmacokinetics and Pharmacodynamics of Oral AUR107 in Patients with Relapsed Advanced Malignancies (SHAKTI -1) | 15-06-23 | 14-06-27 | Aurigene Oncology Limited | Private |
| N-2414 | Dr. Deepam Pushpam | “A phase 1, Open label Dose Escalation, Dose Expansion, Multicenter Study Evaluating the safety , Pharmacokinetics and Pharmacodynamics of Oral AUR108 in patients with Relapsed Advanced Lymphoma (ASHA-1) | 1/12/2023 | 30-11-25 | Aurigene Oncology Limited | Private |
| N-2516 | Dr. Sachin Khurana | A Phase II, Open-label, Randomized, Dose-ranging Study Evaluating the Efficacy, Safety, Confidential AUR-1019-202(Study Code: C2A03824) Study Pharmacokinetics and Pharmacodynamics of AUR 109 in Patients with Colorectal, Ovarian, and Renal Cancers (TEJAS-2)” | 15-11-24 | 14-11-29 | Aurigene Oncology Limited | Private |
| N2320 | Dr. Samarth Mittal | Post Market Clinical Follow-up-study: A non-randomized, prospective to evaluate the Safety and Performance of Proximal Femoral Nail Anti-rotation (PFNA) intended for femur related fracture fixation | 1/3/2023 | 28-02-25 | Auxein Medical Private Limited | Private |
| N-2337 | Dr. Bhavuk Garg | “A prospective single arm, multi-centric, post marketing clinical follow-up study to evaluate the safety and performance of pedicle screws in patient with spinal disorders” | 1/5/2023 | 31-03-25 | Auxein Medical Private Limited | Private |
| N-2423 | Dr. Samarth Mittal | A Prospective Single arm Post Market Clinical Follow-up study to evaluate the Safety and Performance of Radius system intended for Radius fracture fixation. | 1/2/2024 | 31-01-26 | Auxein Medical Private Limited | Private |
| N-2420 | Dr. Vijay Kumar D. | A Post Market Clinical Follow-up (PMCF) study to evaluate the Safety and Performance of knee Arthroscopy System | 15-02-24 | 14-02-26 | Auxein Medical Private Limited | Private |
| N-2514 | Dr. Vivek Trikha | “A non-randomized, prospective post market clinical follow-up study to evaluate the safety and performance of pelvic plating system” | 10/12/2024 | 9/12/2026 | Auxein Medical Private Limited | Private |
| N-2515 | Dr. Samarth Mittal | “Post Market Clinical follow-Up Study to evaluate the safety and performance of femoral neck system, dynamic hip system or Cannulated cancellous screws in patient with femoral neck fracture” | 10/12/2024 | 9/12/2026 | Auxein Medical Private Limited | Private |
| N-2476 | Dr. Namrata Sharma | Comparison of Isopure Premium Monofocal IOL with Tecnis Enhanced Monofocal IOL | 22-08-24 | 21-06-25 | AV Meditech Private Limited | Private |
| N2192 | Dr. Haresh K.P. | A randomized, double-blind, placebo-controlled Phase 3 study of darolutamide in addition to androgen deprivation therapy (ADT) versus placebo plus ADT in men with metastatic hormone-sensitive prostate cancer (mHSPC) | 1/6/2021 | 31-12-25 | Bayer Pharmaceutical Pvt Ltd. | Private |
| N2219 | Dr. Haresh K.P. | A phase 2 basket study of the oral TRK inhibitor larotrectinib in subjects with NTRK fusion-positive tumors | 1/6/2021 | 31-12-25 | Bayer Pharmaceutical Pvt Ltd. | Private |
| N2221 | Dr. Hari Krishna Raju Sagiraju | Screening for rick factors and precancerous lesions of head & neck and prostate cancers in the geographical areas near National Cancer Institute-India | 20-12-21 | 19-12-26 | Bayer Pharmaceutical Pvt Ltd. | Private |
| N2261 | Dr. Sanjay K. Agarwal | A randomized, double-blind, placebo-controlled, parallel-group, multicenter Phase 3 study to investigate the efficacy and safety of Flnerenone, in addition to standard of care, on the progression of kidney disease in patients with Non-Diabetic Chronic kidney Disease | 1/5/2022 | 31-07-26 | Bayer Pharmaceutical Pvt Ltd. | Private |
| N-2409 | DR. NITISH NAIK | “A multicenter, international, randomized, active comparator controlled, double–blind- double - dummy, parallel –group, 2 arm, phase 3 study to compare the efficacy and safety of the oral FXIainhibitor asundexian (BAY 2433334) with apixaban for the prevention of stroke or systemic embolism in male and female participants aged 18 years and older with atrial fibrillation at risk for stroke | 7/11/2023 | 6/11/2026 | Bayer Pharmaceutical Pvt Ltd. | Private |
| N-2426 | Dr. Ayush Agarwal | Phase 3 study to investigate the efficacy and safety of the oral FXla inhibitor Asundexian (Bay 2433334) compared with placebo in participants after and acute non-cardioembolic ischemic stroke or high –risk TIA“ | 2/3/2024 | 1/3/2026 | Bayer Pharmaceutical Pvt Ltd. | Private |
| N1346 | DR. SHYAM PRAKASH | Rapid diagnostic evaluation of micro pcr for hepatitis B virus dna (HBV DNA) quantitation | 13-04-12 | 31-12-25 | bigtec private limited | Private |
| N-2360 | Dr. Ajay Gogia | A Prospective, Multicenter, Non-Interventional, Observational, Real-World Study to Evaluate the Sefety, Adherence to Therapy, and Effectiveness of a T-DMI Antibody-Drug Conjugate Biosimilar in Indian Patients with HER2-Positive Early Breast Cancer | 3/7/2023 | 2/7/2025 | BioQuest Solutions Private Limited | Private |
| N-2467 | Dr. Namrata Sharma | A Prospective, randomized, controlled, post-marketing clinical study to assess clinical performance and safety of EYECRYL Sert intracular lens (IOL) versus Rayner EMV/HOYA Impress IOL in patients with planned age-related cataract surgery. | 11/7/2024 | 10/11/2025 | Biotech Vision Care Priavate Limited | Private |
| N-2483 | DR. M.VANATHI | Evaluation of visual, refractive outcome and changes in ocular parameters after Eyecryl phakic IOL implantation in patients with moderate to high myopia and astigmatism: A prospective comparative study with EVO/EVO+ Visian implantable lenses” | 2/9/2024 | 1/9/2025 | Biotech Vision Care Priavate Limited | Private |
| N-2466 | DR. TULIKA SETH | A Phase IV Study of luspatercept for the treatment of transfusion dependent anemia associated with Myelodysplastic Syndromes and Beta-thalassemia in India | 1/7/2024 | 30-06-26 | BRISTOL MYER SQUIBB INDIA PRIVATE LIMITED | Private |
| N1799 | Dr. Pranay Tanwar | A prospective study to elucidate genetics, clinical and molecular factors in gall bladder carcinoma in Indian patients | 1/12/2017 | 30-11-27 | Cancer Foundation | Private |
| N-2501 | Dr. Ashok Sharma | Study the Efficacy of Cancer Healer Therapy Polyherbal Formulation and Uncover its Anticancer Potential in Breast and Ovarian Cancer Cell Lines. | 15-10-24 | 14-10-25 | Cancer Healer Center | Private |
| N2186 | Dr. Rachna Meel | A Prospective Collaborative Study for Newly Diagnosed Patients with Retinoblastoma in India | 1/6/2020 | 31-05-26 | CanKids KidsCan | Private |
| N2098 | DR. SAMEER BAKHSHI | Childhood Cancer Survivorship Program | 1/10/2020 | 30-09-25 | CanKids KidsCan | Private |
| N-2403 | DR. DEEPAK AGRAWAL | Brain Tumor registry with AI based management across different AIIMS hospital across India | 1/12/2023 | 30-11-28 | CanKids KidsCan | Private |
| N-2406 | Dr. Namrata Sharma | Assessment of visual performance of new panfocal intraocular lens for visual quality and safety (Naturo, Caregroup SS Pvt Ltd) | 18-12-23 | 31-12-25 | Care Group Sight Solution Private Limited | Private |
| N-2498 | Dr. Prasun Chatterjee | Effect of NMN and Ca-AKG on cognitive impairment in older Indians attending Memory clinic, National Centre for Ageing, AIIMS, New Delhi. | 15-10-24 | 14-10-27 | Centenarians Life Sciences Private Limited | Private |
| N2260 | DR. SANJAY K. RAI | The direct and indirect protection derived by vaccinating children against covid-19: An ambispective cohort study | 16-06-22 | 28-02-25 | CLINICAL RESEARCH NETWORK INDIA | Private |
| N-2356 | Dr. Rebika | Comparison of VR-display based Active Dichoptic Therapy Vs Patching in Anisometropic Amblyopia | 16-07-23 | 15-07-25 | Cognihab Healthcare Solutions Private Limited | Private |
| N1673 | DR. SAMEER BAKHSHI | Establishing a nutritional counseling program and developing a nutritional detabse in pediatrics patients with cancer. | 1/7/2016 | 31-05-25 | Cuddles Foundation | Private |
| N2017 | DR. RACHNA SETH | Improving Nutrition in children with cancer. | 11/10/2019 | 10/10/2025 | Cuddles Foundation | Private |
| N-2505 | Dr. Chethan R. | ICS/CUR/2023-006:A Prospective, Randomized, Double-Blind, Multicentric, Parallel Group Phase-III Clinical study to Evaluate the Efficacy, Safety and Immunogenicity of BP01 (Bevaciizumab) Versus EU approved Avastin along with chemotherapy XELOX in Metastatic colorectal cancer patients” | 1/11/2024 | 31-10-25 | CuraTeQ Biologics Private Limited | Private |
| N-2519 | DR. UMA KUMAR | A randomized, double-blind multicentre study comparing the efficacy, safety, and immunogenicity of proposed Abatacept biosimilar (DRL_AB) with Orencia administered by the intravenous route as an add-on to methotrexate in the treatment of patients with moderate to severe rheumatoid arthritis” | 1/8/2024 | 30-10-26 | Dr. Reddys Lab. . Ltd. | Private |
| N-2446 | DR. MADHULIKA KABRA | A Double Blind, Placebo-Controlled, Multicentre Study to Evaluate the Efficacy and Safety of 2' O Methyl Antisense Olingonucleotide in Patients with Duchenne Muscular Dystrophy | 1/6/2024 | 31-05-26 | Dystrophy Annihilation Research Trust (DART) | Private |
| N2319 | Dr. Ranjit Kumar Sahoo | “A multicenter, open-label, randomized, phase III clinical trial to evaluate efficacy and safety of PF-114 versus imatinib at 600 or 800 mg daily in adult patients with Philadelphia chromosome positive (Ph+) chronic myeloid leukemia (CML) in the chronic phase (CP) resistant to imatinib at daily doses of 400 or 600 mg” | 9/11/2022 | 8/11/2025 | Edenwell Therapeutics Private Limited | Private |
| N-2487 | Dr. Vivek Trikha | “A Multi-center, Prospective, Open-Label, Assessor-Blinded, Randomised, Controlled, Non-Inferiority, Pivotal Clinical Investigation to evaluate the Performance and Safety of 3-D Scaffold Matrix-a Class C Medical Device Bone Void Filler as a Bone Graft Substitute in Orthopaedic Surgery” | 15-09-24 | 14-09-25 | EffecMed Private Limited | Private |
| N2139 | Dr. Namrata Sharma | Evaluate efficacy of intracameral injection of Tropicamide-Phenylephrine-Lidocaine (Phenocaine Plus) for pre-operative mydriasis in patients undergoing cataract surgery | 1/3/2021 | 30-05-25 | Entod Pharmaceuticals Ltd. (India) | Private |
| N-2372 | DR. RAKESH YADAV | “Multicentre, Randomized, Double -Blind, Parallel- Group, Comparative, Active-controlled, Phase III Clinical Trial to Evaluate the Efficacy, Safety and Tolerability of Fixed –Dose Combination of Dapagliflozin 10 mg and metoprolol 50 mg XR Versus only Metoprolol 50 mg in patients with heart failure post Acute Myocardial Infraction “ AIIMS. | 21-07-23 | 20-07-25 | Eris Lifesciences Limited | Private |
| N-2482 | Dr. Namrata Sharma | Comparative Evaluation of Topical 0.01% Hypochlorous Acid vs standard therapy In Fungal Keratitis: A Prospective Randomized Controlled Clinical Trial” | 11/9/2024 | 10/9/2025 | Faith Innovations | Private |
| N-2530 | Dr. Surender K Sharawat | Uncovering the impact of tRNA Modifications in Acute Myeloid Leukemia: Developing a Next-Generation Prognostic Score through a Multimodal Approach | 20-11-24 | 19-11-27 | Genes 2Me Private Limited | Private |
| N-1884-A | DR. Manjari Tripathi | Magnetoencephalography (MEG) Resource Facility for Drug Resistant Epilepsy | 27-12-23 | 26-12-26 | Gridlabs Research Foundation | Private |
| N-2473 | Dr. Shalimar | Phase3 Multicenter Randomized, Double-Blind, Study to Assess the Efficacy and Safety of treatment with Bepirovirsen in HBeAg-negative Nucleos(t)ide Analogue- treated Participants with Chronic Hepatitis B Virus (B-well 2). | 1/7/2023 | 30-06-26 | GSK India Pharma Private Limited | Private |
| N-2442 | Dr. Shailesh B. Gaikwad | Gravity Stent-Retriever System For Reperfusion Of Large Vessel Occlusion Stroke Trial (GRASSROOT) | 15-04-24 | 14-04-25 | Gurutva Medical Technology Private Limited | Private |
| N-2449 | Dr. Deepti Vibha | Gravity Stent –Retriever System For Reperfusion of Large Vessel Occlusion Stroke Trial (GRASSROOT) | 1/5/2024 | 30-04-25 | Gurutva Medical Technology Private Limited | Private |
| N-2485-CSR | Dr. Jitendra Kumar Meena | Life course approach to Women health A sustainable strategy for effective cancer prevention in India | 28-03-24 | 27-03-27 | Higher Education Financing Agency (HEFA) | Private |
| N2109 | Dr. Rajeev Kumar | Phase IIb/III study to determine efficacy of Curcumin and Metformin to reduce the incidence of econd primary tumors of aero-digestive tract in patients with historyof head and neck squamous cell carcinoma | 6/11/2020 | 5/11/2026 | HNCOG | Private |
| N-2374 | Dr. Neetu Bhari | Defining the role of skin microbiome in modulating the skin microenviroment in children with atopic dermatitis | 30-07-23 | 31-07-25 | IADVL | Private |
| N-2523 | Dr. Vishal Gupta | Drug resistance in reactional and non-reactional leprosy:A cross-sectional comparative study | 2/8/2024 | 1/8/2026 | IADVL | Private |
| N-2522 | Dr. Deepti Vibha | Thalidomde in the treatment of Intracerebral Tuberculoma: A Prospective Randomized Open Blinded Endpoint (Prober) Study | 1/1/2025 | 31-12-26 | Indian Academy of Neurology | Private |
| N2178 | DR. RACHNA SETH | Partnership in cancer survivorship optimization | 25-05-21 | 24-05-26 | Indian Cancer Society | Private |
| N-2480 | Dr. Atul Batra | Real World Treatment Patterns and Clinical Outcomes Among Patients with Urothellial Carcinoms in India” | 2/9/2024 | 1/9/2027 | Insignia Communications | Private |
| N-2481 | Dr. Atul Batra | Real World Treatment Patterns and Clinical Outcomes Among Patients with Metastatic Adenocarcinoma of the Prostate” | 2/9/2024 | 1/9/2027 | Insignia Communications | Private |
| N-2432 | Dr. Atul Batra | Prospective Registry for Prostate Cancer and Urinary Bladder Cancer | 15-03-24 | 14-03-25 | Insignia Private Limited | Private |
| N-2533 | DR. TULIKA SETH | A Phse 2 Open-label Study to Evaluate the Activity of Etavopivat on Transcranial Doppler Velocities in Pediatric Patients with Sickle Cell Disease who are at Increased Risk for Primary Stroke” | 20-01-25 | 19-01-26 | IQVIA Biotech | Private |
| N-2399 | DR. VINEET AHUJA | “A randomized, double-blind, multicenter phase III study to evaluate the long-term efficacy and safety of ABX464 25 mg or 50mg once daily as a maintenance therapy in subject with moderately to severely active ulcerative colitis”, (Short title: ABTECT-Maintenance) | 1/12/2023 | 31-12-26 | IQVIA RDS (India) Pvt. Ltd | Private |
| N-2520 | DR. RAKESH YADAV | A Phase3, Randomized, Double-blind, Placebo-controlled, Event-driven Study to Demonstrate the Efficacy and Safety of Milvexian, an oral Factor Xla Inhibitor, After a Recent Acute Coronary Syndrome” | 5/12/2024 | 4/6/2027 | IQVIA RDS (India) Pvt. Ltd | Private |
| N-2521 | DR. RAKESH YADAV | A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and Safety of Milvexian, an Oral Factor Xia Inhibitor, Versus Apixaban in Participants with Atria Fibrillation” | 5/12/2024 | 4/12/2028 | IQVIA RDS (India) Pvt. Ltd | Private |
| N-2341 | Dr. Sameer Rastogi | “A Double-Blind Placebo-Controlled Comparative Randomized Clinical Study of the Efficacy and Safety of BCD-217 (Nurulimab=Treatment) Followed by Anti-PD-1 Compared to Anti-PD-1 Monotherapy as First-Line Treatment in Subjects with Unresectable/Metastatic Melamona” | 21-02-23 | 20-02-25 | IR Innovate Research Private Limited | Private |
| N-2475 | Dr. Ajay Gogia | “A Multicentre, Single-arm, Open-label, Phase 4 Study to Evaluate the Safety and Efficacy of Brentuximab Vedotin plus Doxorubicin, Vinablastine and Dacarbazine in Indian Patients with Untreated Stage 3/4 Classical Hodgkin Lymphoma)” | 2/8/2024 | 1/8/2026 | JSS Medical Research Asia Pacific Pvt Ltd. | Private |
| N-2502 | DR. GOVIND K MAKHARIA | Comparative analysis of two different techniques for evaluation of HLA gene haplotypes in patients with Celiac disease. | 15-10-24 | 14-04-25 | Kanishk International Healthcare Group | Private |
| N-2376 | DR. SAMEER BAKHSHI | A Phase 3, Randomized, Double-Blind, Placebo - Controlled Study of Acalabrutinib in Combinatiion with Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in subjects < 70 years with previously Untreated Non-Germinal Center Diffuse Large B-Cell Lymphoma” | 8/8/2023 | 7/8/2028 | Labcorp Drug Development India Private Limited | Private |
| N-2495 | Dr. Atul Batra | A Phase-2, Open-label, Randomized, Parallel-group, Three arm, Study to Assess Efficacy and Safety of Cabazitaxel Lipid Tablet in Combination with Prednisone for the Treatment of Adult Men with Metastatic Castration-Resistant Prostate Cancer Previously Treated with a Docataxel-containing Treatment Regimen” | 19-07-24 | 18-07-26 | Lambda Therapeutic Research Ltd. | Private |
| N1830 | DR. NIKHIL TANDON | To devlop a strategy for postpartum follow up of woman with history of gestational diabetes mellitus by using the right test and frequency of testing and developing patient centric approach after incorporating their views | 27-02-18 | 26-02-26 | lupin limited | Private |
| N2214 | Dr. Namrata Sharma | . A randomized, double, group, active controlled, multicentric, phase III study comparing the efficacy, safety and tolerability of Lifitegrast 5% eye drops in patients with dry eye disease” | 1/12/2021 | 10/3/2025 | Medclin Research Private Limited | Private |
| N-2493 | Dr. Soumita Bagchi | A Phase 2b/3,Multicentre part, randomized, Double blinded, Placebo - Controlled Study the efficacy and safety of Atacicept in subject with LgA nephropathy (IgAN) this study is sponsored by vera Thrapeutics and legal applicant medpace clinical Research India Pvt Ltd. | 6/2/2024 | 5/2/2029 | Medpace Clinical Research India Private Limited | Private |
| N-2497 | Dr. Anubhuti Rana | Evaluation of efficacy and safety of different dosage of oral micronized progesterone sustained release formulation in treatment of threatened miscarriage and its impact on parameters in immunomodulation and uteroplacental blood flow: A Randomized controlled trial” | 10/10/2024 | 9/4/2026 | Medwiz Healthcare Communications Private Limited | Private |
| N-2456 | Dr. Vijay Kumar | A Prospective, Multicenter, First-In Man, Pilot Clinical Investigation To Evaluate The Safety And Performance Of The Freedom Total Knee System With Peek-Optima Femoral Component | 15-05-24 | 14-05-27 | Meril Life Sciences India Pvt. Ltd. | Private |
| N-2508 | Dr. Deepam Pushpam | A Prospective, Single-Arm,Open-Label, Multi-center, PhaseI/II Study of the safety and Efficacy of MyCART-01 in Patients with CD-19+ Relapsed or Refractory B cell Malignancies” | 1/10/2024 | 30-09-27 | Micro Crispr Private Limited | Private |
| N2003 | Dr. Sameer Rastogi | A Prospective Open-label, Phase 4 study to Evaluate the safetyof Pembrolizumab (KEYTRUDA® in subjects with Unresectale or Metastatic Melanoma or PD-LI positive Non-small Cell Lung Cancer (NSCLC) in India | 9/9/2019 | 8/9/2025 | MSD ,Pharmaceuticals Pvt. Ltd. | Private |
| N-2383 | Dr. Sameer Rastogi | A Phase3, Randomized, Double-Blind, Active- Comparator- Controlled Clinical Study of Adjuvant MK- 7684A (Vibostolimab with Pembrolizumab) Versus Adjuvant Pembrolizumab in Participants with High-risk Stage II-IV Melanoma(KEY VIBE -010) | 21-09-23 | 20-09-26 | MSD ,Pharmaceuticals Pvt. Ltd. | Private |
| N-2444 | Dr. Prabhat Singh Malik | “ A Phase3, Multi-center, Randomized, Double-Blind Study of MK-7684 with Pembrolizumab as a coformulation (MK-7684A) versus Pembrolizumab Monotherapy as First line treatment for Participants with PD-L1 Positive Metastatic Non small cell lung cancer (KEYVIBE-003) ” | 20-04-24 | 19-04-29 | MSD ,Pharmaceuticals Pvt. Ltd. | Private |
| N-2500 | Dr. Prabhat Singh Malik | A Phase 1, Multicenter, Open-Label, Dose Escalation/ Consolidation Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of Orally Administered JBI-778 in EGFR Mutated Lung Cancer Patients with or without Brain Metastasis, Isocitrate Dehydrogenase (IDH) Mutated WHO Grade ¾ Recurrent Giloma and Adeniod Cystic Carcinoma (ACC)” | 1/11/2024 | 31-10-29 | Navitas Lifesciences Private Limited | Private |
| N-2504 | Dr. Shalimar | A Multi-Centre, Randomized, Open-Label, Phase II Study of Ambrisentan in Patients with Hepatorenal Syndrome | 29-04-24 | 28-04-25 | Nextvel Consulting LLP | Private |
| N-2513 | Dr. Namrata Sharma | A Single Arm, Open Label, Multicenter Clinical Investigation to Evaluate the Clinical Safety and Performance of the CorNeat Keratoprosthesis, for Treatment of Corneal Blindness” | 25-11-24 | 24-11-26 | Nextvel Consulting LLP | Private |
| N1986 | DR. VIVEKA P. JYOTSNA | An open-lable, multi-centre, roll-over to assess long term safety in patients with endogenous Cushing's syndrome who have compleyed a prior Novartis-sponsored osilodrostat (LCI699) study and are judges by the investigator to benifit from continued treatment with osilodrostat | 1/8/2019 | 30-06-25 | NOVARTIS | Private |
| N2250 | DR. NEENA KHANNA | A multi-center, randomized, double-blind, placebo controlled study to investigate the efficacy and safety of ligelizumab (QGE031) in the treatment of Chronic Inducible Urticaria (CINDU) in adults and adolescents inadequately controlled with H1-antihistamines | 1/4/2022 | 30-04-27 | NOVARTIS | Private |
| N2251 | Dr. Neetu Bhari | A Multicenter randomized, double-blind, placebo-controlled phase 3 study of remibrutinib (LOU064) to investigate the efficacy, safety and tolerability for 52 weeks in adult chronic spontaneous urticaria patients inadequately controlled by H1-antihistamines | 1/4/2022 | 25-12-25 | NOVARTIS | Private |
| N2313 | Dr. Arun Kumar S | An adaptive, randomized, double-blind, dose exploration, parallel group, placebo-controlled, multicenter phase 2 trial to evaluate the efficacy, safety and tolerability of LNPO23 in combination with standard-of-care with and without oral corticosteroids in adult patients with active lupus nephritis Class III-IV,+/-V | 15-01-23 | 14-01-26 | NOVARTIS | Private |
| N2135 | Dr. Neetu Bhari | A Multi-center, double-blind, and open-lael extension study to evaluate the efficacy and safety of ligelizumab as retreatment, self-administered and monotherapy in Chronic Spontanaeous Urticaria patients who completed studies CQGE031C2302, CQGE03102303, CQGE031C2202, or CQGE031C1301 | 1/3/2021 | 31-03-26 | Novartis Healthcare Pvt Ltd. | Private |
| N2215 | Dr. Soumita Bagchi | A multi-centre, randomized , double-blind, placebo-controlled, parallel group, phase III study to evaluate the efficacy and safety of LNP023 in primary IgA nephropathy patinets. | 27-10-21 | 28-10-25 | Novartis Healthcare Pvt Ltd. | Private |
| N2243 | Dr. Soumita Bagchi | A multicenter, randomized, double-blind, parallel group, placebo-controlled study to evaluate the efficacy and safety of iptacopan (LNPO23) in complement 3 glomerulopathy | 25-03-22 | 30-03-26 | Novartis Healthcare Pvt Ltd. | Private |
| N2275 | Dr. C.S. Bal | A randomized, double-blind, placebo-controlled Phase III study to evaluate the efficacy and safety of dabrafenib plus trametinib in previously treated patients with locally advanced or metastatic, radio-active iodine refractory BRAFV600E mutation - positive Differentiated Thyroid Cancer | 13-05-22 | 12/5/2026 | Novartis Healthcare Pvt Ltd. | Private |
| N2308 | Dr. Deepam Pushpam | “A prospective, multicenter, open-label, Phase IV, interventional study to assess the safety and efficacy of Capmatinib in Indian patients with mesenchymal epithelial transition (MET) exon 1” | 12/12/2022 | 30-01-26 | Novartis Healthcare Pvt Ltd. | Private |
| N-2479 | Dr. Soumita Bagchi | 'A Multicentre, randomized, double-blind parallel group, placebo-controlled study to evaluate the efficacy and safety of iptacopan (LNPO23) in idiopathic immune complex mediated membranoproliferative glomerulonephritis (IC-MPGN) | 28-04-24 | 27-06-25 | Novartis Healthcare Pvt Ltd. | Private |
| N-2443 | Dr. Neetu Bhari | A global, multicenter, randomized, double-blind, double-dummy, parallel-group, Phase 3b study to assess the efficacy, safety, and tolerability of remibrutinib 25mg b.i.d. in comparison to placebo with omalizumab 300mg every 4 weeks as active control over 52 weeks in adult patients with chronic spontaneous urticaria inadequately controlled by second-generaion H1-antihistamines” | 1/5/2024 | 30-03-27 | Novartis Healthcare Pvt Ltd. | Private |
| N-2506 | DR. UMA KUMAR | A randomized, double-blind, parallel group, placebo-controlled multicenter study to evaluate efficacy, safety and tolerability of ianalumab in participants with diffuse cutaneous systemic sclerosis” | 1/11/2024 | 31-10-25 | Novartis Healthcare Pvt Ltd. | Private |
| N-2525 | Dr. Neetu Bhari | A 52-week multi-center, randomized, double-blind, placebo controlled, basket study with an open-label extension to investigate the efficacy, safety, and tolerability of remibrutinib (LOU064) in chronic Inducible Urticaria (CINDU) in adults inadequately controlled by H1- antihistamines” | 10/1/2025 | 30-06-29 | Novartis Healthcare Pvt Ltd. | Private |
| N-2401 | DR. UMA KUMAR | “A randomized, double-blind, placebo controlled, 3-arm multicenter phase 3 study to assess the efficacy and safety of ianalumab in with active SjÖgren’s syndrome (NEPTUNUS-2)” | 18-07-23 | 31-07-26 | Novartis India Ltd. | Private |
| N2057 | Dr. Ajay Gogia | A phase II randomized study of the combination of Ribociclib plus goserelin acetate with Hormonal Therapy versus physician choice chemotherapy in premenopausal or perimenopausal patients with hormone receptor postive/HER2-negative inoperable locally advanced or metastatic breast cancer-RIGHT Choice Study. | 9/3/2020 | 31-12-25 | Novartis India Pvt Ltd. | Private |
| N-2361 | Dr. Neetu Bhari | A multicenter, double-blind, placebo-controlled, randomized withdrawal and open-label extension study followed by long-term open-label treatment cycles to assess the efficacy, safety and tolerability of remibrutinib (LOU064) in adult chronic spontaneous urticaria patients who completed the preceding remibrutinib Phase 3 studies | 1/7/2023 | 31-03-27 | Novartis Pharmaceuticals | Private |
| N1914 | Dr. Yashdeep Gupta | Effect and safety of semaglutide 2.4 mg once weekly in subjects with overweight or obseity. | 25-10-18 | 31-12-25 | Novo Nordisk India Pvt Ltd. | Private |
| N1977 | DR. NIKHIL TANDON | Long-term effects of semaglutide on diabetic retinopathy in subjects with type 2 diabetes (FOCUS). | 13-06-19 | 31-01-28 | Novo Nordisk India Pvt Ltd. | Private |
| N1989 | DR. RAJESH KHADGAWAT | A Trial comparing the effect and safety of once weekly dosing of somapacitan with daily Norditropin R in children with growth hormone deficiency | 26-07-19 | 25-07-26 | Novo Nordisk India Pvt Ltd. | Private |
| N2037 | DR. NIKHIL TANDON | SOUL_ Semaglutide cardiovascular outcomes trial in patients with type 2 diabetes | 20-11-19 | 19-11-25 | Novo Nordisk India Pvt Ltd. | Private |
| N2053 | DR. TULIKA SETH | NN7415-4311(explorer 7), Efficacy and saftey of concizumab prophylaxis in patient with haemophilia A and B with inhibitors | 14-02-20 | 31-12-25 | Novo Nordisk India Pvt Ltd. | Private |
| N2230 | DR. RAJESH KHADGAWAT | Efficacy and safety of once-daily oral semaglutide 25 mg 50 mg compared with 14 mg in subjects with type 2 diabetes | 1/7/2021 | 3/3/2025 | Novo Nordisk India Pvt Ltd. | Private |
| N-2381 | DR. RAJESH KHADGAWAT | “A Study comparing the effect and safety of once weekly dosing of somapacitan with daily Norditropin® as well as evaluating long – term safety of somapacitan in a basket study design in children with short either born small for gestational age or with turner syndrome, Noonam Syndrome, or idiopathic short stature’’ | 15-10-22 | 14-10-26 | Novo Nordisk India Pvt Ltd. | Private |
| N-2365 | Dr. Rashmi Ramachandran | “Preparing a Centre of Excellence for education of Health professionals” | 1/4/2023 | 31-03-25 | Novo Nordisk India Pvt Ltd. | Private |
| N-2335 | Dr. Sandeep Aggarwal | “Efficacy and safety of cagrilintide s.c. 2.4 mg in combination with semaglutide s.c. 2.4 (CagriSema s.c. 2.4 mg/2.4 mg) once-weekly in participants with overweight of obesity” | 24-04-23 | 23-04-28 | Novo Nordisk India Pvt Ltd. | Private |
| N-2373 | Dr. Yashdeep Gupta | Efficacy and safety of cagrilintide s.c. 2.4 m.g in combination with semaglutide s.c. 2.4 mg (CagriSema s.c. 2.4 mg/2.4) once weekly in participants with overweight or obesity and type 2 diabetes. | 21-06-23 | 20-06-25 | Novo Nordisk India Pvt Ltd. | Private |
| N-2396 | DR. NIKHIL TANDON | NN9838 -4942 The cardiovasular safety of cagrilinitide 2.4 mg s.c in combination with semaglutide 2.4 mg. s.c (Cagrisema 2.4 mg/ 2.4 mg s.c) once – weekly in participants with obesity and established cardiovascular disease “(Redefine 3)” | 9/10/2023 | 8/10/2027 | Novo Nordisk India Pvt Ltd. | Private |
| N-2464 | DR. RAKESH YADAV | ARTEMIS-Effects of ziltivekimab versus placebo on cardiovascular outcomes in patients with acute myocardial infarction. | 1/7/2024 | 31-07-26 | Novo Nordisk India Pvt Ltd. | Private |
| N-2484 | Dr. Ambuj Roy | Athena Effects of Ziltivekimab versus placebo on heart failure symptoms and physical function in patients with heart failure with mildly or reduced preserved ejection fraction and systemic inflammation” | 1/8/2024 | 31-07-27 | Novo Nordisk India Pvt Ltd. | Private |
| N-2509 | DR. SANDEEP SETH | HERMES:Effects of ziltivekimab versus placebo on morbidity and mortality in patients with heart failure with mildly reduced or preserved ejection fraction and systemic inflammation | 8/11/2024 | 7/11/2027 | Novo Nordisk India Pvt Ltd. | Private |
| N1983 | DR. SOMESH GUPTA | Development of artificial intelligence driven mobile phone application for dermatological disease diagnosis to assist non specialists | 16-07-19 | 15-07-29 | Nurithm Private Labs | Private |
| SERB-72 | DR. ROHIT SAXENA | Assessment of magnitude and progression of myopia in urban school going children. | 3/9/2024 | 2/9/2027 | Onesight Essilorluxottica Foundation | Private |
| N-2499 | DR. ROHIT SAXENA | Assessment of Magnitude, Progression and Effective Refractive Error Coverage among School going Children. | 1/11/2024 | 31-10-27 | Onesight Essilorluxottica Foundation | Private |
| N-2491 | Dr. K Aparna Sharma | Role of Artificial Intelligence in Fetal Imaging Workflows; Prospective Evaluation | 1/10/2024 | 30-09-25 | Origin Medical Research Lab India Private Limited | Private |
| T-304 | Dr. Ahitagni Biswas | A Phase III Randomized Controlled study comparing Xerostomia after Tubararial salivary Gland sparing IMRT versus standard IMRT in patients with Locally Advanced Oropharyngeal Squamous cell carcinoma | 1/11/2023 | 31-10-26 | Others | Private |
| N-2496 | DR. SHEFFALI GULATI | Long-term Follow-up of Patients with Spinal Muscular Atrophy Treated with OAV101 IT or OAV101 IV in Clinical Trials” | 26-09-24 | 27-09-39 | Parexel International (India) Private Limited | Private |
| N2325 | DR. SANDEEP SETH | A Phase iv interventional post approval trial to investigate effectiveness and safety of vericiguat therapy in Indian patients with chronic heat failure with reduced ejection fraction after a worsening heart failure event | 25-03-23 | 31-12-26 | PAREXEL INTERNATIONAL Clinical Research Pvt Ltd | Private |
| N-2387 | Dr. Arun Kumar S | “A prospective, interventional, multicenter, Phase IV, open-label, single arm study to assess the safety and effectiveness of finerenone in participants from India with chronic kidney disease associated with type 2 diabetes.” | 2/6/2023 | 1/3/2025 | PAREXEL INTERNATIONAL Clinical Research Pvt Ltd | Private |
| N-2405 | Dr. Saurabh Kedia | A Phase 2b Randomized, Double – blind, Active – and Placebo – controlled, Parallel – group, Multicenter Study to Evaluate the efficacy and safety of Induction and Maintenance Combination Therapy with Guselkumab and Golimumab in Participants with Moderately to severely Active Ulcerative Colitis | 4/12/2023 | 28-02-29 | PAREXEL INTERNATIONAL Clinical Research Pvt Ltd | Private |
| N-2402 | DR. VINEET AHUJA | “A Phase 2b Randomized, Double – blind, Active – and Placebo – controlled, Parallel – group, , Multicenter Study to Evaluate the efficacy and safety of Induction and Maintenance Combination Therapy with Guselkumab and Golimumab in Participants with Moderately to severely Active Colitis Disease | 4/12/2023 | 28-02-29 | PAREXEL INTERNATIONAL Clinical Research Pvt Ltd | Private |
| N-2534 | DR. TULIKA SETH | A Phase 2, Two-Part, Randomized, Double-Blind, Placebo Controlled, Multicenter Study To Evaluate The Efficacy, Safety, And Tolerability Of Subcutaneously Administered Regn7999 (An Inhibitor Of Tmprss6) In Participants With Iron Overload Due To Nontransfusion Dependent- Thalassemia” | 13-12-24 | 12/6/2026 | PAREXEL INTERNATIONAL Clinical Research Pvt Ltd | Private |
| N-2524 | Dr. Divyani Garg | Pan-Indian Registry for Progressive Supranuclear Palsy (PAIR-PSP) | 16-12-24 | 15-12-25 | Parkindon's Research Alliance of India | Private |
| N-2334 | Dr. MD Ray | Evaluation of peri-operative efficacy of Divya-Cystogrit-Diamond capsules as Immunonutrient in patients with Advanced Ovarian Cancer undergoing Cytoreductive Surgery and HIPEC; An open label dual-arm prospective observational clinical study. | 11/4/2023 | 10/4/2025 | Patanjali Research Institute, Haridwar | Private |
| N2293 | DR. RAJESH KHADGAWAT | . A randomized, controlled, multicenter study to evaluate the safety and efficacy of paltusotine in subjects with non-pharmacologically treated aeromegaly” | 3/10/2022 | 8/6/2025 | PHARM-OLAM INTERNATIONAL, LTD. | Private |
| N2310 | DR. SAMEER BAKHSHI | “A Randomized, Open-Label Study of the Efficacy and Safety of Galinpepimut-S (GPS) Maintenance Monotherapy Compared to Investigator’s Choice of Best Available Therapy in Subjects With Acute Myeloid Leukemia Who Have Achieved Complete Remission After Second-Line Salvage Therapy” | 19-12-22 | 31-12-27 | PPD Pharmaceutical Development India Pvt. Ltd. | Private |
| N-2470 | DR. ROHIT SAXENA | A Multi-Centric, Retrospective, Real World Clinical follow-up study to demonstrate the Efficacy, Safety, Acceptability and Quality of Life implications of Essilor Stellest Spectacle Lenses in slowing down Myopia progression in children and adolescents in India” | 16-08-24 | 15-02-26 | ProClin Research Private Limited | Private |
| N2278 | Dr. C.S. Bal | A Prospective, Randomized, Controlled, Open-label, Multicenter Trial to Evaluate Efficacy, Safety and Patient-reported Outcomes of Peptide Receptor Radionuclide Therapy (PRRT) with Lutetium (177Lu) Endotreotide compared to Best Standard of Care in Patients with well-differentiated Aggressive Grade 2 and Grade 3. Somatostatin Receptor-positive (SSTR+), Neuroendocrine Tumors of GastroEnteric or Pancreatic Origin (COMPOSE). | 14-12-21 | 13-12-26 | PSI CRO Pharma India Pvt Ltd | Private |
| N-2447 | DR. VINEET AHUJA | A Phase 2b, Randomized, Double-blind, Placebo- controlled Study to Evaluate the safety and Efficacy of 3 Active Dose Regimens of MORF- 057 in Adults with Moderately to severely Active Ulcerative Colitis (EMERALD-2)” | 24-01-24 | 23-01-26 | PSI CRO Pharma India Pvt Ltd | Private |
| N-2451 | Dr. Pranay Tanwar | A comparative study to evaluate the HPV 16/18 testing of NeuMoDxtm System(s) with Hybrid captures HC2 | 15-05-24 | 14-05-27 | QIAGEN India Private Limited | Private |
| N2229 | DR. SAMEER BAKHSHI | A Phase III, Open-label, Multicenter, Randomized study evaluating the safety and efficacy of Polatuzumab Vedotin in combination with Rituximab plus Gemcitabine plus Oxaliplatin (R-GEMOX) versus R-GEMOX alone in patients with relapsed/refractory diffuse large B-cell Iymphoma” | 13-12-21 | 12/12/2025 | ROCHE Products(India) Pvt Ltd. | Private |
| N-2303 | Dr. Prabhat Singh Malik | Randomized, open label , multicenter, Phase III Study of entrectinib versus crizotinib in patients with locally advanced or metastatic non-small cell lung cancer harboring ros1 gene rearrangements with and without central nervous system metastases | 30-11-22 | 29-11-27 | ROCHE Products(India) Pvt Ltd. | Private |
| N-2343 | Dr. Ajay Gogia | “A Phase IV, Randomized, Multicenter, Open-Label, Crossover study to Evaluate the Safety and Efficacy of Subcutaneous Administration of the Fixes-Dose Combination of Pertuzumab and Trastuzumab (Phesgo) In Indian Patients with Her2-Positive Breast Cancer” | 15-05-23 | 8/6/2025 | ROCHE Products(India) Pvt Ltd. | Private |
| N-2433 | Dr. Aditi Sinha | A phase III, multicenter, single –arm study evaluating the efficacy, safety, Pharmacokinetics, and pharmacodynamics of crovalimab in adult and adolescent patients with atypical hemolytic uremic syndrome (aHUS)” | 18-03-24 | 17-03-28 | ROCHE Products(India) Pvt Ltd. | Private |
| N-2434 | Dr. Aditi Sinha | A phase III, multicenter, single –arm study evaluation the efficacy, safety, Pharmacokinetics, and pharmacodynamics of crovalimab in pediatric patients with atypical hemolytic uremic syndrome (aHUS) | 18-03-24 | 17-03-28 | ROCHE Products(India) Pvt Ltd. | Private |
| N-2419 | Dr. Rakesh Kumar | Clinical validation and operational feasibility study of Swaasa AI platform for detecting likely presence of pulmonary tuberculosis among patients presenting with cough in India | 15-12-23 | 31-03-25 | Salcit Technologies Private Limited | Private |
| N-2429 | Dr. Jyoti Meena | A Phase-IV, single -arm, multicentric study to assess the safety of SIIPL'S qHPV vaccine ((CERVAVAC®) when administered in a two-dose schedule to girls an boys aged 9-14 years and in a three-dose schedule to women and men aged 15-26 years | 1/3/2024 | 28-02-25 | Serum Instt. Of India | Private |
| N2282 | DR. NEERJA GUPTA | A prospective, open-label, multicentre, interventional, single-arm, phase IV study to evaluate the safety and efficacy of agalsidase alfa (r-DNA origin) (Replagal) in Indian children and adults with fabry disease. | 27-06-22 | 26-06-25 | SIRO CLIN PHARMA PVT. LTD | Private |
| N2276 | Dr. Ajay Gogia | ALPelisib INdia Safety Study (ALPINIST): a Phase IV, prospective, multicenter, open-label, non-comparative, interventional study to assess the safety of alpelisib plus fulvestrant, in men and post-menopausal women with HRpositive, HER2-negative, advanced breast cancer (aBC) with a PIK3CA mutation, whose disease has progressed on or after endocrine based treatment | 15-07-22 | 25-07-26 | SIRO CLIN PHARMA PVT. LTD | Private |
| N2289 | Dr. Reeta Mahey | “A Randomized, Parallel-group, Multi-Center, Assessor-blind Phase 3 Study to Compare the Effcacy, Safety and Ease of Use of Two Follicle Stimulating Hormone-Human Recombinant (r-hFSH) 900 IU (66.0ug)/ 1.5mL Solution for Injection in Prefilled Pen (Foligraf®-Manufactured by BSV and Gonal-f® Manufactured by Merck Serono) in Subjects Undergoing Controlled Ovarian Stimulation for Assisted Reproductive Technology [REFRESH]” | 23-09-22 | 30-09-25 | SIRO CLIN PHARMA PVT. LTD | Private |
| N2311 | DR. Manjari Tripathi | “An Open-Label, Prospective, Multicenter, Postmarketing Surveillance (Phase IV) Study to Evaluate the Safety, Tolerability, and Efficacy of Lemborexant in Adult Subjects (Age 18-65 years) With Insomnia in India” | 9/12/2022 | 8/3/2025 | SIRO Clinpharm Pvt. Ltd. | Private |
| N2213 | Dr. Reeta Mahey | Study of Effects and Safety of Gold IUD Copper T375 Au | 1/11/2021 | 31-10-26 | SMB Corporation of India | Private |
| N2309 | Dr. Sachin Khurana | QPT-ORE-005 “A Phase 3, Double-Blind, Placebo-Controlled, Multicenter Clinical Study comparing Chemo-Immunotherapy (Paclitaxel-Carboplatin-Oregovomab) versus Chemotherapy (Paclitaxel-Carboplatin-Placebo) in Patients with Advanced Eqithelial Ovarian, Fallopian Tube or Peritoneal Carcinoma FLORA-5” | 20-10-22 | 19-10-27 | Star Genomics India Private Limited | Private |
| N2258 | Dr. Deepak Gunjan | Standard medical therapy plus Rifaximin Vs. Standard medical therapy alone for the management of Sarcopenia in patients with cirrhosis: A Pilot Randomized controlled trial | 18-04-22 | 17-04-25 | Sun Pharma Laboratories Limited | Private |
| N1712 | Dr. Vivek Gupta | Patterns and pathways of care seeking for cataract and common ocular morbidities and impact of local volunteers on the pathwways among urban vulnerable population settings of West Delhi. | 1/1/2017 | 31-03-25 | Swami Sivananda Memorial Institute | Private |
| N2274 | DR. VINEET AHUJA | “A Multicenter, Single-arm, Open-label, Phase 4 Study to Evaluate the Safety and Efficacy of Vedolizumab in Indian Patients With Ulcerative Colitis and Crohn’s Disease” | 1/3/2022 | 30-06-25 | Takeda Pharmaceuticals India Private Limited | Private |
| N-2428 | DR. SHEFFALI GULATI | Holding hand in magical years: early childhood development & neurorehabilitation centre | 1/4/2023 | 31-03-26 | The Hans Foundation | Private |
| N1922 | DR. RAKESH YADAV | A post marketing surveillance study of Prax A 75 (fixed dose combination capsule containing prasugrel 10mg and aspirin 75mg) in patients with Acute Coronary Syndrome (ACS) who are to be managed with Percutaneous Coronary Intervention (PCI). | 15-11-18 | 31-03-25 | Torrent Pharmaceuticals Ltd | Private |
| N-2448 | Dr. Anubhuti Rana | Evaluation of efficacy and safety of intravenous (IV) ferric carboxymaltose (FCM) in pregnant and postpartum women with mild to moderate iron deficiency anaemia | 1/5/2024 | 30-04-25 | Torrent Pharmaceuticals Ltd | Private |
| N-2453 | Dr. Harshal Ramesh Salve | Development of model for managment of cardiovascular disease at primary and secondary health care setting using artifical intelligence technology in Delhi NCR | 15-05-24 | 14-05-25 | Tricog Health India Private Limited | Private |
| N-2392 | Dr. Ransi Ann Abraham | The impact of co- administration of probiotic Bacillus coagulans Unique IS2 with plant protein on post prandial protein absorption in young adults | 2/11/2023 | 30-04-25 | Unique Biotech Ltd | Private |
| N-2472 | Dr. Manoj K. Tembhre | “A randomized double-blind placebo controlled trial to compare the safety and efficacy of probiotic formulation in Indian patients with Atopic Dermatitis” | 1/8/2024 | 31-07-26 | Unique Biotech Ltd | Private |
| N-2440 | DR. DEEPAK AGRAWAL | A study to assess the utility of an automated transcription of prescription and discharge summary into local languages for all patients admitted in seven AIIMS, India | 15-04-24 | 14-04-27 | VAAG Health Foundation | Private |
| N-2462 | Dr. Ranjit Kumar Sahoo | “A Multicentre, open label, balanced, randomized, two-treatment, four-period, two sequence, full replicate, single dose, cross-over bioequivalence study of Azacitidine 300mg film-coated tablets of MSN Laboratoires Private Limited, India with that of ONUREG (Azacitidine) 300mg film-coated tablets of Bristol-Myers Squibb Pharma Ireland in adult patients with acute myeloid leukemia (AML) in remission phase under fasting condition” | 3/4/2024 | 2/4/2026 | Veeda Clinical reserach Pvt. Ltd. | Private |
| N-2461 | DR. VINEET AHUJA | “A Randomised, double blind, parallel, interventional phase IIa proof of concept trial to evaluate the efficacy and safety of ZYIL1 for the treatment of patients with mild to moderately active Ulcerative colitis resistant or intolerant to oral aminosalicylates” | 20-03-24 | 19-03-26 | Zydus Lifesciences Limited | Private |
Call Us:
Dean (Research)
+91-11-26594483
Associate Dean (Research)
+91-11-26593441
Administrative Officer
+91-11-26593280
Accounts Officer
+91-11-26593273
Stores Officer
+91-11-26596733
Dean (Research) Secretariat
+91-11-29593277
Administrative Wing
+91-11-26594258
Accounts Wing
+91-11-26593554
Stores Wing
+91-11-26594929
IPR & TTD
+91-11-26593741
CCRF
+91-11-26549672